LEONA M & HARRY B HELMSLEY CHARITABLE TRUST: Form 990PF, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- LEONA M & HARRY B HELMSLEY CHARITABLE TRUST (EIN 13-7184401)
- Tax period
- 2022-04-01 to 2023-03-31
- Filed
- 2024-02-06
- IRS object ID
- 202400379349100025
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990-PF
- Accounting Fees Schedule
- All Oth Prog Rltd Investments Sch
- Expenditure Responsibility Stmt
- General Explanation Attachment
- Investments Corp Stock Schedule
- Investments Other Schedule2
- Land Etc Schedule2
- Legal Fees Schedule
- Other Assets Schedule
- Other Decreases Schedule
- Other Expenses Schedule
- Other Income Schedule2
- Other Increases Schedule
- Other Liabilities Schedule
- Other Professional Fees Schedule
- Taxes Schedule
- Transfers Frm Controlled Entities
- Transfers To Controlled Entities
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-02-06T15:26:35-06:00 | ReturnTs |
| Tax Period End | 2023-03-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 873231666 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PKF O'CONNOR DAVIES ADVISORY LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 245 PARK AVENUE 12TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10167 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990PF | ReturnTypeCd |
| Tax Period Begin | 2022-04-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 137184401 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE LEONA M AND HARRY B HELMSLEY | BusinessNameLine1Txt |
| Business Name Line2 | CHARITABLE TRUST | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | LEON | BusinessNameControlTxt |
| Phone | 2126793600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 PARK AVENUE 659 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10169 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | NICHOLAS J SCHIAVO | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 2126793600 | PhoneNum |
| Signature | 2024-02-02 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | NICHOLAS | PersonFirstNm |
| Person Last | SCHIAVO | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | XXX-XX-XXXX | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | THOMAS BLANEY | PreparerPersonNm |
| PTIN | P00234022 | PTIN |
| Phone | 2122862600 | PhoneNum |
| Preparation | 2024-02-02 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990-PF IRS990PF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization501c3 Exempt PF | Yes (X) | Organization501c3ExemptPFInd |
| FMV Assets EOY | $7,256,835,636 | FMVAssetsEOYAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contri Rcvd Rev And Expnss | $1,000 | ContriRcvdRevAndExpnssAmt |
| Schedule B Not Required | Yes (X) | ScheduleBNotRequiredInd |
| Interest On Sav Rev And Expnss | $4,992,185 | InterestOnSavRevAndExpnssAmt |
| Interest On Sav Net Invst Incm | $4,992,185 | InterestOnSavNetInvstIncmAmt |
| Dividends Rev And Expnss | $53,271,499 | DividendsRevAndExpnssAmt |
| Dividends Net Invst Incm | $126,037,349 | DividendsNetInvstIncmAmt |
| Net Gain Sale Ast Rev And Expnss | $533,646,105 | NetGainSaleAstRevAndExpnssAmt |
| Gross Sales Price | $900,001,356 | GrossSalesPriceAmt |
| Cap Gain Net Incm Net Invst Incm | $27,587,383 | CapGainNetIncmNetInvstIncmAmt |
| Other Income Rev And Expnss | $37,222,660 | OtherIncomeRevAndExpnssAmt |
| Other Income Net Invst Incm | $38,655,140 | OtherIncomeNetInvstIncmAmt |
| Total Rev And Expnss | $629,133,449 | TotalRevAndExpnssAmt |
| Total Net Invst Incm | $197,272,057 | TotalNetInvstIncmAmt |
| Comp Ofcr Dir Trst Rev And Expnss | $3,673,306 | CompOfcrDirTrstRevAndExpnssAmt |
| Comp Ofcr Dir Trst Net Invst Incm | $1,664,961 | CompOfcrDirTrstNetInvstIncmAmt |
| Comp Ofcr Dir Trst Dsbrs Chrtbl | $2,043,829 | CompOfcrDirTrstDsbrsChrtblAmt |
| Oth Empl Slrs Wgs Rev And Expnss | $16,867,015 | OthEmplSlrsWgsRevAndExpnssAmt |
| Oth Empl Slrs Wgs Net Invst Incm | $5,442,683 | OthEmplSlrsWgsNetInvstIncmAmt |
| Oth Empl Slrs Wgs Dsbrs Chrtbl | $12,311,957 | OthEmplSlrsWgsDsbrsChrtblAmt |
| Pension Empl Bnft Rev And Expnss | $7,855,693 | PensionEmplBnftRevAndExpnssAmt |
| Pension Empl Bnft Net Invst Incm | $1,747,806 | PensionEmplBnftNetInvstIncmAmt |
| Pension Empl Bnft Dsbrs Chrtbl | $6,013,349 | PensionEmplBnftDsbrsChrtblAmt |
| Legal Fees Rev And Expnss | $488,830 | LegalFeesRevAndExpnssAmt |
| Legal Fees Net Invst Incm | $149,412 | LegalFeesNetInvstIncmAmt |
| Legal Fees Dsbrs Chrtbl | $298,766 | LegalFeesDsbrsChrtblAmt |
| Accounting Fees Rev And Expnss | $919,279 | AccountingFeesRevAndExpnssAmt |
| Accounting Fees Net Invst Incm | $548,119 | AccountingFeesNetInvstIncmAmt |
| Accounting Fees Chrtbl Prps | $320,265 | AccountingFeesChrtblPrpsAmt |
| Other Prof Fees Rev And Expnss | $12,357,121 | OtherProfFeesRevAndExpnssAmt |
| Other Prof Fees Net Invst Incm | $9,749,159 | OtherProfFeesNetInvstIncmAmt |
| Other Prof Fees Dsbrs Chrtbl | $2,541,292 | OtherProfFeesDsbrsChrtblAmt |
| Interest Net Invst Incm | $2,209,414 | InterestNetInvstIncmAmt |
| Taxes Rev And Expnss | $17,178,917 | TaxesRevAndExpnssAmt |
| Taxes Net Invst Incm | $2,824,376 | TaxesNetInvstIncmAmt |
| Taxes Dsbrs Chrtbl | $0 | TaxesDsbrsChrtblAmt |
| Deprec And Dpltn Rev And Expnss | $707,246 | DeprecAndDpltnRevAndExpnssAmt |
| Deprec And Dpltn Net Invst Incm | $47,140 | DeprecAndDpltnNetInvstIncmAmt |
| Occupancy Rev And Expnss | $1,446,314 | OccupancyRevAndExpnssAmt |
| Occupancy Net Invst Incm | $17,574 | OccupancyNetInvstIncmAmt |
| Occupancy Dsbrs Chrtbl | $1,162,258 | OccupancyDsbrsChrtblAmt |
| Trav Conf Meeting Rev And Expnss | $1,821,654 | TravConfMeetingRevAndExpnssAmt |
| Trav Conf Meeting Net Invst Incm | $307,998 | TravConfMeetingNetInvstIncmAmt |
| Trav Conf Meeting Dsbrs Chrtbl | $1,306,913 | TravConfMeetingDsbrsChrtblAmt |
| Other Expenses Rev And Expnss | $17,265,633 | OtherExpensesRevAndExpnssAmt |
| Other Expenses Net Invst Incm | $53,161,789 | OtherExpensesNetInvstIncmAmt |
| Other Expenses Dsbrs Chrtbl | $2,633,118 | OtherExpensesDsbrsChrtblAmt |
| Tot Opr Expenses Rev And Expnss | $80,581,008 | TotOprExpensesRevAndExpnssAmt |
| Tot Opr Expenses Net Invst Incm | $77,870,431 | TotOprExpensesNetInvstIncmAmt |
| Tot Opr Expenses Dsbrs Chrtbl | $28,631,747 | TotOprExpensesDsbrsChrtblAmt |
| Contri Paid Rev And Expnss | $454,329,910 | ContriPaidRevAndExpnssAmt |
| Contri Paid Dsbrs Chrtbl | $433,687,275 | ContriPaidDsbrsChrtblAmt |
| Total Expenses Rev And Expnss | $534,910,918 | TotalExpensesRevAndExpnssAmt |
| Total Expenses Net Invst Incm | $77,870,431 | TotalExpensesNetInvstIncmAmt |
| Total Expenses Dsbrs Chrtbl | $462,319,022 | TotalExpensesDsbrsChrtblAmt |
| Excess Revenue Over Expenses | $94,222,531 | ExcessRevenueOverExpensesAmt |
| Net Investment Income | $119,401,626 | NetInvestmentIncomeAmt |
Form990 PF Balance Sheets Form990PFBalanceSheetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cash BOY | $27,238,568 | CashBOYAmt |
| Cash EOY | $85,800,732 | CashEOYAmt |
| Cash EOYFMV | $85,800,732 | CashEOYFMVAmt |
| Sav And Temp Cash Invst BOY | $53,717,402 | SavAndTempCashInvstBOYAmt |
| Sav And Temp Cash Invst EOY | $143,734,047 | SavAndTempCashInvstEOYAmt |
| Sav And Temp Cash Invst EOYFMV | $143,734,047 | SavAndTempCashInvstEOYFMVAmt |
| Acct Rcvbl | $680,960 | AcctRcvblAmt |
| Acct Rcvbl BOY | $449,759 | AcctRcvblBOYAmt |
| Acct Rcvbl EOY | $680,960 | AcctRcvblEOYAmt |
| Acct Rcvbl EOYFMV | $680,960 | AcctRcvblEOYFMVAmt |
| Prepaid Expenses BOY | $993,143 | PrepaidExpensesBOYAmt |
| Prepaid Expenses EOY | $1,129,528 | PrepaidExpensesEOYAmt |
| Prepaid Expenses EOYFMV | $1,129,528 | PrepaidExpensesEOYFMVAmt |
| Corporate Stock BOY | $591,948,988 | CorporateStockBOYAmt |
| Corporate Stock EOY | $512,806,017 | CorporateStockEOYAmt |
| Corporate Stock EOYFMV | $512,806,017 | CorporateStockEOYFMVAmt |
| Other Investments BOY | $7,406,511,362 | OtherInvestmentsBOYAmt |
| Other Investments EOY | $6,449,780,993 | OtherInvestmentsEOYAmt |
| Other Investments EOYFMV | $6,449,780,993 | OtherInvestmentsEOYFMVAmt |
| Land Bldg Equip Cost Or Other Bss | $9,935,728 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $3,045,409 | LandBldgEquipAccumDeprecAmt |
| Land BOY | $7,299,371 | LandBOYAmt |
| Land EOY | $6,890,319 | LandEOYAmt |
| Land EOYFMV | $6,890,319 | LandEOYFMVAmt |
| Other Assets BOY | $133,517,019 | OtherAssetsBOYAmt |
| Other Assets EOY | $56,013,040 | OtherAssetsEOYAmt |
| Other Assets EOYFMV | $56,013,040 | OtherAssetsEOYFMVAmt |
| Total Assets BOY | $8,221,675,612 | TotalAssetsBOYAmt |
| Total Assets EOY | $7,256,835,636 | TotalAssetsEOYAmt |
| Total Assets EOYFMV | $7,256,835,636 | TotalAssetsEOYFMVAmt |
| Accounts Payable BOY | $12,198,129 | AccountsPayableBOYAmt |
| Accounts Payable EOY | $11,336,884 | AccountsPayableEOYAmt |
| Grants Payable BOY | $462,030,416 | GrantsPayableBOYAmt |
| Grants Payable EOY | $482,673,051 | GrantsPayableEOYAmt |
| Other Liabilities BOY | $42,966,460 | OtherLiabilitiesBOYAmt |
| Other Liabilities EOY | $41,684,887 | OtherLiabilitiesEOYAmt |
| Total Liabilities BOY | $517,195,005 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $535,694,822 | TotalLiabilitiesEOYAmt |
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
| No Donor Rstr Net Assests BOY | $7,704,480,607 | NoDonorRstrNetAssestsBOYAmt |
| No Donor Rstr Net Assests EOY | $6,721,140,814 | NoDonorRstrNetAssestsEOYAmt |
| Tot Net Ast Or Fund Balances BOY | $7,704,480,607 | TotNetAstOrFundBalancesBOYAmt |
| Tot Net Ast Or Fund Balances EOY | $6,721,140,814 | TotNetAstOrFundBalancesEOYAmt |
| Total Liabilities Net Ast BOY | $8,221,675,612 | TotalLiabilitiesNetAstBOYAmt |
| Total Liabilities Net Ast EOY | $7,256,835,636 | TotalLiabilitiesNetAstEOYAmt |
Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Net Ast Or Fund Balances BOY | $7,704,480,607 | TotNetAstOrFundBalancesBOYAmt |
| Excess Revenue Over Expenses | $94,222,531 | ExcessRevenueOverExpensesAmt |
| Other Increases | $15,189,247 | OtherIncreasesAmt |
| Subtotal | $7,813,892,385 | SubtotalAmt |
| Other Decreases | $1,092,751,571 | OtherDecreasesAmt |
| Tot Net Ast Or Fund Balances EOY | $6,721,140,814 | TotNetAstOrFundBalancesEOYAmt |
Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail
Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp (426 entries)
| PropertyPropertyDesc | How AcquiredHowAcquiredCd | Gross Sales PriceGrossSalesPriceAmt | Gain Or LossGainOrLossAmt | Gains Minus Excess Or LossesGainsMinusExcessOrLossesAmt | SoldSoldDt | Cost Or Other BasisCostOrOtherBasisAmt |
|---|---|---|---|---|---|---|
| SALE OF PUBLICLY TRADED SECURITIES | P | $111,466,353 | $111,466,353 | $111,466,353 | ||
| EPIRIS FUND II B LP | P | $108,024 | $108,024 | $108,024 | 2022-11-23 | |
| EPIRIS FUND II B LP | P | $9,097 | $9,097 | $9,097 | 2022-07-06 | |
| EPIRIS FUND II B LP | P | $4,609,105 | $4,609,105 | $4,609,105 | 2022-09-30 | |
| EPIRIS FUND II B LP | P | $35,515 | $35,515 | $35,515 | 2023-02-09 | |
| EPIRIS FUND II B LP | P | $141,155 | $141,155 | $141,155 | 2022-05-03 | |
| ACADIAN FRONTIER MARKETS | P | $436,838 | $436,838 | $436,838 | 2023-02-03 | |
| ACADIAN FRONTIER MARKETS | P | $11,604 | $11,604 | $11,604 | 2023-02-10 | |
| ACADIAN FRONTIER MARKETS | P | $259,155 | $259,155 | $259,155 | 2023-02-17 | |
| FDAF DISLOCATED I LP | P | $1,197,999 | $1,197,999 | $1,197,999 | 2023-01-05 | |
| FRAZIER LIFE SCI PUBLIC FD LP | P | $188,575 | $188,575 | $188,575 | 2023-01-18 | |
| FRAZIER LIFE SCI PUBLIC FD LP | P | $764,109 | $764,109 | $764,109 | 2022-07-08 | |
| FRAZIER LIFE SCI PUBLIC FD LP | P | $686,779 | $686,779 | $686,779 | 2022-04-29 | |
| HIGHCLERE INTL SMID CAP FUND | P | $54,225 | $54,225 | $54,225 | 2022-04-30 | |
| HIGHCLERE INTL SMID CAP FUND | P | $46,174 | $46,174 | $46,174 | 2023-03-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $45,869 | $45,869 | $45,869 | 2023-02-28 | |
| HIGHCLERE INTL SMID CAP FUND | P | $46,852 | $46,852 | $46,852 | 2023-01-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $43,276 | $43,276 | $43,276 | 2022-12-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $38,637 | $38,637 | $38,637 | 2022-10-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $15,000,000 | $15,000,000 | $15,000,000 | 2022-05-06 | |
| HIGHCLERE INTL SMID CAP FUND | P | $45,305 | $45,305 | $45,305 | 2022-05-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $41,627 | $41,627 | $41,627 | 2022-06-30 | |
| HIGHCLERE INTL SMID CAP FUND | P | $43,149 | $43,149 | $43,149 | 2022-07-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $40,710 | $40,710 | $40,710 | 2022-08-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $37,024 | $37,024 | $37,024 | 2022-09-30 | |
| HIGHCLERE INTL SMID CAP FUND | P | $42,487 | $42,487 | $42,487 | 2022-11-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $104,030 | $104,030 | $104,030 | 2022-05-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $98,668 | $98,668 | $98,668 | 2023-03-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $97,462 | $97,462 | $97,462 | 2023-02-28 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $100,508 | $100,508 | $100,508 | 2023-01-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $94,864 | $94,864 | $94,864 | 2022-12-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $93,455 | $93,455 | $93,455 | 2022-11-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $88,541 | $88,541 | $88,541 | 2022-10-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $85,564 | $85,564 | $85,564 | 2022-09-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $95,844 | $95,844 | $95,844 | 2022-08-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $100,604 | $100,604 | $100,604 | 2022-07-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $95,275 | $95,275 | $95,275 | 2022-06-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $15,000,000 | $15,000,000 | $15,000,000 | 2022-05-06 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $115,161 | $115,161 | $115,161 | 2022-04-30 | |
| ACADIAN FRONTIER MARKETS | P | $4,208,062 | $4,208,062 | $4,208,062 | 2022-05-13 | |
| ACADIAN FRONTIER MARKETS | P | $2,990,472 | $2,990,472 | $2,990,472 | 2022-05-20 | |
| ACADIAN FRONTIER MARKETS | P | $1,101,600 | $1,101,600 | $1,101,600 | 2022-05-27 | |
| ACADIAN FRONTIER MARKETS | P | -$443,545 | -$443,545 | 2019-07-01 | $443,545 | |
| ACADIAN FRONTIER MARKETS | P | $243,622 | $243,622 | $243,622 | 2022-06-03 | |
| ACADIAN FRONTIER MARKETS | P | $2,126,548 | $2,126,548 | $2,126,548 | 2022-06-10 | |
| ACADIAN FRONTIER MARKETS | P | $6,592,050 | $6,592,050 | $6,592,050 | 2022-06-17 | |
| ACADIAN FRONTIER MARKETS | P | $687,808 | $687,808 | $687,808 | 2022-07-08 | |
| ACADIAN FRONTIER MARKETS | P | $4,980,132 | $4,980,132 | $4,980,132 | 2022-07-15 | |
| ACADIAN FRONTIER MARKETS | P | $2,228,858 | $2,228,858 | $2,228,858 | 2022-07-22 | |
| ACADIAN FRONTIER MARKETS | P | $1,085,738 | $1,085,738 | $1,085,738 | 2022-07-29 | |
| ACADIAN FRONTIER MARKETS | P | $452,886 | $452,886 | $452,886 | 2022-08-05 | |
| ACADIAN FRONTIER MARKETS | P | $7,131,197 | $7,131,197 | $7,131,197 | 2022-08-12 | |
| ACADIAN FRONTIER MARKETS | P | $1,714,214 | $1,714,214 | $1,714,214 | 2022-09-02 | |
| ACADIAN FRONTIER MARKETS | P | $2,210,663 | $2,210,663 | $2,210,663 | 2022-09-09 | |
| ACADIAN FRONTIER MARKETS | P | $4,804,526 | $4,804,526 | $4,804,526 | 2022-09-23 | |
| ACADIAN FRONTIER MARKETS | P | $856,588 | $856,588 | $856,588 | 2022-06-24 | |
| ACADIAN FRONTIER MARKETS | P | $447,336 | $447,336 | $447,336 | 2022-09-30 | |
| ACADIAN FRONTIER MARKETS | P | $5,111,460 | $5,111,460 | $5,111,460 | 2022-10-11 | |
| ACADIAN FRONTIER MARKETS | P | $2,955,250 | $2,955,250 | $2,955,250 | 2022-10-28 | |
| ACADIAN FRONTIER MARKETS | P | $157,852 | $157,852 | $157,852 | 2022-11-25 | |
| ACADIAN FRONTIER MARKETS | P | $6,349,893 | $6,349,893 | $6,349,893 | 2022-11-14 | |
| ACADIAN FRONTIER MARKETS | P | $1,516,813 | $1,516,813 | $1,516,813 | 2022-11-18 | |
| ACADIAN FRONTIER MARKETS | P | $635,988 | $635,988 | $635,988 | 2022-12-02 | |
| ACADIAN FRONTIER MARKETS | P | $7,055,410 | $7,055,410 | $7,055,410 | 2022-12-09 | |
| ACADIAN FRONTIER MARKETS | P | $3,843,387 | $3,843,387 | $3,843,387 | 2022-12-16 | |
| ACADIAN FRONTIER MARKETS | P | $2,089,676 | $2,089,676 | $2,089,676 | 2022-12-23 | |
| ACADIAN FRONTIER MARKETS | P | $178,059 | $178,059 | $178,059 | 2022-12-30 | |
| ACADIAN FRONTIER MARKETS | P | $519,344 | $519,344 | $519,344 | 2023-01-11 | |
| ACADIAN FRONTIER MARKETS | P | $3,896,492 | $3,896,492 | $3,896,492 | 2023-01-13 | |
| ACADIAN FRONTIER MARKETS | P | $738,170 | $738,170 | $738,170 | 2023-01-20 | |
| ACADIAN FRONTIER MARKETS | P | $8,199,943 | $8,199,943 | $8,199,943 | 2022-04-14 | |
| ACADIAN FRONTIER MARKETS | P | $402,678 | $402,678 | $402,678 | 2022-04-22 | |
| ACADIAN FRONTIER MARKETS | P | $498,861 | $498,861 | $498,861 | 2022-04-29 | |
| BRILLIANT US FEEDER 2 FUND LTD | P | $17,347,230 | -$3,226,948 | -$3,226,948 | 2023-02-24 | $20,574,178 |
| BRILLIANT US FEEDER 2 FUND LTD | P | $14,440,458 | -$6,133,720 | -$6,133,720 | 2022-12-29 | $20,574,178 |
| BRILLIANT US FEEDER 2 FUND LTD | P | $12,196,681 | -$5,180,703 | -$5,180,703 | 2022-11-28 | $17,377,384 |
| BRILLIANT US FEEDER 2 FUND LTD | P | $14,669,169 | -$6,230,913 | -$6,230,913 | 2022-10-31 | $20,900,082 |
| BRILLIANT US FEEDER 2 FUND LTD | P | $15,637,450 | -$4,936,728 | -$4,936,728 | 2023-01-25 | $20,574,178 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,591,814 | $2,591,814 | 2022-11-30 | $2,408,186 |
| CHATHAM CO INVEST | P | $10,000,000 | $5,540,485 | $5,540,485 | 2022-12-31 | $4,459,515 |
| CHATHAM CO INVEST | P | $10,000,000 | $5,979,267 | $5,979,267 | 2023-01-31 | $4,020,733 |
| CHATHAM CO INVEST | P | $10,000,000 | $6,261,869 | $6,261,869 | 2023-02-28 | $3,738,131 |
| CHATHAM CO INVEST | P | $11,230,000 | $7,678,215 | $7,678,215 | 2023-03-31 | $3,551,785 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,591,814 | $2,591,814 | 2022-11-30 | $2,408,186 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,658,269 | $2,658,269 | 2022-10-31 | $2,341,731 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,730,762 | $2,730,762 | 2022-09-30 | $2,269,238 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,692,490 | $2,692,490 | 2022-08-31 | $2,307,510 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,549,037 | $2,549,037 | 2022-07-31 | $2,450,963 |
| CHATHAM CO INVEST | P | $229,186 | $156,700 | $156,700 | 2023-03-31 | $72,486 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,495,903 | $2,495,903 | 2022-06-30 | $2,504,097 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,296,199 | $2,296,199 | 2022-04-30 | $2,703,801 |
| CHATHAM CO INVEST | P | $5,000,000 | $2,349,408 | $2,349,408 | 2022-05-31 | $2,650,592 |
| BLACKROCK US DEBT INDEX FUND B | P | $20,305 | -$3,904 | -$3,904 | 2022-11-02 | $24,209 |
| BLACKROCK US DEBT INDEX FUND B | P | $19,815 | -$2,564 | -$2,564 | 2023-02-08 | $22,379 |
| BLACKROCK US DEBT INDEX FUND B | P | $20,379 | -$1,837 | -$1,837 | 2022-08-01 | $22,216 |
| BLACKROCK US DEBT INDEX FUND B | P | $23,774 | -$2,950 | -$2,950 | 2022-05-06 | $26,724 |
| CHATHAM ASSET PARTNERS HIGH | P | $5,000,000 | $2,221,675 | $2,221,675 | 2022-09-30 | $2,778,325 |
| CHATHAM ASSET PARTNERS HIGH | P | $5,000,000 | $2,177,603 | $2,177,603 | 2022-06-30 | $2,822,397 |
| CHATHAM ASSET HIGH YIELD | P | $5,000,000 | $2,153,393 | $2,153,393 | 2022-06-30 | $2,846,607 |
| CHATHAM ASSET HIGH YIELD | P | $5,000,000 | $2,248,984 | $2,248,984 | 2022-09-30 | $2,751,016 |
| GOLDENTREE OFFSHORE FUND SIDE | P | -$130,055 | -$130,055 | 2022-02-28 | $130,055 | |
| GOLDENTREE OFFSHORE FUND SIDE | P | $130,113 | $130,113 | $130,113 | 2022-02-28 | |
| CAMBER CAPITAL OFFSHORE FUND | P | $30,000,000 | $9,668,546 | $9,668,546 | 2022-12-31 | $20,331,454 |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,216 | $13,216 | $13,216 | 2023-03-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,161 | $13,161 | $13,161 | 2023-01-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $12,853 | $12,853 | $12,853 | 2023-02-28 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $12,571 | $12,571 | $12,571 | 2022-12-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $12,859 | $12,859 | $12,859 | 2022-11-30 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $9,282 | $9,282 | $9,282 | 2022-10-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $11,403 | $11,403 | $11,403 | 2022-09-30 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $12,474 | $12,474 | $12,474 | 2022-08-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $12,885 | $12,885 | $12,885 | 2022-07-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $12,196 | $12,196 | $12,196 | 2022-06-30 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $10,000,000 | $10,000,000 | $10,000,000 | 2022-06-06 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $14,845 | $14,845 | $14,845 | 2022-05-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $15,000,000 | $15,000,000 | $15,000,000 | 2022-05-05 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $17,372 | $17,372 | $17,372 | 2022-04-30 | |
| THE MARATHON-LONDON GLOBAL | P | $63,988 | $7,755 | $7,755 | 2022-12-30 | $56,233 |
| THE MARATHON-LONDON GLOBAL | P | $65,373 | $9,280 | $9,280 | 2022-11-30 | $56,093 |
| THE MARATHON-LONDON GLOBAL | P | $59,405 | $2,438 | $2,438 | 2022-10-31 | $56,967 |
| THE MARATHON-LONDON GLOBAL | P | $62,269 | $5,649 | $5,649 | 2022-08-31 | $56,620 |
| THE MARATHON-LONDON GLOBAL | P | $57,013 | -$386 | -$386 | 2022-09-30 | $57,399 |
| THE MARATHON-LONDON GLOBAL | P | $67,850 | $12,569 | $12,569 | 2023-01-31 | $55,281 |
| THE MARATHON-LONDON GLOBAL | P | $61,049 | $4,177 | $4,177 | 2022-06-30 | $56,872 |
| THE MARATHON-LONDON GLOBAL | P | $65,908 | $9,654 | $9,654 | 2022-05-31 | $56,254 |
| THE MARATHON-LONDON GLOBAL | P | $64,932 | $8,518 | $8,518 | 2022-04-29 | $56,414 |
| THE MARATHON-LONDON GLOBAL | P | $68,480 | $13,567 | $13,567 | 2023-03-31 | $54,913 |
| THE MARATHON-LONDON GLOBAL | P | $66,345 | $10,484 | $10,484 | 2023-02-28 | $55,861 |
| THE MARATHON-LONDON GLOBAL | P | $64,859 | $8,549 | $8,549 | 2022-07-29 | $56,310 |
| LACM WORLD SMALL CAP EQUITY | P | $12,768 | $12,768 | $12,768 | 2022-07-29 | |
| LACM WORLD SMALL CAP EQUITY | P | $11,713 | $11,713 | $11,713 | 2022-06-30 | |
| LACM WORLD SMALL CAP EQUITY | P | $10,000,000 | $10,000,000 | $10,000,000 | 2022-06-06 | |
| LACM WORLD SMALL CAP EQUITY | P | $14,822 | $14,822 | $14,822 | 2022-05-31 | |
| LACM WORLD SMALL CAP EQUITY | P | $15,000,000 | -$12,524,860 | -$12,524,860 | 2022-05-05 | $27,524,860 |
| LACM WORLD SMALL CAP EQUITY | P | $17,216 | -$625,297 | -$625,297 | 2022-04-29 | $642,513 |
| LACM WORLD SMALL CAP EQUITY | P | $12,307 | $12,307 | $12,307 | 2022-08-31 | |
| LACM WORLD SMALL CAP EQUITY | P | $11,452 | $11,452 | $11,452 | 2022-10-31 | |
| LACM WORLD SMALL CAP EQUITY | P | $11,177 | $11,177 | $11,177 | 2022-09-30 | |
| LACM WORLD SMALL CAP EQUITY | P | $12,938 | $12,938 | $12,938 | 2022-11-30 | |
| LACM WORLD SMALL CAP EQUITY | P | $12,559 | $12,559 | $12,559 | 2022-12-30 | |
| LACM WORLD SMALL CAP EQUITY | P | $13,300 | $13,300 | $13,300 | 2023-03-31 | |
| LACM WORLD SMALL CAP EQUITY | P | $13,764 | $13,764 | $13,764 | 2023-01-31 | |
| LACM WORLD SMALL CAP EQUITY | P | $13,609 | $13,609 | $13,609 | 2023-02-28 | |
| RIDGEWOOD ENERGY OIL & GAS FD | P | $51,043 | $51,043 | $51,043 | 2022-09-29 | |
| RIDGEWOOD ENERGY OIL & GAS FD | P | $86,923 | $86,923 | $86,923 | 2022-06-27 | |
| HARBOUR ENERGY FUND LP | P | $437,156 | $437,156 | $437,156 | 2022-12-27 | |
| SEQUOIA CAP CHINA GROWTH IV LP | P | $1,605,960 | $1,605,960 | $1,605,960 | 2022-12-16 | |
| SEQUOIA CAP CHINA GROWTH IV LP | P | $1,589,903 | $1,589,903 | $1,589,903 | 2022-04-22 | |
| MHR INSTITUTIONAL PTNRS IV LP | P | $1,029 | $1,029 | $1,029 | 2022-12-28 | |
| MHR INSTITUTIONAL PTNRS IV LP | P | $727,731 | $727,731 | $727,731 | 2023-02-22 | |
| MHR INSTITUTIONAL PTNRS IV LP | P | $34,416 | $34,416 | $34,416 | 2022-09-30 | |
| MHR INSTITUTIONAL PTNRS IV LP | P | $162,699 | $162,699 | $162,699 | 2022-05-24 | |
| FDAF DISLOCATED II LP | P | $3,314,638 | $3,314,638 | $3,314,638 | 2022-07-08 | |
| COLLER INTL PARTNERS VII LP | P | $1,616,063 | $1,616,063 | $1,616,063 | 2023-03-30 | |
| COLLER INTL PARTNERS VII LP | P | $586,823 | $586,823 | $586,823 | 2023-02-01 | |
| HIG BRAZIL & LATIN AME PTNRS | P | $62,808 | $62,808 | $62,808 | 2022-07-28 | |
| HIG BRAZIL & LATIN AME PTNRS | P | $60,180 | $60,180 | $60,180 | 2022-09-28 | |
| HIG BRAZIL & LATIN AME PTNRS | P | $62,808 | $62,808 | $62,808 | 2022-07-28 | |
| HIG BRAZIL & LATIN AME PTNRS | P | $60,180 | $60,180 | $60,180 | 2022-09-28 | |
| IDG CHINA CAPITAL FUND III LP | P | $563,968 | $563,968 | $563,968 | 2022-08-18 | |
| IDG CHINA CAPITAL FUND III LP | P | -$54,049 | -$54,049 | 2022-12-28 | $54,049 | |
| ORBIMED PRIVATE INVEST VI LP | P | $1,078,047 | $1,078,047 | $1,078,047 | 2022-08-23 | |
| ORBIMED PRIVATE INVEST VI LP | P | $102,313 | $102,313 | $102,313 | 2023-01-12 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $1,304,133 | $1,304,133 | $1,304,133 | 2022-12-14 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $1,410,518 | $1,410,518 | $1,410,518 | 2022-05-27 | |
| ANGELENO INVESTORS III | P | $969,295 | $969,295 | $969,295 | 2022-09-08 | |
| GSO CAPITAL SOLUTION | P | $383,012 | $383,012 | $383,012 | 2023-02-17 | |
| ENERGY FUND XV-A LP | P | $3,128 | $3,128 | $3,128 | 2023-01-06 | |
| ENERGY FUND XV-A LP | P | $173,634 | $173,634 | $173,634 | 2022-08-26 | |
| ENERGY FUND XV-A LP | P | $85,839 | $85,839 | $85,839 | 2022-11-01 | |
| HIG BIOVENTURES II | P | $1,845,838 | $1,845,838 | $1,845,838 | 2023-01-09 | |
| IDG-ACCEL CHINA GROWTH FUND | P | $358,328 | $358,328 | $358,328 | 2022-06-30 | |
| IDG-ACCEL CHINA GROWTH FUND | P | $892,819 | $892,819 | $892,819 | 2023-02-14 | |
| IDG-ACCEL CHINA CAPITAL FUND | P | $1,200,880 | $1,200,880 | $1,200,880 | 2022-09-29 | |
| H.I.G. GROWTH BUYOUTS & EQUITY | P | $962,530 | $962,530 | $962,530 | 2022-06-21 | |
| H.I.G. GROWTH BUYOUTS & EQUITY | P | $2,739,853 | $2,739,853 | $2,739,853 | 2023-02-28 | |
| H.I.G. GROWTH BUYOUTS & EQUITY | P | $5,389,421 | $5,389,421 | $5,389,421 | 2022-05-27 | |
| ACCEL XI | P | $215,852 | $215,852 | $215,852 | 2023-03-31 | |
| COLLER INTERNATIONAL PARTNERS | P | $472,500 | $472,500 | $472,500 | 2022-05-27 | |
| COLLER INTERNATIONAL PARTNERS | P | $343,000 | $343,000 | $343,000 | 2022-06-29 | |
| COLLER INTERNATIONAL PARTNERS | P | $189,000 | $189,000 | $189,000 | 2023-03-28 | |
| COLLER INTERNATIONAL PARTNERS | P | $490,000 | $490,000 | $490,000 | 2022-11-30 | |
| COLLER INTERNATIONAL PARTNERS | P | $354,200 | $354,200 | $354,200 | 2023-01-20 | |
| COLLER INTERNATIONAL PARTNERS | P | $261,845 | $261,845 | $261,845 | 2022-09-30 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $969,235 | $969,235 | $969,235 | 2022-05-27 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $86,130 | $86,130 | $86,130 | 2022-08-31 | |
| SEQUOIA CAP CHINA VENTURE FD | P | $1,793,535 | $1,793,535 | $1,793,535 | 2022-11-03 | |
| SEQUOIA CAPITAL ISRAEL VENTURE | P | $100,508 | $100,508 | $100,508 | 2022-10-07 | |
| GSO CAPITAL SOLUTIONS FUND II | P | $68,808 | $68,808 | $68,808 | 2022-11-14 | |
| GENERAL ATLANTIC SERVICE | P | $5,937,285 | $5,937,285 | $5,937,285 | 2022-05-05 | |
| GENERAL ATLANTIC SERVICE | P | $273,890 | $273,890 | $273,890 | 2022-06-28 | |
| GENERAL ATLANTIC SERVICE | P | $117,654 | $117,654 | $117,654 | 2022-08-10 | |
| GENERAL ATLANTIC SERVICE | P | $488,732 | $488,732 | $488,732 | 2022-09-01 | |
| GENERAL ATLANTIC SERVICE | P | $639,230 | $639,230 | $639,230 | 2022-09-28 | |
| GENERAL ATLANTIC SERVICE | P | $2,041,621 | $2,041,621 | $2,041,621 | 2022-11-15 | |
| GENERAL ATLANTIC SERVICE | P | $493,219 | $493,219 | $493,219 | 2022-12-15 | |
| GENERAL ATLANTIC SERVICE | P | -$66,239 | -$66,239 | 2022-09-09 | $66,239 | |
| GENERAL ATLANTIC SERVICE | P | $657,223 | $657,223 | $657,223 | 2022-09-22 | |
| GENERAL ATLANTIC SERVICE | P | $26,556 | $26,556 | $26,556 | 2022-11-22 | |
| GENERAL ATLANTIC SERVICE | P | $1,088,910 | $1,088,910 | $1,088,910 | 2022-12-01 | |
| GENERAL ATLANTIC SERVICE | P | $314,363 | $314,363 | $314,363 | 2022-12-23 | |
| GENERAL ATLANTIC SERVICE | P | -$520,499 | -$520,499 | 2022-12-28 | $520,499 | |
| GENERAL ATLANTIC SERVICE | P | $1,252,737 | $1,252,737 | $1,252,737 | 2023-02-13 | |
| GENERAL ATLANTIC SERVICE | P | $811,993 | $811,993 | $811,993 | 2022-04-13 | |
| GENERAL ATLANTIC SERVICE | P | $442,504 | $442,504 | $442,504 | 2022-05-13 | |
| HIG CAPITAL PARTNERS V L P | P | $313,965 | $313,965 | $313,965 | 2022-04-27 | |
| HIG CAPITAL PARTNERS V L P | P | $316,366 | $316,366 | $316,366 | 2022-09-19 | |
| HIG CAPITAL PARTNERS V L P | P | $1,134,270 | $1,134,270 | $1,134,270 | 2022-10-31 | |
| HIG CAPITAL PARTNERS V L P | P | $1,456,647 | $1,456,647 | $1,456,647 | 2022-12-09 | |
| HIG CAPITAL PARTNERS V L P | P | $3,483,920 | $3,483,920 | $3,483,920 | 2023-01-26 | |
| EIG ENERGY FUND XVI LP | P | $3,250,586 | $3,250,586 | $3,250,586 | 2022-05-31 | |
| CRESTVIEW PARTNERS III LP | P | $329,312 | $329,312 | $329,312 | 2022-10-31 | |
| CRESTVIEW PARTNERS III LP | P | $1,766,140 | $1,766,140 | $1,766,140 | 2023-01-13 | |
| HIG MIDDLE MKT LBO FD II LP | P | $327,477 | $327,477 | $327,477 | 2022-05-16 | |
| ACCEL XII LP | P | $549,404 | $549,404 | $549,404 | 2022-09-12 | |
| ACCEL GROWTH FUND III LP | P | $2,295,401 | $2,295,401 | $2,295,401 | 2023-01-24 | |
| ACCEL GROWTH FUND III LP | P | $338,994 | $338,994 | $338,994 | 2023-03-31 | |
| SEQUOIA CAP CHINA GROWTH FD | P | $1,525,192 | $1,525,192 | $1,525,192 | 2022-12-14 | |
| BAYVIEW OPPORTUNITY OFFSHORE | P | $5,346,389 | $5,346,389 | $5,346,389 | 2022-12-15 | |
| BAYVIEW OPPORTUNITY OFFSHORE | P | $15,122,989 | $15,122,989 | $15,122,989 | 2022-09-13 | |
| BAYVIEW OPPORTUNITY OFFSHORE | P | $32,962,679 | $32,962,679 | $32,962,679 | 2022-05-13 | |
| BAYVIEW OPPORTUNITY OFFSHORE | P | $1,735,120 | $1,735,120 | $1,735,120 | 2022-04-13 | |
| BAYVIEW OPPORTUNITY OFFSHORE | P | $1,000,000 | $1,000,000 | $1,000,000 | 2022-05-13 | |
| BAYVIEW OPPORTUNITY OFFSHORE | P | $5,021,099 | $5,021,099 | $5,021,099 | 2022-06-15 | |
| BAYVIEW OPPORTUNITY OFFSHORE | P | $535,409 | $535,409 | $535,409 | 2022-11-15 | |
| GAVEA INVESTMENT FUND V B LP | P | $945,261 | $945,261 | $945,261 | 2022-09-27 | |
| GAVEA INVESTMENT FUND V B LP | P | $1,234,873 | $1,234,873 | $1,234,873 | 2022-04-19 | |
| GAVEA INVESTMENT FUND V B LP | P | $209,845 | $209,845 | $209,845 | 2022-06-24 | |
| GAVEA INVESTMENT FUND V B LP | P | $404,145 | $404,145 | $404,145 | 2022-08-25 | |
| GAVEA INVESTMENT FUND V B LP | P | $361,684 | $361,684 | $361,684 | 2022-12-27 | |
| FRAZIER LIFE SCIENCES X LP | P | $272,754 | $272,754 | $272,754 | 2022-04-28 | |
| FRAZIER LIFE SCIENCES X LP | P | $156,427 | $156,427 | $156,427 | 2022-07-08 | |
| ORBIMED ASIA PARTNERS IV LP | P | $1,400,360 | $1,400,360 | $1,400,360 | 2022-08-05 | |
| SEQUOIA CAP US GR FUND IX LP | P | $51,823 | $51,823 | $51,823 | 2022-09-07 | |
| PEG SECONDARY PE INVESTORS III | P | $69,059 | $69,059 | $69,059 | 2022-12-23 | |
| PEG SECONDARY PE INVESTORS III | P | $103,515 | $103,515 | $103,515 | 2022-04-25 | |
| FDAF DISLOCATED III LP | P | $3,350,383 | $3,350,383 | $3,350,383 | 2022-04-14 | |
| FDAF DISLOCATED III LP | P | $510,163 | $510,163 | $510,163 | 2022-12-08 | |
| FDAF DISLOCATED III LP | P | $3,812,352 | $3,812,352 | $3,812,352 | 2022-07-08 | |
| GSO CAPITAL SOLUTIONS FD III | P | $8,074 | $8,074 | $8,074 | 2022-09-01 | |
| GSO CAPITAL SOLUTIONS FD III | P | $138,797 | $138,797 | $138,797 | 2022-04-07 | |
| GSO CAPITAL SOLUTIONS FD III | P | $574 | $574 | $574 | 2022-06-07 | |
| GSO CAPITAL SOLUTIONS FD III | P | $4,767 | $4,767 | $4,767 | 2023-03-13 | |
| GSO CAPITAL SOLUTIONS FD III | P | $125,153 | $125,153 | $125,153 | 2022-10-19 | |
| GSO CAPITAL SOLUTIONS FD III | P | $2,897 | $2,897 | $2,897 | 2022-12-06 | |
| IDG CHINA VENTURE CAPITAL V LP | P | -$29,910 | -$29,910 | 2022-05-31 | $29,910 | |
| EIG ENERGY FD XVII LP | P | $13,967 | $13,967 | $13,967 | 2022-12-16 | |
| EIG ENERGY FD XVII LP | P | -$13,967 | -$13,967 | 2022-12-16 | $13,967 | |
| EIG ENERGY FD XVII LP | P | $651,863 | $651,863 | $651,863 | 2022-05-27 | |
| FRAZIER LIFE SCIENCES IX LP | P | $89,357 | $89,357 | $89,357 | 2023-01-25 | |
| FRAZIER LIFE SCIENCES IX LP | P | -$324,425 | -$324,425 | 2022-08-31 | $324,425 | |
| S CAPITAL LP | P | $1,151,735 | $1,151,735 | $1,151,735 | 2022-12-27 | |
| ORBIMED PRIVATE INVEST VII LP | P | $4,443,455 | $4,443,455 | $4,443,455 | 2022-07-08 | |
| GAVEA INVEST FD V PLUS B LP | P | $79,169 | $79,169 | $79,169 | 2022-12-23 | |
| SEQUOIA CAP CN VENT FD VII LP | P | $527,957 | $527,957 | $527,957 | 2022-12-14 | |
| SEQUOIA CAP CHINA GR FD V LP | P | $261,116 | $261,116 | $261,116 | 2022-12-14 | |
| GA MANAGED ACCOUNT PROGRAM | P | $33,497 | $33,497 | $33,497 | 2022-08-03 | |
| GA MANAGED ACCOUNT PROGRAM | P | $175,604 | $175,604 | $175,604 | 2022-06-14 | |
| GA MANAGED ACCOUNT PROGRAM | P | $177,058 | $177,058 | $177,058 | 2022-06-08 | |
| GA MANAGED ACCOUNT PROGRAM | P | $51,142 | $51,142 | $51,142 | 2023-03-16 | |
| GA MANAGED ACCOUNT PROGRAM | P | $301,585 | $301,585 | $301,585 | 2022-12-30 | |
| GA MANAGED ACCOUNT PROGRAM | P | $63,221 | $63,221 | $63,221 | 2022-12-22 | |
| GA MANAGED ACCOUNT PROGRAM | P | $11,664 | $11,664 | $11,664 | 2022-11-22 | |
| GA MANAGED ACCOUNT PROGRAM | P | $40,618 | $40,618 | $40,618 | 2022-11-01 | |
| GA MANAGED ACCOUNT PROGRAM | P | $122,530 | $122,530 | $122,530 | 2022-09-26 | |
| GA MANAGED ACCOUNT PROGRAM | P | $4,251 | $4,251 | $4,251 | 2022-08-10 | |
| GA MANAGED ACCOUNT PROGRAM | P | $317,252 | $317,252 | $317,252 | 2023-03-09 | |
| CRESTVIEW PARTNERS IV LP | P | $139,853 | $139,853 | $139,853 | 2023-01-06 | |
| CRESTVIEW PARTNERS IV LP | P | $506,346 | $506,346 | $506,346 | 2022-06-30 | |
| FRAZIER LIFE SCIENCES XI LP | P | $127,727 | $127,727 | $127,727 | 2023-01-26 | |
| FRAZIER LIFE SCI PUBLIC | P | $370,586 | $370,586 | $370,586 | 2023-01-18 | |
| IDG CHINA VENTURE CAP FD IV LP | P | -$108,071 | -$108,071 | 2022-12-28 | $108,071 | |
| PEG SECONDARY PE INVESTORS LLC | P | -$1,638,552 | -$1,638,552 | 2022-01-18 | $1,638,552 | |
| PEG SECONDARY PE INVESTORS LLC | P | $1,638,552 | $1,638,552 | $1,638,552 | 2022-01-18 | |
| HARBOUR ENERGY FUND LP | P | $162,213,018 | $162,213,018 | $162,213,018 | 2022-07-08 | |
| HARBOUR ENERGY FUND LP | P | -$109,064,493 | -$109,064,493 | 2022-07-08 | $109,064,493 | |
| SEQUOIA CAP CHINA GROWTH IV LP | P | $665,612 | $665,612 | $665,612 | 2022-06-02 | |
| SEQUOIA CAP CHINA GROWTH IV LP | P | $635,410 | $635,410 | $635,410 | 2022-06-01 | |
| SEQUOIA CAP CHINA GROWTH IV LP | P | $635,410 | $635,410 | $635,410 | 2022-05-31 | |
| SEQUOIA CAP CHINA GROWTH IV LP | P | -$635,410 | -$635,410 | 2022-06-01 | $635,410 | |
| VENTURE LENDING & LEASING VIII | P | $100,731 | $100,731 | $100,731 | 2022-09-15 | |
| SEQUOIA CAP US GROWTH FD VII | P | $59,414 | $59,414 | $59,414 | 2023-03-28 | |
| SEQUOIA CAP US GROWTH FD VII | P | $168,955 | $168,955 | $168,955 | 2023-03-07 | |
| SEQUOIA CAP US GROWTH FD VII | P | $168,229 | $168,229 | $168,229 | 2023-02-14 | |
| SEQUOIA CAP US GROWTH FD VII | P | $160,406 | $160,406 | $160,406 | 2023-02-02 | |
| SEQUOIA CAP US GROWTH FD VII | P | $383,070 | $383,070 | $383,070 | 2022-12-12 | |
| SEQUOIA CAP US GROWTH FD VII | P | $157,945 | $157,945 | $157,945 | 2023-02-28 | |
| SEQUOIA CAP US GROWTH FD VII | P | $133,782 | $133,782 | $133,782 | 2022-11-30 | |
| SEQUOIA CAP US GROWTH FD VII | P | $21,360 | $21,360 | $21,360 | 2022-05-06 | |
| SEQUOIA CAP US GROWTH FD VII | P | $33,421 | $33,421 | $33,421 | 2022-08-05 | |
| SEQUOIA CAP US GROWTH FD VII | P | $199,587 | $199,587 | $199,587 | 2022-08-15 | |
| SEQUOIA CAP US GROWTH FD VII | P | $482,725 | $482,725 | $482,725 | 2022-09-09 | |
| SEQUOIA CAP US GROWTH FD VII | P | $121,882 | $121,882 | $121,882 | 2022-11-10 | |
| SEQUOIA CAP US GROWTH FD VII | P | $83,138 | $83,138 | $83,138 | 2022-12-09 | |
| SEQUOIA CAP US GROWTH FD VII | P | $1 | $1 | $1 | 2022-11-10 | |
| SEQUOIA CAP US GROWTH FD VII | P | $66,073 | $66,073 | $66,073 | 2023-03-31 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $253,159 | $253,159 | $253,159 | 2022-05-06 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $478,985 | $478,985 | $478,985 | 2023-03-07 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $447,146 | $447,146 | $447,146 | 2023-02-28 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $408,252 | $408,252 | $408,252 | 2022-08-05 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $413,953 | $413,953 | $413,953 | 2022-06-02 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $391,481 | $391,481 | $391,481 | 2022-05-31 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $391,481 | $391,481 | $391,481 | 2022-06-01 | |
| SEQUOIA CAP GBL GROWTH FD II | P | -$391,481 | -$391,481 | 2022-06-01 | $391,481 | |
| ACCEL LEADERS FUND LP | P | $542,803 | $542,803 | $542,803 | 2022-04-13 | |
| ACCEL GROWTH FD IV LP | P | $635,287 | $635,287 | $635,287 | 2023-02-07 | |
| ACCEL GROWTH FD IV LP | P | $411,921 | $411,921 | $411,921 | 2023-01-23 | |
| SEQUOIA CAPITAL U.S. GROWTH | P | $565,022 | $565,022 | $565,022 | 2022-05-06 | |
| SEQUOIA CAPITAL U.S. GROWTH | P | $909,173 | $909,173 | $909,173 | 2022-05-25 | |
| AH PARALLEL FUND III LP | P | $606,504 | $606,504 | $606,504 | 2022-05-25 | |
| ANDREESSEN HOROWITZ FD III LP | P | $1,027,581 | $1,027,581 | $1,027,581 | 2022-05-25 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $206,335 | $206,335 | $206,335 | 2022-08-05 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $950,313 | $950,313 | $950,313 | 2022-08-05 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $88,965 | $88,965 | $88,965 | 2023-02-28 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $884,407 | $884,407 | $884,407 | 2022-05-25 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $1,048,917 | $1,048,917 | $1,048,917 | 2022-05-25 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $123,364 | $123,364 | $123,364 | 2022-05-25 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $172,514 | $172,514 | $172,514 | 2022-05-06 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $1,134,279 | $1,134,279 | $1,134,279 | 2022-05-06 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $433,171 | $433,171 | $433,171 | 2023-03-07 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $901,021 | $901,021 | $901,021 | 2022-12-02 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $1,015,853 | $1,015,853 | $1,015,853 | 2023-02-28 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $1,001,349 | $1,001,349 | $1,001,349 | 2022-08-24 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $406,774 | $406,774 | $406,774 | 2023-02-18 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $1,056,367 | $1,056,367 | $1,056,367 | 2023-02-15 | |
| SEQUOIA CAPITAL U.S. VENTURE | P | $966,912 | $966,912 | $966,912 | 2022-11-16 | |
| VENTURE LENDING & LEASING VII | P | $322,991 | $322,991 | $322,991 | 2022-09-15 | |
| PEG SECONDARY PE INVESTORS II | P | $1,943,541 | $1,943,541 | $1,943,541 | 2022-01-18 | |
| PEG SECONDARY PE INVESTORS II | P | -$1,943,541 | -$1,943,541 | 2022-01-18 | $1,943,541 | |
| THE SILCHESTER INTERNATIONAL | P | $70,505 | $3,676 | $3,676 | 2022-04-29 | $66,829 |
| THE SILCHESTER INTERNATIONAL | P | $70,921 | $4,230 | $4,230 | 2022-05-31 | $66,691 |
| THE SILCHESTER INTERNATIONAL | P | $69,694 | $8,722 | $8,722 | 2023-03-31 | $60,972 |
| THE SILCHESTER INTERNATIONAL | P | $69,099 | $7,955 | $7,955 | 2023-02-28 | $61,144 |
| THE SILCHESTER INTERNATIONAL | P | $69,625 | $8,572 | $8,572 | 2023-01-31 | $61,053 |
| THE SILCHESTER INTERNATIONAL | P | $65,942 | $3,939 | $3,939 | 2022-12-30 | $62,003 |
| THE SILCHESTER INTERNATIONAL | P | $64,682 | $2,301 | $2,301 | 2022-11-30 | $62,381 |
| THE SILCHESTER INTERNATIONAL | P | $59,435 | -$4,627 | -$4,627 | 2022-10-31 | $64,062 |
| THE SILCHESTER INTERNATIONAL | P | $10,000,000 | $682,748 | $682,748 | 2022-06-06 | $9,317,252 |
| THE SILCHESTER INTERNATIONAL | P | $63,211 | $232 | $232 | 2022-06-30 | $62,979 |
| THE SILCHESTER INTERNATIONAL | P | $64,486 | $1,912 | $1,912 | 2022-07-29 | $62,574 |
| THE SILCHESTER INTERNATIONAL | P | $61,994 | -$1,289 | -$1,289 | 2022-08-31 | $63,283 |
| THE SILCHESTER INTERNATIONAL | P | $57,858 | -$6,813 | -$6,813 | 2022-09-30 | $64,671 |
| ACCEL XII LP | P | $496,351 | $496,351 | $496,351 | 2023-01-23 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $335,547 | $335,547 | $335,547 | 2023-02-18 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $349,095 | $349,095 | $349,095 | 2023-02-15 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $262,830 | $262,830 | $262,830 | 2022-09-09 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $296,259 | $296,259 | $296,259 | 2022-12-02 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $11,205 | $11,205 | $11,205 | 2022-12-06 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $152,484 | $152,484 | $152,484 | 2023-03-07 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $317,935 | $317,935 | $317,935 | 2022-11-16 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $8,446 | $8,446 | $8,446 | 2022-12-12 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $284,920 | $284,920 | $284,920 | 2023-02-28 | |
| ANDREESSEN HOROWITZ FD IV LP | P | $443,562 | $443,562 | $443,562 | 2022-09-06 | |
| SEQUOIA CAP US GR FD VIII LP | P | $20,548 | $20,548 | $20,548 | 2022-11-10 | |
| SEQUOIA CAP US GR FD VIII LP | P | $23,961 | $23,961 | $23,961 | 2022-11-30 | |
| SEQUOIA CAP US GR FD VIII LP | P | $31,600 | $31,600 | $31,600 | 2023-02-02 | |
| SEQUOIA CAP US GR FD VIII LP | P | $53,320 | $53,320 | $53,320 | 2023-03-28 | |
| SEQUOIA CAP US GR FD VIII LP | P | $63,483 | $63,483 | $63,483 | 2023-03-31 | |
| SEQUOIA CAP US GR FD VIII LP | P | $42,840 | $42,840 | $42,840 | 2022-08-15 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $1,470,885 | $1,470,885 | $1,470,885 | 2022-09-09 | |
| SEQUOIA CAPITAL GLOBAL GROWTH | P | $1,154,086 | $1,154,086 | $1,154,086 | 2022-12-12 | |
| MHR LONGEVITY FUND LP | P | $2,969,326 | $454,900 | $454,900 | 2022-05-02 | $2,514,426 |
| MHR LONGEVITY FUND LP | P | $2,499,792 | $431,670 | $431,670 | 2022-02-18 | $2,068,122 |
| MHR LONGEVITY FUND LP | P | $6,449,504 | $1,057,361 | $1,057,361 | 2022-08-08 | $5,392,143 |
| SEQUOIA CAPITAL FUND | P | $21,038 | -$4,095 | -$4,095 | 2022-11-30 | $25,133 |
| SEQUOIA CAPITAL FUND | P | $159,018 | -$35,979 | -$35,979 | 2022-07-31 | $194,997 |
| SEQUOIA CAPITAL FUND | P | $47,705 | -$10,794 | -$10,794 | 2022-08-26 | $58,499 |
| SEQUOIA CAPITAL FUND | P | $333,938 | -$75,555 | -$75,555 | 2022-09-20 | $409,493 |
| SEQUOIA CAPITAL FUND | P | $21,038 | -$4,175 | -$4,175 | 2022-10-21 | $25,213 |
| SEQUOIA CAPITAL FUND | P | $21,038 | -$2,997 | -$2,997 | 2023-03-31 | $24,035 |
| SEQUOIA CAPITAL FUND | P | $524,759 | -$104,135 | -$104,135 | 2022-10-21 | $628,894 |
| SEQUOIA CAPITAL FUND | P | $524,759 | -$102,145 | -$102,145 | 2022-11-04 | $626,904 |
| SEQUOIA CAPITAL FUND | P | $178,050 | -$34,658 | -$34,658 | 2022-11-30 | $212,708 |
| SEQUOIA CAPITAL FUND | P | $79,509 | -$15,477 | -$15,477 | 2022-11-30 | $94,986 |
| SEQUOIA CAPITAL FUND | P | $21,038 | -$4,760 | -$4,760 | 2022-08-26 | $25,798 |
| SEQUOIA CAPITAL FUND | P | $21,038 | -$3,758 | -$3,758 | 2022-12-31 | $24,796 |
| SEQUOIA CAPITAL FUND | P | $21,038 | -$3,758 | -$3,758 | 2023-01-31 | $24,796 |
| IRON POINT RE PARTNERS IV LP | P | $253,320 | $253,320 | $253,320 | 2023-03-29 | |
| IRON POINT RE PARTNERS IV LP | P | $738,305 | $738,305 | $738,305 | 2022-11-30 | |
| IRON POINT RE PARTNERS IV LP | P | $490,226 | $490,226 | $490,226 | 2022-07-29 | |
| IRON POINT RE PARTNERS IV LP | P | $1,533,567 | $1,533,567 | $1,533,567 | 2022-05-31 | |
| ACADIAN FRONTIER | P | -$519,621 | -$519,621 | 2022-11-30 | $519,621 | |
| ACADIAN FRONTIER | P | -$604,199 | -$604,199 | 2023-02-28 | $604,199 | |
| ACADIAN FRONTIER | P | -$656,749 | -$656,749 | 2022-10-31 | $656,749 | |
| ACADIAN FRONTIER | P | -$63,133 | -$63,133 | 2023-01-31 | $63,133 | |
| ACADIAN FRONTIER | P | -$57,826 | -$57,826 | 2023-02-28 | $57,826 | |
| ACADIAN FRONTIER | P | -$29,950 | -$29,950 | 2023-03-31 | $29,950 | |
| ACADIAN FRONTIER | P | -$41,642 | -$41,642 | 2023-02-28 | $41,642 | |
| ACADIAN FRONTIER | P | -$466 | -$466 | 2023-03-31 | $466 | |
| ACADIAN FRONTIER | P | $519,621 | $519,621 | $519,621 | 2022-10-31 | |
| ACADIAN FRONTIER | P | $8,264,216 | $8,264,216 | $8,264,216 | 2022-09-30 | |
| ACADIAN FRONTIER | P | $1,745,328 | $1,745,328 | $1,745,328 | 2022-10-31 | |
| ACADIAN FRONTIER | P | $1,948,974 | $1,948,974 | $1,948,974 | 2022-11-30 | |
| ACADIAN FRONTIER | P | -$4,168,430 | -$4,168,430 | 2022-12-31 | $4,168,430 | |
| ACADIAN FRONTIER | P | $733,825 | $733,825 | $733,825 | 2023-01-31 | |
| ACADIAN FRONTIER | P | $24,294 | $24,294 | $24,294 | 2023-03-31 | |
| ACADIAN FRONTIER | P | $944,347 | $944,347 | $944,347 | 2022-09-30 | |
| ACADIAN FRONTIER | P | $243,597 | $243,597 | $243,597 | 2022-11-30 | |
| ACADIAN FRONTIER | P | $261,840 | $261,840 | $261,840 | 2022-12-31 | |
| ACADIAN FRONTIER | P | $7,431 | $7,431 | $7,431 | 2022-09-30 | |
| ACADIAN FRONTIER | P | $31,709 | $31,709 | $31,709 | 2022-10-31 | |
| ACADIAN FRONTIER | P | $91,239 | $91,239 | $91,239 | 2022-11-30 | |
| ACADIAN FRONTIER | P | -$118,517 | -$118,517 | 2022-12-31 | $118,517 | |
| ACADIAN FRONTIER | P | $30,469 | $30,469 | $30,469 | 2023-01-31 | |
| ARBORETUM IV | P | $4,818,402 | $4,818,402 | $4,818,402 | 2022-04-28 | |
| ARBORETUM IV | P | $147,954 | $147,954 | $147,954 | 2023-02-13 | |
| GENERL ATLANTIC 2013 | P | $96,864 | $96,864 | $96,864 | 2022-06-28 | |
| GENERL ATLANTIC 2013 | P | $136,841 | $136,841 | $136,841 | 2022-09-01 | |
| GENERL ATLANTIC 2013 | P | $187,531 | $187,531 | $187,531 | 2023-02-13 | |
| CRESTVIEW III | P | $456,641 | $456,641 | $456,641 | 2022-10-31 | |
| CRESTVIEW III | P | $184,847 | $184,847 | $184,847 | 2023-01-13 | |
| FORTISSIMO V | P | $696,000 | $696,000 | $696,000 | 2022-09-29 | |
| FORTISSIMO V | P | $480,000 | $480,000 | $480,000 | 2023-01-04 | |
| GENERL ATLANTIC 2018 | P | -$85,399 | -$85,399 | 2022-09-09 | $85,399 | |
| GENERL ATLANTIC 2018 | P | $18,218 | $18,218 | $18,218 | 2022-09-22 | |
| GENERL ATLANTIC 2018 | P | $34,150 | $34,150 | $34,150 | 2022-09-26 | |
| GENERL ATLANTIC 2018 | P | $138,544 | $138,544 | $138,544 | 2023-02-27 | |
| CRESTVIEW IV | P | $2,074,447 | $2,074,447 | $2,074,447 | 2022-06-30 | |
| CRESTVIEW IV | P | $626,024 | $626,024 | $626,024 | 2023-01-06 | |
| GOLDEN GATE CAPITAL OPPORTUNITY FUND | P | -$13,138,789 | -$13,138,789 | $13,138,789 | ||
| NEWPORT CARRY LP | P | $118,414 | $118,414 | $118,414 | ||
| FDAF DISLOCATED I | P | -$423,557 | -$423,557 | $423,557 | ||
| GSO I | P | -$1,184,353 | -$1,184,353 | $1,184,353 | ||
| HARBOUR ENERGY FUND LP | P | -$213,604,729 | -$213,604,729 | $213,604,729 | ||
| ACADIAN FRONTIER | P | -$5,261,285 | -$5,261,285 | |||
| K-1 ADJUSTMENTS, NET OF UBI AND RELATED AMOUNTS ABOVE | P | -$296,309,383 | -$296,309,383 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Capital Gain Net Income | $27,587,383 | CapitalGainNetIncomeAmt |
Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Income Excise Tax | $1,659,683 | InvestmentIncomeExciseTaxAmt |
| Tax Under Section511 | $0 | TaxUnderSection511Amt |
| Subtotal | $1,659,683 | SubtotalAmt |
| Subtitle A Tax | $0 | SubtitleATaxAmt |
| Tax Based On Investment Income | $1,659,683 | TaxBasedOnInvestmentIncomeAmt |
| Estimated Plus Ovpmt Incm Tx | $16,183,219 | EstimatedPlusOvpmtIncmTxAmt |
| Exempt Frgn Org Tax Wthld At Srce | $0 | ExemptFrgnOrgTaxWthldAtSrceAmt |
| Extsn Request Income Tax Paid | $2,500,000 | ExtsnRequestIncomeTaxPaidAmt |
| Backup Withholding Withheld | $0 | BackupWithholdingWithheldAmt |
| Total Payments And Credits | $18,683,219 | TotalPaymentsAndCreditsAmt |
| Form2220 Attached | Yes (X) | Form2220AttachedInd |
| Es Penalty | $0 | EsPenaltyAmt |
| Overpayment | $17,023,536 | OverpaymentAmt |
| Applied To ES Tax | $7,023,536 | AppliedToESTaxAmt |
| Refund | $10,000,000 | RefundAmt |
Statements Regarding Acty StatementsRegardingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Legislative Political Acty | 0 | LegislativePoliticalActyInd |
| More Than100 Spent | 0 | MoreThan100SpentInd |
| Form1120 POL Filed | 0 | Form1120POLFiledInd |
| Section4955 Organization Tax | $0 | Section4955OrganizationTaxAmt |
| Section4955 Managers Tax | $0 | Section4955ManagersTaxAmt |
| Tax Reimbursed | $0 | TaxReimbursedAmt |
| Activities Not Previously Rpt | 0 | ActivitiesNotPreviouslyRptInd |
| Changes To Articles Or Bylaws | 0 | ChangesToArticlesOrBylawsInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Organization Dissolved Etc | 0 | OrganizationDissolvedEtcInd |
| Section508e Rqr Satisfied | Yes (1) | Section508eRqrSatisfiedInd |
| At Least5000 In Assets | Yes (1) | AtLeast5000InAssetsInd |
| Org Report Or Register State | NY | OrgReportOrRegisterStateCd |
| Form990 PF Filed With Atty Gen | Yes (1) | Form990PFFiledWithAttyGenInd |
| Private Operating Foundation | 0 | PrivateOperatingFoundationInd |
| New Substantial Contributors | 0 | NewSubstantialContributorsInd |
| Own Controlled Entity | Yes (1) | OwnControlledEntityInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Comply With Public Insp Rqr | Yes (1) | ComplyWithPublicInspRqrInd |
| Website Address | HELMSLEYTRUST.ORG | WebsiteAddressTxt |
Persons With Books Name PersonsWithBooksName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | NICHOLAS J SCHIAVO CFO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 2126793600 | PhoneNum |
Location Of Books US Address LocationOfBooksUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 PARK AVENUE SUITE 659 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10169 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Foreign Accounts Question | Yes (1) | ForeignAccountsQuestionInd |
| Foreign Country | AS | ForeignCountryCd |
| Foreign Country | AU | ForeignCountryCd |
| Foreign Country | BE | ForeignCountryCd |
| Foreign Country | CA | ForeignCountryCd |
| Foreign Country | DA | ForeignCountryCd |
| Foreign Country | FI | ForeignCountryCd |
| Foreign Country | FR | ForeignCountryCd |
| Foreign Country | GM | ForeignCountryCd |
| Foreign Country | HK | ForeignCountryCd |
| Foreign Country | ID | ForeignCountryCd |
| Foreign Country | IT | ForeignCountryCd |
| Foreign Country | JA | ForeignCountryCd |
| Foreign Country | NL | ForeignCountryCd |
| Foreign Country | NZ | ForeignCountryCd |
| Foreign Country | NO | ForeignCountryCd |
| Foreign Country | PO | ForeignCountryCd |
| Foreign Country | SN | ForeignCountryCd |
| Foreign Country | KS | ForeignCountryCd |
| Foreign Country | SP | ForeignCountryCd |
| Foreign Country | SW | ForeignCountryCd |
| Foreign Country | SZ | ForeignCountryCd |
| Foreign Country | TW | ForeignCountryCd |
| Foreign Country | UK | ForeignCountryCd |
Statements Regarding Acty4720 StatementsRegardingActy4720Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Sale Or Exch Disqualified Prsn | Yes (1) | SaleOrExchDisqualifiedPrsnInd |
| Brrw Or Lend Disqualified Prsn | 0 | BrrwOrLendDisqualifiedPrsnInd |
| Furn Goods Disqualified Prsn | Yes (1) | FurnGoodsDisqualifiedPrsnInd |
| Pay Comp Disqualified Prsn | Yes (1) | PayCompDisqualifiedPrsnInd |
| Transfer Ast Disqualified Prsn | 0 | TransferAstDisqualifiedPrsnInd |
| Payment To Government Official | 0 | PaymentToGovernmentOfficialInd |
| Acts Fail To Qlfy As Exceptions | 0 | ActsFailToQlfyAsExceptionsInd |
| Uncorrected Prior Acts | 0 | UncorrectedPriorActsInd |
| Undistributed Income PY | 0 | UndistributedIncomePYInd |
| Business Holdings | Yes (1) | BusinessHoldingsInd |
| Excess Business Holdings | 0 | ExcessBusinessHoldingsInd |
| Jeopardy Investments | 0 | JeopardyInvestmentsInd |
| Uncorrected PY Jeopardy Invst | 0 | UncorrectedPYJeopardyInvstInd |
| Influence Legislation | 0 | InfluenceLegislationInd |
| Influence Election | 0 | InfluenceElectionInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Noncharitable Purpose | 0 | NoncharitablePurposeInd |
| Transactions Fail To Qlfy As Exc | 0 | TransactionsFailToQlfyAsExcInd |
| Maintained Expenditure Rspns | Yes (1) | MaintainedExpenditureRspnsInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (1) | SubjToTaxRmnrtnExPrchtPymtInd |
Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp
Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | TitleTitleTxt | Average Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRt | CompensationCompensationAmt | Employee Benefit ProgramEmployeeBenefitProgramAmt | Expense Account Other AllwncExpenseAccountOtherAllwncAmt |
|---|---|---|---|---|---|---|---|---|
| SANDOR FRANKEL | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | TRUSTEE | 25.00 | $141,667 | $0 | $0 |
| DAVID PANZIRER | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | TRUSTEE | 35.00 | $141,667 | $0 | $0 |
| WALTER PANZIRER | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | TRUSTEE | 32.00 | $141,667 | $0 | $0 |
| SARAH E PAUL | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | CHIEF EXECUTIVE OFFICER | 40.00 | $747,100 | $178,123 | $0 |
| JACQUELINE F BAUSCH | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | GENERAL COUNSEL | 40.00 | $561,541 | $82,702 | $0 |
| ROSALIND M HEWSENIAN | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | CHIEF INVESTMENT OFFICER | 40.00 | $1,739,805 | $193,856 | $0 |
| NICHOLAS J SCHIAVO | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | CHIEF FINANCIAL OFFICER | 40.00 | $413,802 | $124,112 | $0 |
Compensation Highest Paid Empl CompensationHighestPaidEmplGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | TitleTitleTxt | Average Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRt | CompensationCompensationAmt | Employee BenefitsEmployeeBenefitsAmt | Expense AccountExpenseAccountAmt |
|---|---|---|---|---|---|---|---|---|
| MEENAKSHI C LAKSHMAN | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIR. OF STRATEGY & R | 40.00 | $964,169 | $156,520 | $0 |
| JOSHUA W FENTON | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIRECTOR OF INVESTME | 40.00 | $962,255 | $156,520 | $0 |
| AL Y KIM | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIRECTOR OF INVESTME | 40.00 | $952,777 | $156,520 | $0 |
| CHRISTOPHER J RAPCEWICZ | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIR. OF RISK MNGMT. | 40.00 | $960,510 | $139,472 | $0 |
| BRIAN B CHUN | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | INVESTMENT OFFICER | 40.00 | $468,187 | $78,701 | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Employee Paid Over50k | 88 | OtherEmployeePaidOver50kCnt |
Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Service TypeServiceTypeTxt | CompensationCompensationAmt | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|
| STARWOOD X | |||||||||
| 591 WEST PUTNAM AVENUE | GREENWICH | CT | 06830 | INVESTMENT MANAGEMENT | $4,022,881 | ||||
| HIG GROWTH II | |||||||||
| 600 5TH AVE 24TH FL | NEW YORK | NY | 10020 | INVESTMENT MANAGEMENT | $2,249,370 | ||||
| HIG CAPITAL PARTNERS V LP | |||||||||
| 600 5TH AVE 24TH FL | NEW YORK | NY | 10020 | INVESTMENT MANAGEMENT | $1,742,107 | ||||
| HIGHCLERE INTERNATIONAL INVESTORS | |||||||||
| INVESTMENT MANAGEMENT | $1,695,311 | 2 MANCHESTER SQUARE | LONDON | UK | |||||
| IFP GLOBAL FRANCHISE | |||||||||
| INVESTMENT MANAGEMENT | $1,080,516 | LEVEL 1 10 PORTMAN SQUARE | LONDON | UK | W1H 6AZ | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contractor Paid Over50k | 44 | ContractorPaidOver50kCnt |
Summary Of Direct Chrtbl Acty SummaryOfDirectChrtblActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description1 | FOR THE PRODUCTION OF VIDEO AND OTHER DESIGN SUPPORT TO COMMUNICATE IMPACT IN FURTHERANCE OF THE FOUNDATION'S MISSION. | Description1Txt |
| Expenses1 | $1,219,560 | Expenses1Amt |
| Description2 | FOR TECHNICAL SUPPORT TO GRANTEES TO MEET THEIR STRATEGIC AND COMMUNICATIONS NEEDS TO DRIVE FURTHER IMPACT OF THEIR CHARITABLE WORK. | Description2Txt |
| Expenses2 | $174,112 | Expenses2Amt |
| Description3 | FOR CONVENING EXPERTS TO EXPLORE PROGRAM PRIORITIES, SHARE RESEARCH AND IDEAS, AND BRAINSTORM NEW AREAS OF IMPACT IN SUPPORT OF THE FOUNDATION'S MISSION. | Description3Txt |
| Expenses3 | $419,722 | Expenses3Amt |
Sum Of Program Related Invst SumOfProgramRelatedInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description1 | STARTUP HEALTH T1D PRI LP - CATALYZING SEED AND EARLY STAGE COMPANIES DEVELOPING INNOVATIVE T1D SOLUTIONS | Description1Txt |
| Expenses1 | $2,500,000 | Expenses1Amt |
| Description2 | DIABETOMICS, INC. - POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION | Description2Txt |
| Expenses2 | $1,000,000 | Expenses2Amt |
| All Other Program Rltd Invst Tot | $1,243,630 | AllOtherProgramRltdInvstTotAmt |
| Total | $4,743,630 | TotalAmt |
Minimum Investment Return MinimumInvestmentReturnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Average Monthly FMV Of Sec | $7,158,769,720 | AverageMonthlyFMVOfSecAmt |
| Average Monthly Cash Balances | $338,688,785 | AverageMonthlyCashBalancesAmt |
| FMV All Other Noncharitable Ast | $450,277 | FMVAllOtherNoncharitableAstAmt |
| Total FMV Of Unused Assets | $7,497,908,782 | TotalFMVOfUnusedAssetsAmt |
| Reduction Claimed | $0 | ReductionClaimedAmt |
| Acquisition Indebtedness | $0 | AcquisitionIndebtednessAmt |
| Adjusted Total FMV Of Unused Ast | $7,497,908,782 | AdjustedTotalFMVOfUnusedAstAmt |
| Cash Deemed Charitable | $112,468,632 | CashDeemedCharitableAmt |
| Net Vl Noncharitable Assets | $7,385,440,150 | NetVlNoncharitableAssetsAmt |
| Minimum Investment Return | $369,272,008 | MinimumInvestmentReturnAmt |
Distributable Amount DistributableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Minimum Investment Return | $369,272,008 | MinimumInvestmentReturnAmt |
| Tax Based On Investment Income | $1,659,683 | TaxBasedOnInvestmentIncomeAmt |
| Income Tax | $911,010 | IncomeTaxAmt |
| Total Tax | $2,570,693 | TotalTaxAmt |
| Distributable Before Adj | $366,701,315 | DistributableBeforeAdjAmt |
| Recoveries Qualfied Distri | $441,259 | RecoveriesQualfiedDistriAmt |
| Distributable Before Ded | $367,142,574 | DistributableBeforeDedAmt |
| Deduction From Distributable | $0 | DeductionFromDistributableAmt |
| Distributable As Adjusted | $367,142,574 | DistributableAsAdjustedAmt |
PF Qualifying Distributions PFQualifyingDistributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expenses And Contributions | $462,319,022 | ExpensesAndContributionsAmt |
| Program Related Invst Total | $4,743,630 | ProgramRelatedInvstTotalAmt |
| Charitable Assets Acquis Paid | $298,195 | CharitableAssetsAcquisPaidAmt |
| Qualifying Distributions | $467,360,847 | QualifyingDistributionsAmt |
Undistributed Income UndistributedIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Distributable As Adjusted | $367,142,574 | DistributableAsAdjustedAmt |
| Undistributed Income PY | $100,386,880 | UndistributedIncomePYAmt |
| Total For Prior Years | $0 | TotalForPriorYearsAmt |
| Total Excess Distribution Cyov | $0 | TotalExcessDistributionCyovAmt |
| Qualifying Distributions | $467,360,847 | QualifyingDistributionsAmt |
| Applied To Year1 | $100,386,880 | AppliedToYear1Amt |
| Applied To Prior Years | $0 | AppliedToPriorYearsAmt |
| Treated As Distri From Corpus | $0 | TreatedAsDistriFromCorpusAmt |
| Applied To Current Year | $366,973,967 | AppliedToCurrentYearAmt |
| Remaining Distri From Corpus | $0 | RemainingDistriFromCorpusAmt |
| Excess Distri Cyov App CY Corpus | $0 | ExcessDistriCyovAppCYCorpusAmt |
| Excess Distribution Cyov App CY | $0 | ExcessDistributionCyovAppCYAmt |
| Total Corpus | $0 | TotalCorpusAmt |
| Prior Year Undistributed Incm | $0 | PriorYearUndistributedIncmAmt |
| Prior Year Deficiency Or Tax | $0 | PriorYearDeficiencyOrTaxAmt |
| Taxable1 | $0 | Taxable1Amt |
| Taxable2 | $0 | Taxable2Amt |
| Undistributed Income CY | $168,607 | UndistributedIncomeCYAmt |
| Corpus Distri170b1 E Or4942g3 | $0 | CorpusDistri170b1EOr4942g3Amt |
| Excess Distri Cyov From Yr5 | $0 | ExcessDistriCyovFromYr5Amt |
| Excess Distri Cyov To Next Yr | $0 | ExcessDistriCyovToNextYrAmt |
Supplementary Information SupplementaryInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Only Contri To Preselected | Yes (X) | OnlyContriToPreselectedInd |
Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (577 entries)
| Address Line1RecipientUSAddress/AddressLine1Txt | CityRecipientUSAddress/CityNm | State AbbreviationRecipientUSAddress/StateAbbreviationCd | ZIPRecipientUSAddress/ZIPCd | Recipient RelationshipRecipientRelationshipTxt | Recipient Foundation StatusRecipientFoundationStatusTxt | Grant Or Contribution PurposeGrantOrContributionPurposeTxt | AmtAmt | Address Line1RecipientForeignAddress/AddressLine1Txt | CityRecipientForeignAddress/CityNm | CountryRecipientForeignAddress/CountryCd | Address Line2RecipientUSAddress/AddressLine2Txt | Address Line2RecipientForeignAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4YOUANDME | ||||||||||||
| 2901 THIRD AVENUE | SEATTLE | WA | 98121 | N/A | PC | LEVERAGING WEARABLES TO MEASURE STRESS AND FORECAST SYMPTOM TRANSITIONS IN CROHNS DISEASE | $110,128 | |||||
| A GLIMMER OF HOPE FOUNDATION | ||||||||||||
| 3103 BEE CAVES ROAD | AUSTIN | TX | 78746 | N/A | PF | INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA | $1,129,775 | |||||
| A GLIMMER OF HOPE FOUNDATION | ||||||||||||
| 3103 BEE CAVES ROAD | AUSTIN | TX | 78746 | N/A | PF | EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY | $1,300,000 | |||||
| ADVENTIST HEALTH SYSTEMSUNBELT INC | ||||||||||||
| 601 EAST ROLLINS STREET | ORLANDO | FL | 32803 | N/A | PC | DETERMINING WHETHER A NOVEL CLASS OF DRUGS MIGHT PREVENT HYPOGLYCEMIA IN T1D PATIENTS | $731,837 | |||||
| AITKIN COMMUNITY HOSPITAL INC | ||||||||||||
| 200 BUNKER HILL DRIVE | AITKIN | MN | 56431 | N/A | PC | AITKIN COMMUNITY HOSPITAL/ RIVERWOOD HEALTHCARE CENTER ULTRASOUND PROJECT | $233,092 | |||||
| ALASKA NATIVE TRIBAL HEALTH CONSORTIUM | ||||||||||||
| 4000 AMBASSADOR DRIVE | ANCHORAGE | AK | 99508 | N/A | PC | YAKUTAT UTILITY PROJECT | $1,373,068 | |||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | ||||||||||||
| 1300 MORRIS PARK AVE | BRONX | NY | 104611975 | N/A | PC | PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY | $163,648 | |||||
| ALIMENTIV INC | ||||||||||||
| N/A | NC | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | $948,511 | 100 DUNDAS STREET | LONDON | CA | ||||||
| ALLINA ASSOCIATED FOUNDATION | ||||||||||||
| 3915 GOLDEN VALLEY ROAD | MINNEAPOLIS | MN | 55422 | N/A | PC | ALLINA HEALTH ULTRASOUND PROJECT | $758,911 | |||||
| ALVIN AILEY DANCE FOUNDATION INC | ||||||||||||
| THE JOAN WEILL CENTER FOR DANCE | NEW YORK | NY | 10019 | N/A | PC | GENERAL OPERATING SUPPORT | $10,000 | |||||
| ALYN HOSPITAL - REHABILITATION CENTER FOR CHILDREN AND YOUTH | ||||||||||||
| N/A | PC | ALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH | $717,219 | 84 SHMARYAHU LEVIN ST | JERUSALEM | IS | ||||||
| AMC MEDICAL RESEARCH BV | ||||||||||||
| N/A | PC | IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE | $610,817 | MEIBERGDREEF 9 | AMSTERDAM | NL | ||||||
| AMERICAN CAMPING ASSOCIATION INC | ||||||||||||
| 5000 STATE ROAD 67 NORTH | MARTINSVILLE | IN | 46151 | N/A | PC | ACA PROFESSIONAL DEVELOPMENT 2022-2024 | $48,955 | |||||
| AMERICAN COLLEGE OF DIABETOLOGY INC | ||||||||||||
| PO BOX 87633 | FAYETTEVILLE | NC | 28304 | N/A | PC | IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS | $810,203 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | ADAS FOCUS ON FELLOWS, DIABETES IS PRIMARY, AND PROFESSIONAL MEMBERSHIP INTEREST GROUPS PROJECTS (2020-2022) | $300,000 | |||||
| AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE | ||||||||||||
| 4930 DEL RAY AVE | BETHESDA | MD | 20814 | N/A | PC | STRATEGIES FOR INDIVIDUALIZING MANAGEMENT OF INFLAMMATORY BOWEL DISEASE FOR ADVANCED PRACTICE PROVIDERS | $155,930 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | AMERICAN BOARD OF TELEHEALTH PROGRAM EXPANSION | $200,000 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | MISSION: LIFELINE STROKE MONTANA AND POST-ACUTE STROKE CARE QUALITY STANDARDS FIELD TESTING | $1,321,419 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | POST-ACUTE STROKE CARE: IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA | $403,132 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | MISSION: LIFELINE STROKE IOWA | $1,680,053 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | $993,762 | |||||
| AMERICAN PHARMACISTS ASSOCIATION FOUNDATION | ||||||||||||
| 2215 CONSTITUTION AVE NW | WASHINGTON | DC | 20037 | N/A | PC | PROJECT IMPACT CGM: EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES | $1,976,075 | |||||
| AMERICAN TELEMEDICINE ASSOCIATION | ||||||||||||
| 901 NGLEBE RD | ARLINGTON | VA | 22203 | N/A | PC | ATA SPONSORING MEMBERSHIP | $25,500 | |||||
| AMERICARES FOUNDATION INC | ||||||||||||
| 88 HAMILTON AVE | STAMFORD | CT | 06840 | N/A | PC | MATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS | $752,688 | |||||
| ANTHOS HOME INC | ||||||||||||
| 238 SEELEY ST | BROOKLYN | NY | 11218 | N/A | PC | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | $2,500,000 | |||||
| APHP ST ANTOINE HOSPITAL | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $474,464 | 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | ||||||
| APHP ST ANTOINE HOSPITAL | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $474,464 | 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | ||||||
| APPLETON AREA HEALTH | ||||||||||||
| 30 SOUTH BEHL ST | APPLETON | MN | 56208 | N/A | GOV | APPLETON AREA HEALTH ULTRASOUND INITIATIVE | $281,865 | |||||
| AQUAYA INSTITUTE | ||||||||||||
| PO BOX 1603 | SAN ANSELMO | CA | 94979 | N/A | PC | WATER QUALITY ASSURANCE FUND EXPANSION IN GHANA | $1,492,399 | |||||
| ARAD MUNICIPALITY | ||||||||||||
| N/A | GOV | ARAD OCCUPATIONAL REHABILITATION CENTER | $560,000 | 6 HAPALMACH STREET | ARAD | IS | ||||||
| ASIAN HEALTH CARE FOUNDATION | ||||||||||||
| N/A | PC | IMPROVING ACCESS TO DIAGNOSTICS FOR CROHN'S DISEASE PATIENTS LIVING BELOW THE POVERTY LINE IN SOUTHERN INDIA | $210,551 | 6-3-661 SOMAJIGUDA | HYDERABAD | IN | ||||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | ||||||||||||
| 125 SOUTH WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | N/A | NC | EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE | $413,127 | |||||
| ASSOCIATION SANTE DIABTE | ||||||||||||
| N/A | PC | IMPROVE THE MANAGEMENT OF DIABETES AND THE SUPPORT TO PEOPLE AFFECTED BY THE DISEASE IN BURKINA FASO, MALI AND THE UNION OF COMOROS | $272,362 | 17 AVENUE MALHERBE | GRENOBLE | FR | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | ||||||||||||
| N/A | PC | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES | $587,840 | LEVEL 2 | FITZROY | AS | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | ||||||||||||
| N/A | PC | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES | $587,840 | LEVEL 2 | FITZROY | AS | ||||||
| AVERA HEALTH | ||||||||||||
| 3900 W AVERA DR | SIOUX FALLS | SD | 57108 | N/A | PC | AVERA HEALTH ULTRASOUND PROJECT | $682,498 | |||||
| AVERA MCKENNAN FOR THE AVERA MCKENNAN HOSPITAL AND UNI HEALTH CENTER | ||||||||||||
| 1325 S CLIFF AVENUE | SIOUX FALLS | SD | 57105 | N/A | PC | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | $1,500,000 | |||||
| AVERA MCKENNAN FOR THE AVERA MCKENNAN HOSPITAL AND UNI HEALTH CENTER | ||||||||||||
| 1325 S CLIFF AVENUE | SIOUX FALLS | SD | 57105 | N/A | PC | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | $500,000 | |||||
| BANNER HEALTH DBA BANNER CHURCHILL COMMUNITY HOSPITAL | ||||||||||||
| 801 EAST WILLIAMS AVE | FALLON | NV | 89406 | N/A | PC | BANNER CHURCHILL COMMUNITY HOSPITAL ULTRASOUND INITIATIVE | $139,574 | |||||
| BAPTIST MEDICAL CENTRE | ||||||||||||
| N/A | PC | EMERGENCY CENTRE AND DOCTOR HOUSING DEVELOPMENT | $315,000 | BAPTIST MEDICAL CENTRE ROAD | NALERIGU | GH | ||||||
| BEHAVIORAL DIABETES INSTITUTE | ||||||||||||
| 5230 CARROLL CANYON RD | SAN DIEGO | CA | 92121 | N/A | PC | CONSTRUCTION OF UPDATED T1-DIABETES DISTRESS SCALE (T1-DDS) | $346,980 | |||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| N/A | PC | CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING | $1,671,429 | BEN-GURION BLVD 1 | BEER SHEVA | IS | ||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| N/A | PC | COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CROHN'S DISEASE. | $1,066,797 | BEN-GURION BLVD 1 | BEER SHEVA | IS | ||||||
| BETH ISRAEL DEACONESS MEDICAL CENTER INC | ||||||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 022155491 | N/A | PC | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE. | $519,550 | |||||
| BEYOND TYPE 1 | ||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | DIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3 | $149,167 | |||||
| BHSH SYSTEM | ||||||||||||
| 100 MICHIGAN ST NE | GRAND RAPIDS | MI | 49503 | N/A | PC | STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS | $3,670,399 | |||||
| BILLINGS CLINIC FOUNDATION | ||||||||||||
| 2917 TENTH AVENUE NORTH | BILLINGS | MT | 59102 | N/A | PC | MONTANA PSYCHIATRY RESIDENCY PROGRAM SUSTAINING SUPPORT | $1,000,000 | |||||
| BIPARTISAN POLICY CENTER INC | ||||||||||||
| 1225 I ST NW 1000 | WASHINGTON | DC | 20005 | N/A | PC | STRENGTHENING HEALTH CARE DELIVERY AND SERVICES IN RURAL AND FRONTIER AMERICA | $625,293 | |||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $3,500,000 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $2,500,000 | ORANGE STREET | ||||
| BNAI ZION MEDICAL CENTER | ||||||||||||
| N/A | GOV | ACQUISITION OF A DA VINCI XI SURGICAL SYSTEM WITH SINGLE CONSOLE + FIREFLY ROBOTIC SURGICAL SYSTEM. | $2,665,020 | 47 GOLOMB ST | HAIFA | IS | ||||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | CARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM | $597,995 | |||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | ULTRASOUND TRAINING INITIATIVE IN NEVADA | $624,068 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | LONGITUDINAL STUDY OF MYOELECTRIC GUTPRINT OF HEALTHY CONTROLS AND CROHN'S DISEASE PATIENTS DURING FLARES AND IN REMISSION | $150,162 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | DEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D | $1,942,299 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | MICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE | $1,009,155 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | EXERCISE EDUCATION AT NEW ONSET OF T1D | $256,007 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON INTENSIVE INSULIN THERAPY (IIT) | $330,000 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | PROFESSIONAL VERSION OF DIABETESWISE: AVENUE TO INCREASE DIABETES DEVICE UPTAKE IN PEOPLE WITH INSULIN-REQUIRING DIABETES | $1,005,939 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHNS DISEASE | $551,070 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | EXERCISE EDUCATION AT NEW ONSET OF T1D | $339,811 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON INTENSIVE INSULIN THERAPY (IIT) | $1,741,076 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE | $690,953 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | GENERAL OPERATING SUPPORT FOR STANFORD UNIVERSITY GRADUATE SCHOOL OF BUSINESS CLASS OF 1986 35TH REUNION | $25,000 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON INTENSIVE INSULIN THERAPY (IIT) | $1,296,812 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | PROFESSIONAL VERSION OF DIABETESWISE: AVENUE TO INCREASE DIABETES DEVICE UPTAKE IN PEOPLE WITH INSULIN-REQUIRING DIABETES | $817,475 | |||||
| BOSTON SYMPHONY ORCHESTRA INC | ||||||||||||
| 301 MASSACHUSETTS AVENUE | BOSTON | MA | 02115 | N/A | PC | GENERAL OPERATING SUPPORT: | $10,000 | |||||
| BOULDER CITY HOSPITAL INC | ||||||||||||
| 901 ADAMS BLVD | BOULDER CITY | NV | 89005 | N/A | PC | BOULDER CITY HOSPITAL EQUIPMENT REVITALIZATION PROJECT | $37,497 | |||||
| BREAKING GROUND HOUSING DEVELOPMENT FUND CORPORATION | ||||||||||||
| 505 EIGHTH AVENUE 5TH FLOOR | NEW YORK | NY | 10018 | N/A | PC | PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING | $547,655 | |||||
| BRIDGES TO PROSPERITY INC | ||||||||||||
| 1031 33RD STREET | DENVER | CO | 80205 | N/A | PC | TRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA | $2,812,542 | |||||
| BRIDGES TO PROSPERITY INC | ||||||||||||
| 1031 33RD STREET | DENVER | CO | 80205 | N/A | PC | ZAMBIA ASSESSMENT | $142,110 | |||||
| BRIDGES TO PROSPERITY INC | ||||||||||||
| 1031 33RD STREET | DENVER | CO | 80205 | N/A | PC | ETHIOPIA ASSESSMENT | $142,110 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | INVESTIGATION OF ANTI-GM-CSF AUTOANTIBODIES AS A DISEASE DETERMINANT IN CROHNS DISEASE | $698,657 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | PEN-PLUS EXPANSION | $5,661,004 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | $1,308,107 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | INVESTIGATION OF ANTI-GM-CSF AUTOANTIBODIES AS A DISEASE DETERMINANT IN CROHNS DISEASE | $1,189,617 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | GENERAL OPERATING SUPPORT FOR 2022 WOMEN'S HEALTH LUNCHEON | $15,000 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | $1,329,719 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | PASSIVE WIRELESS MONITORING OF CROHNS DISEASE PATIENTS TO TRACK DISEASE ACTIVITY AND PREDICT FLARES | $360,771 | |||||
| CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | ||||||||||||
| N/A | GOV | THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | $955,956 | HILLS ROAD | CAMBRIDGE | UK | ||||||
| CANDID | ||||||||||||
| 32 OLD SLIP 24TH FLOOR | NEW YORK | NY | 10005 | N/A | PC | GENERAL OPERATING SUPPORT AND GUIDESTAR PARTNERSHIP | $17,551 | |||||
| CARE-FOR-RARE FOUNDATION | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MUNICH STUDIES | $54,000 | DR VON HAUNERSCHES KINDERSPITAL | MUNICH | GM | KLINIKUM DER UNIVERSITAT MUNCHEN | |||||
| CASS LAKE INDIAN HOSPITAL | ||||||||||||
| 425 7TH ST NW | CASS LAKE | MN | 56633 | N/A | GOV | CASS LAKE INDIAN HOSPITAL ULTRASOUND PROJECT | $191,462 | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | N/A | PC | KOM-YILMA III BURKINA FASO | $749,145 | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | N/A | PC | INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT (ICOWASH 2.0) | $1,556,214 | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | N/A | PC | MAYI MWANA PROJECT: HELPING ZAMBIAN MOTHERS AND NEWBORNS SURVIVE AND THRIVE | $1,100,098 | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | N/A | PC | REST4D - RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR SYSTEM DEVELOPMENT | $1,344,542 | |||||
| CCM HEALTH | ||||||||||||
| 824 NORTH 11TH STREET | MONTEVIDEO | MN | 56265 | N/A | GOV | CCM HEALTH ULTRASOUND PROJECT | $696,689 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | LONG-TERM RESPONSES TO SARS-COV-2 VACCINATION IN A DIVERSE INFLAMMATORY BOWEL DISEASE POPULATION: A MULTI-OMIC STUDY | $522,999 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $216,002 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION | $459,453 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | INTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO BETTER UNDERSTAND THE CAUSES OF, AND HETEROGENEITY IN, CROHN'S DISEASE | $231,849 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | INTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO BETTER UNDERSTAND THE CAUSES OF, AND HETEROGENEITY IN, CROHN'S DISEASE | $268,151 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $204,837 | |||||
| CENTER FOR EXCELLENCE IN HEALTH CARE JOURNALISM | ||||||||||||
| 10 NEFF HALL | COLUMBIA | MO | 65211 | N/A | SOII | TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND RESOURCES FOR HEALTH REPORTING | $219,995 | |||||
| CENTER FOR HEALTH CARE STRATEGIES INC | ||||||||||||
| 200 AMERICAN METRO BLVD | TRENTON | NJ | 08619 | N/A | PC | TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN | $653,574 | |||||
| CENTER FOR HEALTH CARE STRATEGIES INC | ||||||||||||
| 200 AMERICAN METRO BLVD | TRENTON | NJ | 08619 | N/A | PC | OPPORTUNITIES FOR PEDIATRIC AUTOANTIBODY SCREENING IN MEDICAID | $80,412 | |||||
| CENTRACARE HEALTH SYSTEM | ||||||||||||
| 1406 6TH AVE N | ST CLOUD | MN | 56303 | N/A | PC | CENTRACARE HEALTH SYSTEM ULTRASOUND PROJECT | $1,746,643 | |||||
| CENTRAL MONTANA MEDICAL FACILITIES INC | ||||||||||||
| 408 WENDELL AVE | LEWISTOWN | MT | 59457 | N/A | PC | CANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER | $3,469,965 | |||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | ||||||||||||
| N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $89,352 | 29 AVENUE MAL DE LATTRE DE TASSIGNY | NANCY | FR | ||||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | ||||||||||||
| N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $98,364 | 29 AVENUE MAL DE LATTRE DE TASSIGNY | NANCY | FR | ||||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE | $159,416 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA | $556,046 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | PHARMACOLOGICAL MODULATION TO RESTORE COUNTERREGULATORY GLUCAGON SECRETION IN TYPE 1 DIABETES | $546,306 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | ICARUS IBD: INTERNATIONAL STUDY OF COVID-19 ANTIBODY RESPONSE UNDER SUSTAINED IMMUNE SUPPRESSION IN INFLAMMATORY BOWEL DISEASE | $82,500 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHASE COUNTY COMMUNITY HOSPITAL | ||||||||||||
| 600 WEST 12TH STREET | IMPERIAL | NE | 69033 | N/A | GOV | EEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL | $12,656 | |||||
| CHASE COUNTY COMMUNITY HOSPITAL | ||||||||||||
| 600 WEST 12TH STREET | IMPERIAL | NE | 69033 | N/A | GOV | EEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL | $29,056 | |||||
| CHI HEALTH FOUNDATION | ||||||||||||
| 12809 WEST DODGE ROAD | OMAHA | NE | 68154 | N/A | PC | ULTRASOUND PROJECTS AT BAUDETTE, BRECKENRIDGE, LITTLE FALLS, AND PARK RAPIDS, MINNESOTA | $1,079,546 | |||||
| CHILDREN OF THE LIGHT INTERNATIONAL MINISTRIES INC | ||||||||||||
| 1171 E 95TH STREET | BROOKLYN | NY | 11236 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE | $374,591 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE | $374,591 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | ROLE OF PPAR-ALPHA IN PROMOTING BRUSH BORDER MATURITY OF INTESTINAL ENTEROCYTES | $399,330 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | PRECISION CROHNS DISEASE MANAGEMENT UTILIZING PREDICTIVE PROTEIN PANELS | $235,507 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHNS DISEASE | $282,554 | |||||
| CHILDREN'S HOSPITAL OF PHILADELPHIA | ||||||||||||
| 2716 SOUTH STREET | PHILADELPHIA | PA | 191462305 | N/A | PC | LEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D | $349,553 | |||||
| CHILDREN'S HOSPITAL OF PHILADELPHIA | ||||||||||||
| 2716 SOUTH STREET | PHILADELPHIA | PA | 191462305 | N/A | PC | A CROHNS DISEASE EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM | $272,676 | |||||
| CHILDREN'S HUNGER FUND | ||||||||||||
| 13931 BALBOA BLVD | SYLMAR | CA | 91342 | N/A | PC | MERCY NETWORK FOOD SUPPORT IN ETHIOPIA AND ZAMBIA | $151,800 | |||||
| CHILDREN'S MERCY HOSPITAL | ||||||||||||
| 2401 GILLHAM ROAD | KANSAS CITY | MO | 64108 | N/A | PC | TYPE 1 DIABETES RAPID LEARNING LAB | $2,966,873 | |||||
| CITIZENS HOUSING AND PLANNING COUNCIL OF NEW YORK INC | ||||||||||||
| 42 BROADWAY STE 2010 | NEW YORK | NY | 10004 | N/A | PC | EDUCATION FOR NYC POLICYMAKERS ON HOUSING INITIATIVES TO IMPROVE HEALTH | $200,000 | |||||
| CITY PARKS FOUNDATION | ||||||||||||
| 830 FIFTH AVENUE | NEW YORK | NY | 10065 | N/A | PC | CATALYST: GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES | $491,131 | |||||
| CITY PARKS FOUNDATION | ||||||||||||
| 830 FIFTH AVENUE | NEW YORK | NY | 10065 | N/A | PC | NYC GREEN RELIEF & RECOVERY FUND | $680,000 | |||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | YOSEFTAL HOSPITAL ADDITION | $3,847,500 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | BIOMARKER-BASED MULTIDISCIPLINARY TEAM (BIO-MDT) APPROACH TO PERSONALIZED MICROBIAL-TARGETED TREATMENT OF POUCHITIS AND CROHN'S DISEASE | $599,718 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | $4,100,000 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | $1,032,229 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION | $243,216 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | $406,254 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES | $444,314 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT | $137,856 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION | $242,153 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | YOSEFTAL HOSPITAL ADDITION | $2,058,214 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | COVID-19 VACCINE RESPONSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | $177,281 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLINTON HEALTH ACCESS INITIATIVE INC | ||||||||||||
| 383 DORCHESTER AVENUE SUITE 400 | BOSTON | MA | 02127 | N/A | PC | MARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE | $1,597,167 | |||||
| CLINTON HEALTH ACCESS INITIATIVE INC | ||||||||||||
| 383 DORCHESTER AVENUE SUITE 400 | BOSTON | MA | 02127 | N/A | PC | MARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE | $60,578 | |||||
| COMMUNITY CENTERS INC | ||||||||||||
| 2 ST ROCH AVENUE | GREENWICH | CT | 06830 | N/A | PC | GENERAL OPERATING SUPPORT. | $45,000 | |||||
| COMMUNITY MEMORIAL HOSPITAL DISTRICT | ||||||||||||
| 2731 HEALTHCARE DRIVE | SYRACUSE | NE | 68446 | N/A | GOV | ECARE EMERGENCY AT SYRACUSE AREA HEALTH | $13,320 | |||||
| CONSORCI INSTITUT D'INVESTIGACIONES BIOMDICAS AUGUST PI I SUNYER | ||||||||||||
| N/A | GOV | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING | $177,122 | ROSSELL 149 | BARCELONA | SP | ||||||
| CONSORCI INSTITUT D'INVESTIGACIONES BIOMDICAS AUGUST PI I SUNYER | ||||||||||||
| N/A | GOV | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING | $261,948 | ROSSELL 149 | BARCELONA | SP | ||||||
| COOK COUNTY HOSPITAL DISTRICT | ||||||||||||
| 515 5TH AVENUE WEST | GRAND MARAIS | MN | 55604 | N/A | GOV | NORTH SHORE HEALTH ULTRASOUND PROJECT | $207,235 | |||||
| COUNCIL ON FOUNDATIONS INC | ||||||||||||
| 1255 23RD ST NW | WASHINGTON | DC | 20037 | N/A | PC | GENERAL OPERATING SUPPORT | $34,000 | |||||
| COUNTY OF MURRAY | ||||||||||||
| 2042 JUNIPER AVE | SLAYTON | MN | 56172 | N/A | GOV | ULTRASOUND REVITALIZATION PROJECT | $216,230 | |||||
| CRITICAL PATH INSTITUTE | ||||||||||||
| 1730 E RIVER RD | TUCSON | AZ | 85718 | N/A | PC | T1D CONSORTIUM 2.0 | $266,741 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE | $570,830 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | TRAINING AWARDS PROGRAM - CLASS OF 2021 | $1,067,400 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | IBD VENTURES ACADEMIC INCUBATOR | $1,185,400 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE | $570,831 | |||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE | $253,783 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE | $255,521 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS | $275,688 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS UK | ||||||||||||
| N/A | PC | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK: KNOWLEDGE AND EVIDENCE PERSONNEL | $75,900 | 1 BISHOPS SQUARE | HATFIELD | UK | ||||||
| CROHN'S AND COLITIS UK | ||||||||||||
| N/A | PC | SUPPORT FOR THE CROHNS AND COLITIS UK RESEARCH AWARDS | $329,900 | 1 BISHOPS SQUARE | HATFIELD | UK | ||||||
| CROHN'S AND COLITIS UK | ||||||||||||
| N/A | PC | SUPPORT FOR CROHN'S AND COLITIS UK'S MULTI-CHANNEL HELPLINE SERVICE | $263,570 | 1 BISHOPS SQUARE | HATFIELD | UK | ||||||
| CROHN'S AND COLITIS UK | ||||||||||||
| N/A | PC | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK: KNOWLEDGE AND EVIDENCE PERSONNEL | $75,900 | 1 BISHOPS SQUARE | HATFIELD | UK | ||||||
| CROHN'S COLITIS CURE | ||||||||||||
| N/A | PC | DEVELOPMENT OF A PEDIATRIC-SPECIFIC CROHNS DISEASE ELECTRONIC MEDICAL RECORD TO DRIVE CARE CONSISTENCY AND ENHANCE TRANSITIONS IN CARE | $141,158 | 1 OCONNELL STREET | SYDNEY | AS | ||||||
| CROHN'S COLITIS CURE | ||||||||||||
| N/A | PC | DEVELOPMENT OF A PEDIATRIC-SPECIFIC CROHNS DISEASE ELECTRONIC MEDICAL RECORD TO DRIVE CARE CONSISTENCY AND ENHANCE TRANSITIONS IN CARE | $68,358 | 1 OCONNELL STREET | SYDNEY | AS | ||||||
| CUYUNA REGIONAL MEDICAL CENTER | ||||||||||||
| 320 EAST MAIN STREET | CROSBY | MN | 56401 | N/A | PC | CUYUNA REGIONAL MEDICAL CENTER ULTRASOUND PROJECT | $92,550 | |||||
| DARTMOUTH- HITCHCOCK CLINIC | ||||||||||||
| ONE MEDICAL CENTER DRIVE | LEBANON | NH | 03756 | N/A | PC | CAPACITY BUILDING FOR DARTMOUTH HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | $269,933 | |||||
| DAWSON AREA HOSPITAL DISTRICT | ||||||||||||
| 1282 WALNUT STREET | DAWSON | MN | 56232 | N/A | GOV | JOHNSON MEMORIAL HEALTH SERVICES ULTRASOUND PROJECT | $70,018 | |||||
| DE LA SALLE SOLIDARIET INTERNAZIONALE ONLUS | ||||||||||||
| N/A | PC | ETHIOPIAN CATHOLIC UNIVERSITY DIAGNOSTIC LABORATORY | $191,462 | VIA AUREALIA 476 | ROME | IT | ||||||
| DIABETES NSW | ||||||||||||
| N/A | PC | IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES | $3,000,000 | 26 ARUNDEL ST | SYDNEY | AS | ||||||
| DREAMED DIABETES LTD | ||||||||||||
| N/A | NC | INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES | $1,500,000 | 14 KAPLAN ST | PETAH TIKVA | IS | ||||||
| DUNDY COUNTY HOSPITAL | ||||||||||||
| 1313 N CHEYENNE ST | BENKELMAN | NE | 69021 | N/A | GOV | TELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL | $121,593 | |||||
| EB RESEARCH PARTNERSHIP INC | ||||||||||||
| 244 MADISON AVENUE SUITE 104 | NEW YORK | NY | 10016 | N/A | PC | EB RESEARCH PARTNERSHIP ACCELERATOR | $1,000,000 | |||||
| ELY-BLOOMENSON COMMUNITY HOSPITAL | ||||||||||||
| 328 W CONAN ST | ELY | MN | 55731 | N/A | PC | ELY-BLOONEMSON COMMUNITY HOSPITAL ULTRASOUND REVITALIZATION PROJECT | $285,654 | |||||
| ENGINEERING MINISTRIES INTERNATIONAL USA | ||||||||||||
| 7025 CAMPUS DRIVE | COLORADO SPRINGS | CO | 80920 | N/A | PC | ALASKA WASH PROJECT | $7,020,410 | |||||
| ENGINEERING MINISTRIES INTERNATIONAL USA | ||||||||||||
| 7025 CAMPUS DRIVE | COLORADO SPRINGS | CO | 80920 | N/A | PC | MASTER PLANNING PROJECT AT MOUNT GRANT GENERAL HOSPITAL | $57,000 | |||||
| ESSENTIA HEALTH | ||||||||||||
| 502 E 2ND ST | DULUTH | MN | 55805 | N/A | PC | ESSENTIA HEALTH ULTRASOUND PROJECT | $1,473,638 | |||||
| FLORESTA USA INCORPORATED | ||||||||||||
| 4747 MORENA BLVD STE 100 | SAN DIEGO | CA | 92117 | N/A | PC | SCALING AT THE WATERSHED LEVEL TO EQUIP RURAL FAMILIES | $516,231 | |||||
| FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY (FIRST) | ||||||||||||
| 200 BEDFORD STREET | MANCHESTER | NH | 03101 | N/A | PC | FIRST SENIOR MENTOR PROGRAM | $200,000 | |||||
| FORT ATKINSON FOUNDATION | ||||||||||||
| 201 S 7TH ST | FORT CALHOUN | NE | 68023 | N/A | PC | FORT ATKINSON STATE HISTORICAL PARK FORT RESTORATION AND INTERPRETIVE CENTER REMODEL | $37,639 | |||||
| FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND | ||||||||||||
| N/A | PC | ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT | $1,119,378 | CAMPUS BIOTECH | GENEVA | SZ | ||||||
| FRIENDS OF THE ISRAEL DEFENSE FORCES | ||||||||||||
| 60 EAST 42 STREET | NEW YORK | NY | 10165 | N/A | PC | IMPACT! SCHOLARSHIP PROGRAM | $165,600 | |||||
| FUND FOR PUBLIC HEALTH IN NEW YORK INC | ||||||||||||
| 22 CORTLANDT STREET SUITE 802 | NEW YORK | NY | 10007 | N/A | PC | NYC VACCINE EQUITY PARTNER ENGAGEMENT PROJECT | $700,467 | |||||
| FUND FOR PUBLIC HOUSING INC | ||||||||||||
| 90 CHURCH STREET | NEW YORK | NY | 10007 | N/A | PC | DEVELOPING AND ACTIVATING GREENSPACE USING THE CONNECTED COMMUNITIES' PARTICIPATORY PROCESS AT FOUR NYCHA DEVELOPMENTS | $1,570,000 | |||||
| GEISINGER CLINIC | ||||||||||||
| 100 NORTH ACADEMY AVE | DANVILLE | PA | 178223057 | N/A | PC | STUDY OF PRE-IMPLEMENTATION OUTCOMES REQUIRED TO IMPLEMENT PREVENTIVE SCREENING AT WELL-CHILD VISITS | $701,056 | |||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| N/A | PC | MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $156,725 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | ||||||
| GEORGIA TECH RESEARCH CORPORATION | ||||||||||||
| 505 10TH STREET NW | ATLANTA | GA | 303320420 | N/A | SOIII FI | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | $480,848 | |||||
| GEOSCIENCE AUSTRALIA | ||||||||||||
| N/A | GOV | DIGITAL EARTH AFRICA - SUSTAINABLE UPTAKE AND IMPACT | $6,604,232 | 101 JERRABOMBERRA AVE | SYMONSTON | AS | ||||||
| GIRLS WITH GUTS | ||||||||||||
| 6024 RIDGE AVENUE | PHILADELPHIA | PA | 19128 | N/A | PC | 2021 & 2022 OPERATING SUPPORT TO PROVIDE POST-OPERATIVE AND INFUSION KITS FOR WOMEN WITH INFLAMMATORY BOWEL DISEASE | $11,100 | |||||
| GIRLS WITH GUTS | ||||||||||||
| 6024 RIDGE AVENUE | PHILADELPHIA | PA | 19128 | N/A | PC | 2021 & 2022 OPERATING SUPPORT TO PROVIDE POST-OPERATIVE AND INFUSION KITS FOR WOMEN WITH INFLAMMATORY BOWEL DISEASE | $11,100 | |||||
| GLACIAL RIDGE HOSPITAL DISTRICT | ||||||||||||
| 10 4TH AVE SE | GLENWOOD | MN | 56334 | N/A | PC | GLACIAL RIDGE HEALTH SYSTEM ULTRASOUND PROJECT | $459,547 | |||||
| GLENCOE REGIONAL HEALTH SERVICES | ||||||||||||
| 1805 HENNEPIN AVENUE NORTH | GLENCOE | MN | 55336 | N/A | PC | ULTRASOUND REVITALIZATION PROJECT | $186,843 | |||||
| GLOBAL SOLIDARITY FUND | ||||||||||||
| 425 LEXINGTON AVE | NEW YORK | NY | 10017 | N/A | PC | JOB CREATION IN ETHIOPIA | $1,508,200 | |||||
| GOLDEN RAINBOW OF NEVADA INC | ||||||||||||
| 714 E SAHARA AVE | LAS VEGAS | NV | 89104 | N/A | PC | CAPITAL SUPPORT FOR GOLDEN RAINBOW OF NEVADA, INC. HOUSING | $1,050,000 | |||||
| GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO | ||||||||||||
| N/A | PC | DEVELOPMENT OF A GLUCOSE RESPONSIVE GLUCAGON (GRG) MICRONEEDLE PATCH FOR THE PREVENTION OF HYPOGLYCEMIA | $289,960 | 27 KINGS COLLEGE CIRCLE | TORONTO | CA | ||||||
| GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO | ||||||||||||
| N/A | PC | DEVELOPMENT OF A GLUCOSE RESPONSIVE GLUCAGON (GRG) MICRONEEDLE PATCH FOR THE PREVENTION OF HYPOGLYCEMIA | $185,460 | 27 KINGS COLLEGE CIRCLE | TORONTO | CA | ||||||
| GRAND ITASCA CLINIC AND HOSPITAL | ||||||||||||
| 1601 GOLF COURSE RD | GRAND RAPIDS | MN | 55744 | N/A | PC | GRAND ITASCA CLINIC AND HOSPITAL ULTRASOUND PROJECT | $335,587 | |||||
| GRANTMAKERS IN HEALTH | ||||||||||||
| 1100 CONNECTICUT AVENUE NW | WASHINGTON | DC | 20036 | N/A | PC | GENERAL OPERATING SUPPORT | $23,760 | |||||
| GRANTMAKERS IN HEALTH | ||||||||||||
| 1100 CONNECTICUT AVENUE NW | WASHINGTON | DC | 20036 | N/A | PC | GRANTMAKERS IN HEALTH EFFECTIVE PHILANTHROPY FUND | $119,803 | |||||
| HADASSAH MEDICAL ORGANIZATION | ||||||||||||
| N/A | PC | CREATING AND EQUIPPING A NEW COMPREHENSIVE DIAGNOSTIC AND INTERVENTIONAL IMAGING CENTER | $3,864,000 | EIN KEREM ADDRESS KALMAN YAAKOV MAN | JERUSALEM | IS | STREET | |||||
| HANNOVERSCHE KINDERHEILANSTALT | ||||||||||||
| N/A | PC | FR1DA IN NORTHERN GERMANY: PRE-SYMPTOMATIC TYPE 1 DIABETES TESTING IN CHILDREN | $267,694 | JANUSZ-KORCZAK-ALLEE 12 | HANNOVER | GM | ||||||
| HEALTH ADVOCACY SUMMIT INC | ||||||||||||
| 1962 DOCKSIDE DRIVE | GREENWOOD | IN | 46143 | N/A | PC | CROHNS AND COLITIS YOUNG ADULTS NETWORK LEARNING COMMUNITY, ROUNDTABLE ON ADOLESCENTS AND YOUNG ADULTS WITH IBD | $59,940 | |||||
| HEALTH RESEARCH ALLIANCE INC | ||||||||||||
| 65 TW ALEXANDER DRIVE | RESEARCH TRIANGLE PARK | NC | 27709 | N/A | PC | GENERAL OPERATING SUPPORT | $22,150 | |||||
| HEALTHPARTNERS INSTITUTE | ||||||||||||
| 8170 33RD AVENUE SOUTH | BLOOMINGTON | MN | 554254516 | N/A | PC | DIRECT INTEGRATION OF CGM DATA INTO THE EMR | $751,067 | |||||
| HEALTHPARTNERS INSTITUTE | ||||||||||||
| 8170 33RD AVENUE SOUTH | BLOOMINGTON | MN | 554254516 | N/A | PC | PILOT STUDY OF DIRECT INTEGRATION OF CONTINUOUS GLUCOSE MONITORING DATA INTO THE ELECTRONIC HEALTH RECORD TO IMPROVE DIABETES CARE | $332,200 | |||||
| HEALTHPARTNERS RC | ||||||||||||
| 100 HEALTHY WAY | OLIVIA | MN | 56277 | N/A | PC | OLIVIA HOSPITAL & CLINIC ULTRASOUND PROJECT | $216,022 | |||||
| HEBREW UNIVERSITY OF JERUSALEM | ||||||||||||
| N/A | PC | METHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS DISEASE | $671,024 | OFFICE OF THE PRESIDENT | JERUSALEM | IS | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD BIOSAMPLE RFP | $2,000,000 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | EUROPEAN PRE-T1D REGISTRY | $142,350 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $2,101,247 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $1,257,107 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $644,244 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $1,973,807 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,415,657 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | $232,068 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $697,881 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $691,810 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $513,083 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HENDRICKS COMMUNITY HOSPITAL ASSOCIATION AND RETIREMENT HOME | ||||||||||||
| 503 EAST LINCOLN STREET | HENDRICKS | MN | 56136 | N/A | PC | ULTRASOUND REVITALIZATION PROJECT | $19,850 | |||||
| HENNEPIN COUNTY | ||||||||||||
| 1313 PENN AVENUE NORTH | MINNEAPOLIS | MN | 55411 | N/A | GOV | NORTHPOINT HEALTH AND WELLNESS CENTER ULTRASOUND PROJECT | $44,431 | |||||
| HENRY J KAISER FAMILY FOUNDATION | ||||||||||||
| 185 BERRY STREET NO 2000 | SAN FRANCISCO | CA | 94107 | N/A | PC | KAISER HEALTH NEWS RURAL HEALTH DESK | $1,057,620 | |||||
| HERLEV OG GENTOFTE HOSPITAL | ||||||||||||
| N/A | GOV | TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | $109,023 | HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | ||||||
| HERLEV OG GENTOFTE HOSPITAL | ||||||||||||
| N/A | GOV | UTILIZATION OF INTERACTION BETWEEN AMINO ACIDS & GIP IN PANCREATIC CELLS | $57,744 | HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | ||||||
| HILLEL YAFFE MEDICAL CENTER | ||||||||||||
| N/A | GOV | EYE INSTITUTE AND AMBULATORY SURGERY CENTER | $2,756,300 | HA-SHALOM ST | HADERA | IS | ||||||
| HOLY ROSARY HEALTHCARE FOUNDATION | ||||||||||||
| 2600 WILSON STREET | MILES CITY | MT | 59301 | N/A | PC | HOLY ROSARY HEALTHCARE COMPREHENSIVE CANCER CENTER | $4,000,000 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE | $415,688 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | THE MELODY TRIAL: MODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHN'S DISEASE | $409,388 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE FOR NYCS MOST VULNERABLE MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS. | $547,667 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE | $415,688 | |||||
| ICHUD HATZALAH ISRAEL 1221 (RA) | ||||||||||||
| N/A | PC | UNITED HATZALAH PRE-HOSPITAL EMS SIMULATION TRAINING EQUIPMENT | $499,890 | 78 YIRMIYAHU ST | JERUSALEM | IS | ||||||
| ICHUD HATZALAH ISRAEL 1221 (RA) | ||||||||||||
| N/A | PC | UNITED HATZALAH HUMANITARIAN MISSION FOR UKRAINE | $739,000 | 78 YIRMIYAHU ST | JERUSALEM | IS | ||||||
| IDA COUNTY IOWA COMMUNITY HOSPITAL | ||||||||||||
| 701 EAST SECOND STREET | IDA GROVE | IA | 51445 | N/A | PC | ECARE PHARMACY AT HORN MEMORIAL HOSPITAL | $9,677 | |||||
| IDEOORG | ||||||||||||
| 444 SPEAR STREET | SAN FRANCISCO | CA | 94105 | N/A | PC | HUMAN-CENTERED DESIGN STUDY OF TYPE 1 DIABETES IN MEDICALLY UNDERSERVED COMMUNITIES IN THE U.S. | $227,950 | |||||
| IDEOORG | ||||||||||||
| 444 SPEAR STREET | SAN FRANCISCO | CA | 94105 | N/A | PC | HUMAN-CENTERED DESIGN STUDY OF TYPE 1 DIABETES IN MEDICALLY UNDERSERVED COMMUNITIES IN THE U.S. | $200,000 | |||||
| INCLINE VILLAGE COMMUNITY HOSPITAL FOUNDATION | ||||||||||||
| 880 ALDER AVE | INCLINE VILLAGE | NV | 89451 | N/A | PC | MAMMOGRAPHY FOR INCLINE VILLAGE COMMUNITY HOSPITAL | $1,938,683 | |||||
| INCLINE VILLAGE COMMUNITY HOSPITAL FOUNDATION | ||||||||||||
| 880 ALDER AVE | INCLINE VILLAGE | NV | 89451 | N/A | PC | ULTRASOUND EQUIPMENT FOR INCLINE VILLAGE COMMUNITY HOSPITAL | $87,080 | |||||
| INNODIA | ||||||||||||
| N/A | NC | INNODIA NONPROFIT LAUNCH FOR THE CARE AND PREVENTION OF T1D. | $755,460 | HERESTRAAT 49 | LEUVEN | BE | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $81,892 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | $95,241 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE | ||||||||||||
| N/A | GOV | FROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES: MECHANISTIC CD8+ T-CELL BIOMARKERS OF PROGRESSION | $164,338 | 86 RUE REGNAULT | PARIS | FR | ||||||
| INSULIN FOR LIFE USA INC | ||||||||||||
| 2555 SW 76TH STREET | GAINESVILLE | FL | 32608 | N/A | PC | INSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY | $320,933 | |||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| N/A | NC | DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE. | $718,578 | HARKORTSTR 1 | MUNSTER | GM | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| N/A | NC | DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE. | $779,377 | HARKORTSTR 1 | MUNSTER | GM | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| N/A | NC | POINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES: INTRODUCTION TO INTESTINAL ULTRASONOGRAPHY | $172,967 | HARKORTSTR 1 | MUNSTER | GM | ||||||
| INTERNATIONAL FALLS MEMORIAL HOSPITAL ASSOCIATION | ||||||||||||
| 1400 HIGHWAY 71 | INTERNATIONAL FALLS | MN | 56649 | N/A | PC | RAINY LAKE MEDICAL CENTER ULTRASOUND PROJECT | $173,810 | |||||
| IOWA DEPARTMENT OF PUBLIC HEALTH | ||||||||||||
| 321 EAST 12TH | DES MOINES | IA | 50319 | N/A | GOV | IOWA FIRST RESPONDER AED INITIATIVE | $186,944 | |||||
| ISRAEL ANTIQUITIES AUTHORITY | ||||||||||||
| N/A | GOV | THE JAY AND JEANIE SCHOTTENSTEIN NATIONAL CAMPUS FOR THE ARCHAEOLOGY OF ISRAEL | $400,000 | 27 SULTAN SULEIMAN STREET | JERUSALEM | IS | ||||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $183,039 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | CGM MONITORING OF MATERNAL DYSGLYCEMIA | $100,000 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING | $256,190 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | $625,000 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | CGM MONITORING OF MATERNAL DYSGLYCEMIA | $481,111 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | $400,000 | |||||
| JDRF AUSTRALIA | ||||||||||||
| N/A | PC | ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA | $2,595,980 | 80-84 CHANDOS STREET ST LEONARDS | SYDNEY | AS | 2065 NSW AUSTRALIA | |||||
| JDRF AUSTRALIA | ||||||||||||
| N/A | PC | ENDIA EARLY TO MID CAREER SCIENCE ACCELERATOR AWARDS 2021 | $232,577 | 80-84 CHANDOS STREET ST LEONARDS | SYDNEY | AS | 2065 NSW AUSTRALIA | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | JDRF TRAINING PROGRAMS | $750,000 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | HCP T1D EDUCATION PROGRAM (STATE OF AFFAIRS AND PEAK) | $99,699 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | JDRF GLOBAL DIABETES ACCESS INITIATIVE | $999,800 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | AUTOIMMUNITY SCREENING FOR KIDS PROGRAM TRANSITION TOWARDS A SUSTAINABLE SCREENING FOR T1D AND CELIAC DISEASE IN COLORADO | $511,143 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | CO-FUNDED DEVELOPMENT OF A 3-B-HYDROXYBUTYRATE BINDING PROTEIN BASED CONTINUOUS KETONE MONITORING MICROSENSOR | $200,000 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE | $133,334 | |||||
| JDRF T1D FUND LLC | ||||||||||||
| 50 MILK STREET 16TH FLOOR | BOSTON | MA | 02109 | N/A | PC | T1D FUND INITIATIVE TO DRIVE PHARMA INVESTMENT IN T1D | $500,000 | |||||
| JERUSALEM COLLEGE OF TECHNOLOGY | ||||||||||||
| N/A | PC | HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING | $4,165,000 | 21 HAVAAD HALEUMI ST | JERUSALEM | IS | ||||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | ENGINEERED CYTOKINE/ANTIBODY FUSION PROTEIN TO TREAT CROHNS DISEASE | $750,000 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS | $562,008 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING | $701,873 | |||||
| JUVENILE DIABETES RESEARCH FOUNDATION CANADA | ||||||||||||
| N/A | PC | JDRF CANADA PSYCHOSOCIAL HEALTH INITIATIVE | $36,000 | 235 YORKLAND BLVD SUITE 600 | TORONTO | CA | ||||||
| KATHOLIEKE UNIVERSITEIT LEUVEN | ||||||||||||
| N/A | PC | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | $246,663 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | ||||||
| KATHOLIEKE UNIVERSITEIT LEUVEN | ||||||||||||
| N/A | PC | INNODIA EXPANSION | $807,155 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | ||||||
| KATHOLIEKE UNIVERSITEIT LEUVEN | ||||||||||||
| N/A | PC | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY | $656,542 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | ||||||
| KATHOLIEKE UNIVERSITEIT LEUVEN | ||||||||||||
| N/A | PC | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | $530,354 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | $816,358 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS | $270,269 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL | $288,101 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KITTSON MEMORIAL HOSPITAL ASSOCIATION | ||||||||||||
| 1010 SOUTH BIRCH AVENUE | HALLOCK | MN | 56728 | N/A | PC | KITTSON HEALTHCARE ULTRASOUND PROJECT | $65,393 | |||||
| KITTSON MEMORIAL HOSPITAL ASSOCIATION | ||||||||||||
| 1010 SOUTH BIRCH AVENUE | HALLOCK | MN | 56728 | N/A | PC | EEMERGENCY AT KITTSON HEALTHCARE | $11,729 | |||||
| KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | $1,304,315 | FEODOR-LYNEN-STRABE 17 | MUNCHEN | GM | ||||||
| KMR ADVANCEMENT OF MEDICAL CENTERS LTD | ||||||||||||
| N/A | PC | PROPOSAL FOR BUILDING OF PRINCIPAL INFRASTRUCTURE FOR ALL 20 FLOORS OF THE HELMSLEY HEALTH DISCOVERY TOWER | $2,000,000 | 8 HAALIYAH ST | HAIFA | IS | ||||||
| KYLER CARES FOUNDATION | ||||||||||||
| 1101 DECATUR STREET APARTMENT 302 | NEW ORLEANS | LA | 70116 | N/A | PC | GENERAL OPERATING SUPPORT | $150,000 | |||||
| LAKE REGION HEALTHCARE CORPORATION | ||||||||||||
| 712 SOUTH CASCADE ST | FERGUS FALLS | MN | 56537 | N/A | PC | LAKE REGION HEALTHCARE CORPORATION ULTRASOUND PROJECT | $538,148 | |||||
| LAKE VIEW MEMORIAL HOSPITAL FOUNDATION OF NORTHEAST MINNESOTA | ||||||||||||
| 325 11TH AVE | TWO HARBORS | MN | 55616 | N/A | PC | LAKE VIEW HOSPITAL ULTRASOUND PROJECT | $253,075 | |||||
| LAKES REGIONAL HEALTHCARE | ||||||||||||
| HIGHWAY 71 SOUTH | SPIRIT LAKE | IA | 51360 | N/A | GOV | ECARE PHARMACY AT LAKES REGIONAL HEALTHCARE | $10,856 | |||||
| LAKEWOOD HEALTH SYSTEM | ||||||||||||
| 49725 COUNTY 83 | STAPLES | MN | 56479 | N/A | PC | LAKEWOOD HEALTH SYSTEM ULTRASOUND PROJECT | $574,338 | |||||
| LIFECARE MEDICAL CENTER | ||||||||||||
| 715 DELMORE DRIVE | ROSEAU | MN | 56751 | N/A | PC | LABOR AND DELIVERY POC ULTRASOUND PROJECT | $67,971 | |||||
| LINCOLN COUNTY HOSPITAL DISTRICT | ||||||||||||
| 700 NORTH SPRING STREET | CALIENTE | NV | 89008 | N/A | GOV | GROVER C. DILS MEDICAL CENTER ULTRASOUND PROJECT | $36,064 | |||||
| LIVING WATER INTERNATIONAL | ||||||||||||
| 4001 GREENBRIAR DRIVE | STAFFORD | TX | 77477 | N/A | PC | INTEGRATED WATER ACCESS, SANITATION AND HYGIENE PROGRAM IN CHIPATA DISTRICT, ZAMBIA | $1,369,113 | |||||
| LONDON NORTH WEST UNIVERSITY HEALTHCARE NHS TRUST | ||||||||||||
| N/A | GOV | PERIANAL CROHNS DISEASE CONSORTIUM | $69,442 | NORTHWICK PARK HOSPITAL WATFORD | HARROW | UK | ROAD HARROW MIDDLESEX HA1 3UJ | |||||
| LUCAS COUNTY HEALTH CENTER | ||||||||||||
| 1200 NORTH 7TH STREET | CHARITON | IA | 50049 | N/A | PC | AVERA ECARE EMERGENCY VIRTUAL HEALTH AT LUCAS COUNTY HEALTH CENTER | $45,334 | |||||
| MADELIA HEALTH | ||||||||||||
| 121 DREW AVE SE | MADELIA | MN | 56062 | N/A | PC | MADELIA HEALTH ULTRASOUND PROJECT | $193,530 | |||||
| MADISON COUNTY MEMORIAL HOSPITAL | ||||||||||||
| 300 W HUTCHINGS STREET | WINTERSET | IA | 50273 | N/A | GOV | IMPLEMENTATION OF EEMERGENCY AT MADISON COUNTY HEALTH CARE SYSTEM | $37,965 | |||||
| MARY C WHEELER SCHOOL INC | ||||||||||||
| 216 HOPE STREET | PROVIDENCE | RI | 02906 | N/A | PC | GENERAL OPERATING SUPPORT TO SUPPORT THE PROGRAMS, STUDENTS, AND TEACHERS OF THE WHEELER SCHOOL. | $10,000 | |||||
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | TETHERED CAPSULE ENDOMICROSCOPY FOR DETAILED VISUALIZATION OF THE CROHN'S BOWEL WALL | $546,985 | |||||
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | WIRELESS INFRARED IMAGING CAPSULE FOR PINPOINTING INFLAMMATION IN CROHNS DISEASE | $843,986 | |||||
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | CROHN'S DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION AND BETTER TREATMENT | $350,278 | |||||
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | ||||||||||||
| 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | N/A | PC | COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS | $300,000 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | MAYO CLINIC HEALTH SYSTEM POINT-OF-CARE ULTRASOUND EQUIPMENT | $941,738 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | DEVELOPMENT AND EVALUATION OF A NOVEL ALGORITHM FOR AID CONTROL FOR PREGNANT WOMEN WITH T1D | $1,081,500 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | MAYO CLINIC HEALTH SYSTEM ULTRASOUND PROJECT | $635,535 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | $103,827 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | MILITARY SCIENCES MEDICAL TRAINING 2022-2024 | $182,000 | |||||
| MEDECINS SANS FRONTIRES USA INC | ||||||||||||
| 40 RECTOR STREET | NEW YORK | NY | 10006 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | |||||
| MEDICINES FOR HUMANITY INC | ||||||||||||
| 800 HINGHAM STREET | ROCKLAND | MA | 02370 | N/A | PC | MAI MBELEKI II EXPANSION | $677,164 | |||||
| MEDSTAR HEALTH INC | ||||||||||||
| 3007 TILDEN STREET NW | WASHINGTON | DC | 20008 | N/A | SOIII FI | 2022 SUPPORT FOR THE 'MASTERING CLINICAL CHALLENGES IN IBD' SYMPOSIUM | $35,000 | |||||
| MEEKER MEMORIAL HOSPITAL | ||||||||||||
| 612 S SIBLEY AVE | LITCHFIELD | MN | 55355 | N/A | GOV | ULTRASOUND EQUIPMENT REVITALIZATION | $66,612 | |||||
| MEEKER MEMORIAL HOSPITAL | ||||||||||||
| 612 S SIBLEY AVE | LITCHFIELD | MN | 55355 | N/A | GOV | EPHARMACY AT MEEKER MEMORIAL HOSPITAL | $12,269 | |||||
| MICHIGAN STATE UNIVERSITY | ||||||||||||
| HANNAH ADMINISTRATION BUILDING | EAST LANSING | MI | 488242601 | N/A | PC | A C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH TYPE 1 DIABETES | $382,594 | |||||
| MILLE LACS HEALTH SYSTEM | ||||||||||||
| 200 ELM STREET NORTH | ONAMIA | MN | 56359 | N/A | PC | TELE-PHARMACY AT MILLE LACS HEALTH SYSTEM | $56,434 | |||||
| MINNESOTA ACADEMY OF FAMILY PHYSICIANS FOUNDATION | ||||||||||||
| 1400 VANBUREN STE STE 215 | MINNEAPOLIS | MN | 55413 | N/A | PC | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | $2,362,600 | |||||
| MINNESOTA RURAL HEALTH ASSOCIATION | ||||||||||||
| 27011 460TH AVE | HENNING | MN | 56551 | N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA | $220,100 | |||||
| MINNESOTA STATE COLLEGES AND UNIVERSITIES | ||||||||||||
| 30 E 7TH STREET | ST PAUL | MN | 55101 | N/A | GOV | EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA | $595,848 | |||||
| MONROE COUNTY HOSPITAL | ||||||||||||
| 6580 165TH STREET | ALBIA | IA | 52531 | N/A | GOV | EPHARMACY AT MONROE COUNTY HOSPITAL & CLINICS | $17,577 | |||||
| MONTANA PEDIATRICS | ||||||||||||
| 259 W FRONT STREET | MISSOULA | MT | 59802 | N/A | PC | CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D | $104,900 | |||||
| MONTANA PEDIATRICS | ||||||||||||
| 259 W FRONT STREET | MISSOULA | MT | 59802 | N/A | PC | CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D | $284,500 | |||||
| MONUMENT HEALTH STURGIS HOSPITAL | ||||||||||||
| 2140 JUNCTION AVE | STURGIS | SD | 57785 | N/A | PC | EEMERGENCY AT MONUMENT HEALTH STURGIS HOSPITAL | $41,418 | |||||
| NATIONAL PARK FOUNDATION | ||||||||||||
| 1500 K ST NW | WASHINGTON | DC | 20005 | N/A | PC | BERING LAND BRIDGE VISITOR CENTER | $2,449,328 | |||||
| NATIONAL PARK FOUNDATION | ||||||||||||
| 1500 K ST NW | WASHINGTON | DC | 20005 | N/A | PC | LITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER | $3,150,000 | |||||
| NCD ALLIANCE | ||||||||||||
| N/A | PC | 2023-2025 PARTNERSHIP | $2,409,000 | 31-33 AVENUE GIUSEPPE MOTTA | GENEVA | SZ | ||||||
| NEBRASKA DEPARTOF HEALTH & HUMAN SERVICES DIVISION OF PUBLIC HEALTH | ||||||||||||
| 301 CENTENNIAL MALL SOUTH | LINCOLN | NE | 68508 | N/A | GOV | NEBRASKA FIRST RESPONDER AED PROJECT | $545,083 | |||||
| NEVADA COMMUNITY FOUNDATION INC | ||||||||||||
| 1980 FESTIVAL PLAZA DRIVE | LAS VEGAS | NV | 89135 | N/A | PC | RURAL NEVADA ULTRASOUND CARE INITIATIVE | $1,035,951 | |||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA FIRST RESPONDER AED PROJECT | $6,627,661 | |||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA VIRTUAL CRISIS CARE | $1,333,324 | |||||
| NEVADA HEALTH CENTERS INC | ||||||||||||
| 3325 RESEARCH WAY | CARSON CITY | NV | 89706 | N/A | PC | QUALITY ULTRASOUND SERVICES AND TRAINING PROGRAM | $602,796 | |||||
| NEVADA PRIMARY CARE ASSOCIATION | ||||||||||||
| 755 N ROOP ST | CARSON CITY | NV | 89701 | N/A | PC | POINT-OF-CARE ULTRASOUND EQUIPMENT FOR NEVADA CLINICS | $36,654 | |||||
| NEVADA RURAL HOSPITAL PARTNERS FOUNDATION INC | ||||||||||||
| 4600 KIETZKE LANE | RENO | NV | 89502 | N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL NEVADA HOSPITALS | $33,000 | |||||
| NEW DESTINY HOUSING CORPORATION | ||||||||||||
| 12 W 37TH STREET 7TH FLOOR | NEW YORK | NY | 10018 | N/A | PC | PILOTING AFTERCARE INTERVENTION TO IMPROVE HOUSING AND HEALTH STABILITY FOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS | $296,096 | |||||
| NEW VENTURE FUND | ||||||||||||
| 1201 CONNECTICUT AVE NW SUITE 300 | WASHINGTON | DC | 20036 | N/A | PC | TYPE 1 DIABETES CAMPS PROJECT (2022 - 2024) | $1,435,500 | |||||
| NEW YORK CITY BALLET INC | ||||||||||||
| DAVID H KOCH THEATER | NEW YORK | NY | 10023 | N/A | PC | GENERAL OPERATING SUPPORT FOR NEW COMBINATIONS FUND | $15,000 | |||||
| NEW YORK CITY HEALTH AND HOSPITALS CORPORATION | ||||||||||||
| 125 WORTH STREET | NEW YORK | NY | 10013 | N/A | PC | EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC | $800,000 | |||||
| NEW YORK UNIVERSITY | ||||||||||||
| 665 BROADWAY | NEW YORK | NY | 10012 | N/A | PC | ANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS | $101,043 | |||||
| NEW YORK UNIVERSITY | ||||||||||||
| 665 BROADWAY | NEW YORK | NY | 10012 | N/A | PC | EVALUATION OF PILOT INTERVENTIONS FOR THE COLLABORATIVE FOR HOMELESS HEALTHCARE | $205,596 | |||||
| NEW YORK UNIVERSITY | ||||||||||||
| 665 BROADWAY | NEW YORK | NY | 10012 | N/A | PC | IDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHN'S DISEASE | $1,046,686 | |||||
| NORTH DAKOTA DEPARTMENT OF HEALTH | ||||||||||||
| 600 E BOULEVARD AVENUE | BISMARCK | ND | 585050200 | N/A | GOV | NORTH DAKOTA LAW ENFORCEMENT AED PROJECT | $146,189 | |||||
| NORTHERN ITASCA HOSPITAL DISTRICT | ||||||||||||
| 258 PINE TREE DRIVE | BIGFORK | MN | 56628 | N/A | GOV | BIGFORK VALLEY HOSPITAL ULTRASOUND PROJECT | $102,400 | |||||
| NORTHERN WESTCHESTER HOSPITAL ASSOCIATION | ||||||||||||
| 400 EAST MAIN STREET | MOUNT KISCO | NY | 10549 | N/A | PC | MATERNAL CHILD HEALTH UNIT FACILITIES RENOVATION | $200,000 | |||||
| NURU INTERNATIONAL | ||||||||||||
| 2020 PENNSYLVANIA AVE NW | WASHINGTON | CA | 20006 | N/A | PC | EXPANDING AND SUSTAINING AGRIBUSINESS IMPACT IN ETHIOPIA | $300,000 | |||||
| OAKLAND UNIVERSITY | ||||||||||||
| 2200 NORTH SQUIRREL ROAD | ROCHESTER | MI | 48309 | N/A | GOV | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 1) | $780,628 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT | $784,875 | |||||
| ORTONVILLE AREA HEALTH SERVICES | ||||||||||||
| 450 EASTVOLD AVENUE | ORTONVILLE | MN | 56278 | N/A | GOV | ORTONVILLE AREA HEALTH SERVICES ULTRASOUND PROJECT | $102,614 | |||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | ||||||||||||
| 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $499,175 | |||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | ||||||||||||
| 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $500,825 | |||||
| PANORAMA GLOBAL | ||||||||||||
| 2101 FOURTH AVENUE SUITE 2100 | SEATTLE | WA | 98121 | N/A | PC | PANORAMA - TYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND | $999,473 | |||||
| PATH | ||||||||||||
| 2201 WESTLAKE AVENUE | SEATTLE | WA | 98121 | N/A | PC | THE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE | $2,004,478 | |||||
| PATH | ||||||||||||
| 2201 WESTLAKE AVENUE | SEATTLE | WA | 98121 | N/A | PC | GENERAL OPERATING SUPPORT FOR THE COALITION FOR ACCESS TO NCD MEDICINES & PRODUCTS | $17,750 | |||||
| PAWNEE COUNTY MEMORIAL HOSPITAL | ||||||||||||
| 600 I STREET | PAWNEE CITY | NE | 68420 | N/A | GOV | ECARE PHARMACY AT PAWNEE COUNTY MEMORIAL HOSPITAL | $17,845 | |||||
| PENNINGTON COUNTY HEALTH AND HUMAN SERVICES | ||||||||||||
| 321 KANSAS CITY STREET | RAPID CITY | SD | 57701 | N/A | GOV | PENNINGTON COUNTY CRISIS STABILIZATION UNIT | $2,000,000 | |||||
| PERHAM HOSPITAL DISTRICT | ||||||||||||
| 1000 CONEY STREET WEST | PERHAM | MN | 56573 | N/A | GOV | PERHAM HEALTH VASCULAR ULTRASOUND SERVICE EXPANSION PROJECT | $38,000 | |||||
| PERKINS COUNTY HOSPITAL DISTRICT | ||||||||||||
| 900 LINCOLN AVE | GRANT | NE | 69140 | N/A | GOV | TELE-EMERGENCY SERVICES FOR PERKINS COUNTY HEALTH SERVICES | $106,817 | |||||
| PHILIP HEALTH SERVICES INC | ||||||||||||
| 503 W PINE STREET | PHILIP | SD | 57567 | N/A | PC | IMPLEMENTATION OF AVERA EEMERGENCY AT PHILIP HEALTH SERVICES | $12,317 | |||||
| PHILLIPS COUNTY HOSPITAL ASSOCIATION | ||||||||||||
| 311 S 8TH AVENUE EAST | MALTA | MT | 59538 | N/A | PC | TELE-EMERGENCY AND TELE-PHARMACY AT PHILLIPS COUNTY | $234,588 | |||||
| PIONEER MEDICAL CENTER | ||||||||||||
| 301 WEST 7TH AVE | BIG TIMBER | MT | 59011 | N/A | PC | TELE-PHARMACY AT PIONEER MEDICAL CENTER | $339,522 | |||||
| PIPESTONE COUNTY MEDICAL CENTER | ||||||||||||
| 916 4TH AVE SW | PIPESTONE | MN | 56164 | N/A | GOV | PCMC ULTRASOUND REVITALIZATION PROJECT. | $141,701 | |||||
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | ||||||||||||
| 1033 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 021385366 | N/A | PC | PRE-SYMPTOMATIC AUTOANTIBODY AND VIRAL PROFILE OF US MILITARY PERSONNEL WITH ADULT-ONSET TYPE 1 DIABETES | $274,787 | |||||
| PROJECT HOSPITALITY INC | ||||||||||||
| 100 PARK AVENUE | STATEN ISLAND | NY | 10302 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | |||||
| PROJECT NYAME NSA LTD | ||||||||||||
| 33 WILLETS LANE | MANHASSET | NY | 11030 | N/A | PC | PROJECT NYAME NSA ZAMBIA EXPANSION | $241,600 | |||||
| PROJECT NYAME NSA LTD | ||||||||||||
| 33 WILLETS LANE | MANHASSET | NY | 11030 | N/A | PC | FARM EXPANSION FOR SUSTAINABILITY | $1,215,500 | |||||
| PROVIDENCE MEDICAL CENTER | ||||||||||||
| 1200 PROVIDENCE ROAD | WAYNE | NE | 68787 | N/A | PC | EPHARMACY AT PROVIDENCE MEDICAL CENTER | $8,457 | |||||
| PUBLIC HEALTH SOLUTIONS | ||||||||||||
| 40 WORTH STREET 5TH FLOOR | NEW YORK | NY | 10013 | N/A | PC | NEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS | $812,335 | |||||
| PUBLIC HEALTH SOLUTIONS | ||||||||||||
| 40 WORTH STREET 5TH FLOOR | NEW YORK | NY | 10013 | N/A | PC | NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE | $900,000 | |||||
| PULITZER CENTER ON CRISIS REPORTING | ||||||||||||
| 1779 MASSACHUSETTS AVE NW | WASHINGTON | DC | 20036 | N/A | PC | BUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION | $302,170 | |||||
| RAMBAM HEALTH CORPORATION | ||||||||||||
| N/A | PC | MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S | $951,750 | HAALIA HASNIA 8 | HAIFA | IS | ||||||
| RED LAKE INDIAN HEALTH SERVICES | ||||||||||||
| 24760 HOSPITAL DRIVE | RED LAKE | MN | 56671 | N/A | GOV | RED LAKE IHS HOSPITAL ULTRASOUND PROJECT | $179,899 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | $187,370 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | USING NATURAL LANGUAGE PROCESSING OF CLINICAL DOCUMENTATION TO IMPROVE PERSONALIZATION OF CARE IN CROHN'S DISEASE | $385,780 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 55455 | N/A | GOV | PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES | $250,000 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 55455 | N/A | GOV | REDEFINING THE FUTURE OF EMERGENCY MEDICINE | $5,026,234 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 55455 | N/A | GOV | DEVELOPING OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES | $285,177 | |||||
| REGION HOVEDSTADEN | ||||||||||||
| N/A | GOV | CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES? | $104,349 | KONGENS VNGE 2 | HILLEROD | DA | ||||||
| RENOWN HEALTH FOUNDATION | ||||||||||||
| 245 E LIBERTY ST | RENO | NV | 89501 | N/A | PC | SIMULATION AND INNOVATION CENTER AT RENOWN HEALTH | $3,099,867 | |||||
| RESEARCH TRIANGLE INSTITUTE | ||||||||||||
| 3040 EAST CORNWALLIS ROAD | RESEARCH TRIANGLE PARK | NC | 277092194 | N/A | PC | USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY | $1,172,646 | |||||
| RIDGEVIEW MEDICAL CENTER | ||||||||||||
| 500 SOUTH MAPLE STREET | WACONIA | MN | 55387 | N/A | PC | RIDGEVIEW SIBLEY AND LE SUEUR MEDICAL CENTERS ULTRASOUND PROJECT | $28,382 | |||||
| RIVER'S EDGE HOSPITAL AND CLINIC | ||||||||||||
| 1900 N SUNRISE DRIVE | ST PETER | MN | 56082 | N/A | GOV | TELE-EMERGENCY SERVICES FOR RIVER'S EDGE HOSPITAL | $135,695 | |||||
| ROUNDABOUT THEATRE COMPANY INC | ||||||||||||
| 231 W 39TH STREET 1200 | NEW YORK | NY | 10018 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | |||||
| ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING-MCGILL UNI | ||||||||||||
| N/A | PC | THE HUMAN CELL ATLAS: ETHICS AND DATA GOVERNANCE | $189,596 | JAMES ADMINISTRATION BUILDING | MONTREAL | CA | ||||||
| SAFE WATER NETWORK | ||||||||||||
| 122 EAST 42ND STREET | NEW YORK | NY | 10168 | N/A | PC | SCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY | $1,595,750 | |||||
| SAINT LOUIS UNIVERSITY | ||||||||||||
| 221 NORTH GRAND BOULEVARD | SAINT LOUIS | MO | 63103 | N/A | PC | IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES | $765,477 | |||||
| SANFORD RESEARCH | ||||||||||||
| 2301 E 60TH STREET N | SIOUX FALL | SD | 571040569 | N/A | PC | PLEDGE PHASE 3 | $1,013,239 | |||||
| SANFORD RESEARCH | ||||||||||||
| 2301 E 60TH STREET N | SIOUX FALL | SD | 571040569 | N/A | PC | SANFORD PLEDGE: PHASES 1 AND 2 | $212,565 | |||||
| SANFORD | ||||||||||||
| 801 BROADWAY N | FARGO | ND | 581023641 | N/A | PC | SANFORD HEALTH ULTRASOUND PROJECT | $2,894,734 | |||||
| SAPIR ACADEMIC COLLEGE | ||||||||||||
| N/A | PC | PLANNING FOR SAPIR ACADEMIC COLLEGE LAW SCHOOL BUILDING | $447,000 | DN HOF ASHKELON | REGIONAL COUNCIL SHAAR HA | IS | ||||||
| SEATTLE CHILDREN'S HOSPITAL | ||||||||||||
| PO BOX 5731 M/S S-200 | SEATTLE | WA | 981455005 | N/A | PC | DEVELOPMENT OF ANTIGEN-SPECIFIC ETREG THERAPY IN T1D - STAGE 3 STUDIES | $1,224,949 | |||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT | $1,143,133 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK: THE PIONIR TRIAL (PREVENTING IBD ONSET IN INDIVIDUALS AT RISK) | $148,825 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | SUPPORT OF IMAGING AND PATIENT TREATMENT EQUIPMENT FOR THE HELMSLEY CANCER CENTER AND THE HELMSLEY NEUROLOGICAL INSTITUTE | $2,342,997 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | UPGRADED PET-CT SCANNER UTILIZING NEW TECHNOLOGICAL DEVELOPMENTS FOR MORE ACCURATE, QUICKER AND SAFER DIAGNOSIS AND MONITORING. | $2,700,000 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | RCT OF TASTY & HEALTHY DIETARY APPROACH FOR REMISSION IN CROHNS DISEASE | $527,468 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK: THE PIONIR TRIAL (PREVENTING IBD ONSET IN INDIVIDUALS AT RISK) | $355,916 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | THE HELMSLEY CANCER CENTER AT SHAARE ZEDEK MEDICAL CENTER JERUSALEM | $5,226,272 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHATTERPROOF A NONPROFIT CORP | ||||||||||||
| 101 MERRITT 7 CORPORATE PARK 1ST | NORWALK | CT | 06851 | N/A | PC | GENERAL OPERATING SUPPORT | $230,000 | FLOOR | ||||
| SHENANDOAH MEDICAL CENTER | ||||||||||||
| 300 PERSHING AVE | SHENANDOAH | IA | 51601 | N/A | PC | SHENANDOAH MEDICAL CENTER / AVERA EEMERGENCY IMPLEMENTATION PROJECT | $15,320 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $700,000 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA | $108,298 | |||||
| SIOUX VALLEY MEMORIAL HOSPITAL ASSOCIATION | ||||||||||||
| 300 SIOUX VALLEY DRIVE | CHEROKEE | IA | 51012 | N/A | PC | ECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER | $13,877 | |||||
| SNV NETHERLANDS DEVELOPMENT ORGANISATION | ||||||||||||
| N/A | PC | HEALTHY FUTURE FOR ALL (HF4A) IMPROVING WATER, SANITATION, HYGIENE AND NUTRITION | $1,207,754 | PARKSTRAAT 83 | DEN HAAG | NL | ||||||
| SOCIAL SCIENCE RESEARCH COUNCIL | ||||||||||||
| ONE PIERREPONT PLAZA 15TH FLOOR | BROOKLYN | NY | 11201 | N/A | PC | DATA2GO.NYC REVAMP AND DATA CLINIC | $1,024,408 | |||||
| SOCIETY FOR THE PRESERVATION OF NEW ENGLAND ANTIQUITIES | ||||||||||||
| 141 CAMBRIDGE STREET | BOSTON | MA | 02114 | N/A | PC | GENERAL OPERATING SUPPORT | $40,000 | |||||
| SOS CHILDREN'S VILLAGES-USA INC | ||||||||||||
| 1620 I STREET NW SUITE 220 | WASHINGTON | DC | 20006 | N/A | PC | EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA | $1,386,577 | |||||
| SOUTH LINCOLN HOSPITAL DISTRICT | ||||||||||||
| 711 ONYX ST | KEMMERER | WY | 83101 | N/A | GOV | TELE-EMERGENCY AT SOUTH LINCOLN MEDICAL CENTER | $151,487 | |||||
| SOUTHSIDE COMMUNITY HEALTH SERVICES INC | ||||||||||||
| 4243 4TH AVE SOUTH | MINNEAPOLIS | MN | 55409 | N/A | PC | SOUTHSIDE COMMUNITY HEALTH SERVICES ULTRASOUND PROJECT | $53,240 | |||||
| ST LUKE HEALTH CARE FOUNDATION | ||||||||||||
| 28W609 HICKORY LN | WEST CHICAGO | IL | 60185 | N/A | PC | REPLACEMENT OF ESSENTIAL HEALTH CARE EQUIPMENT | $1,005,020 | |||||
| ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH | ||||||||||||
| N/A | PC | WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D? | $343,506 | 9 PRINCES ST | MELBOURNE | AS | ||||||
| STEVENS COMMUNITY MEDICAL CENTER INC | ||||||||||||
| 400 EAST 1ST STREET | MORRIS | MN | 56267 | N/A | PC | ULTRASOUND REVITALIZATION PROJECT | $130,205 | |||||
| STICHTING ACCESS TO MEDICINE FOUNDATION | ||||||||||||
| N/A | PC | EXPANDING ACCESS TO T1D CARE | $750,000 | NARITAWEG 227 | AMSTERDAM | NL | ||||||
| STICHTING HEALTH ACTION INTERNATIONAL | ||||||||||||
| N/A | PC | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE III | $1,287,681 | OVERTOOM 60/II | AMSTERDAM | NL | ||||||
| STICHTING PHARMACCESS INTERNATIONAL | ||||||||||||
| N/A | PC | MED4ALL EXPANSION | $1,712,785 | AHTC TOWER C4 PAASHEUVELWEG 25 | AMSTERDAM | NL | ||||||
| STIFTELSEN FOR UTBILDNING (IOIBD) | ||||||||||||
| N/A | PC | THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD | $132,000 | DEPT OF GASTROENTEROLOGY | OREBRO | SW | ||||||
| SWIFT COUNTY-BENSON HOSPITAL | ||||||||||||
| 1815 WISCONSIN AVENUE | BENSON | MN | 56215 | N/A | GOV | SWIFT COUNTY BENSON HOSPITAL ULTRASOUND PROJECT | $252,828 | |||||
| SYNERGOS INSTITUTE INC | ||||||||||||
| 3 EAST 54TH STREET | NEW YORK | NY | 10022 | N/A | PC | IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS | $1,063,518 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $1,285,307 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $325,000 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $325,000 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $1,285,307 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | A DATA DRIVEN APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH TYPE 1 DIABETES | $261,908 | |||||
| TEAR AUSTRALIA | ||||||||||||
| N/A | PC | FACILITATE SECURE ENVIRONMENTS FOR AMPLIFIED NUTRITION | $224,000 | 1/4 SOLWOOD LANE | BLACKBURN | AS | ||||||
| TECHNISCHE UNIVERSITAET MUENCHEN | ||||||||||||
| N/A | GOV | METAGENOMIC PILOT PROJECT | $245,905 | ARCISSTRABE 21 | MUNCHEN | GM | ||||||
| TECHNISCHE UNIVERSITAT DRESDEN | ||||||||||||
| N/A | GOV | FR1DA IN SACHSEN | $52,102 | HELMHOLTZSTR 10 | DRESDEN | GM | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| N/A | GOV | IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS | $385,330 | WEIZMAN 6 | TEL AVIV | IS | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| N/A | GOV | GENETICS INSTITUTE AND GENOMICS CENTER | $1,576,052 | WEIZMAN 6 | TEL AVIV | IS | ||||||
| THE ACADEMIC COLLEGE AT TEL-HAI | ||||||||||||
| N/A | PC | THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH | $1,685,000 | TEL-HAI COLLEGE | UPPER GALILEE | IS | ||||||
| THE ASPEN INSTITUTE INC | ||||||||||||
| 2300 N STREET | WASHINGTON | DC | 20037 | N/A | PC | BUILDING VISIONARY AND EFFECTIVE TEAMS TO ACCELERATE PROGRESS AGAINST TYPE 1 DIABETES (T1D) AND OTHER NON-COMMUNICABLE DISEASES (NCDS) | $996,251 | |||||
| THE BARUCH PADEH MEDICAL CENTER PORIYA | ||||||||||||
| N/A | GOV | THE HELMSLEY REHABILITATION CENTER OF THE NORTH | $4,453,113 | THE BARUCH PADEH MEDICAL CENTERPORI | TIBERIAS | IS | A | |||||
| THE BARUCH PADEH MEDICAL CENTER PORIYA | ||||||||||||
| N/A | GOV | ROBOTIC ASSISTED SURGERY - PURCHASE OF A SURGICAL ROBOT | $2,500,000 | THE BARUCH PADEH MEDICAL CENTERPORI | TIBERIAS | IS | A | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS | $956,452 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | $1,500,000 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | A HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE | $463,755 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | $1,500,000 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | A HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE | $463,751 | |||||
| THE CENTER FOR EFFECTIVE PHILANTHROPY INC | ||||||||||||
| 675 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | N/A | PC | GENERAL OPERATING SUPPORT | $41,500 | |||||
| THE CHINESE UNIVERSITY OF HONG KONG | ||||||||||||
| N/A | PC | IBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY | $430,508 | PI CHIU BUILDING | SHATIN | HK | ||||||
| THE CHINESE UNIVERSITY OF HONG KONG | ||||||||||||
| N/A | PC | MOTHER-TO-INFANT TRANSFER OF BACTERIOME, VIROME, FUNGOME AND METABOLOME IN HEALTH AND CROHN'S DISEASE (MOMMY-CD) | $492,017 | PI CHIU BUILDING | SHATIN | HK | ||||||
| THE CHINESE UNIVERSITY OF HONG KONG | ||||||||||||
| N/A | PC | IBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY | $251,789 | PI CHIU BUILDING | SHATIN | HK | ||||||
| THE CITY OF HOPE | ||||||||||||
| 1500 E DUARTE RD | DUARTE | CA | 91010 | N/A | PC | GENETIC PROTECTION BY HLA-DQ6 IN T1D | $197,874 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | DEVELOPMENT OF AN INTESTINAL ULTRASOUND INDEX AND A HISTOPATHOLOGY INDEX FOR STRICTURING SMALL BOWEL CROHNS DISEASE | $348,000 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | $155,544 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | CROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | $1,335,936 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | THE MILESTONE INITIATIVE: EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA | $41,415 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | CROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | $954,604 | |||||
| THE COMMUNICATIONS NETWORK | ||||||||||||
| 1717 NORTH NAPER BLVD | NAPERVILLE | IL | 60563 | N/A | PC | GENERAL OPERATING SUPPORT | $31,000 | |||||
| THE DIATRIBE FOUNDATION | ||||||||||||
| 804 HAIGHT STREET | SAN FRANCISCO | CA | 94117 | N/A | PC | DIATRIBE LEARN MENTAL HEALTH SERIES | $99,715 | |||||
| THE END FUND INC | ||||||||||||
| 2 PARK AVENUE 18TH FLOOR | NEW YORK | NY | 10016 | N/A | PC | NEGLECTED TROPICAL DISEASE: REACHING THE LAST MILE | $22,500,000 | |||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | VISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CROHNS DISEASE: A KNOWLEDGE TRANSLATION STRATEGY | $89,047 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | QUANTITATIVE PROTEOMIC PROFILING OF FIBROSTENOTIC CROHNS DISEASE PATIENTS | $419,010 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $122,854 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | VISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CROHNS DISEASE: A KNOWLEDGE TRANSLATION STRATEGY | $89,047 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | THE CHANGING EPIDEMIOLOGY AND DEMOGRAPHICS OF CROHNS DISEASE IN THE WESTERN WORLD OVER THE NEXT DECADE | $186,777 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $119,554 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE HARDING FORD VISION INC | ||||||||||||
| 157-22 TUSKEGEE AIRMEN WAY | JAMAICA | NY | 11433 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | |||||
| THE HOLE IN THE WALL GANG FUND INC | ||||||||||||
| 555 LONG WHARF DRIVE | NEW HAVEN | CT | 06511 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | |||||
| THE HOSPITAL FOR SICK CHILDREN | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES | $589,623 | 555 UNIVERSITY AVE | TORONTO | CA | ||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | ||||||||||||
| N/A | PC | UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE | $997,937 | EXHIBITION RD | LONDON | UK | ||||||
| THE JEWISH AGENCY FOR ISRAEL | ||||||||||||
| N/A | PC | FLIGHTS FOR NEW IMMIGRANTS FROM RUSSIA | $3,000,000 | 48 KING GEORGE STREET | JERUSALEM | IS | ||||||
| THE JEWISH AGENCY FOR ISRAEL | ||||||||||||
| N/A | PC | THE JEWISH AGENCY SECURITY FUND (THE FUND) | $645,910 | 48 KING GEORGE STREET | JERUSALEM | IS | ||||||
| THE LEGATUM INSTITUTE FOUNDATION | ||||||||||||
| N/A | NC | PHASE TWO OF US PROSPERITY INDEX: EXPANDING COUNTY-LEVEL INDEX TO INCLUDE WYOMING AND DEEPENING IMPACT | $50,000 | 11 CHARLES STREET | LONDON | UK | ||||||
| THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL LTD (CC) | ||||||||||||
| N/A | PC | OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN-ISRAELIS PURSUING NURSING DEGREES | $220,000 | YEZREEL VALLEY | YEZREEL VALLEY | IS | ||||||
| THE MILKEN INSTITUTE | ||||||||||||
| 1250 FOURTH STREET | SANTA MONICA | CA | 90401 | N/A | PC | FASTERCURES LEADERSLINK PROGRAM EXPANSION | $250,000 | |||||
| THE ONE LOVE FOUNDATION IN HONOR OF YEARDLEY LOVE INC | ||||||||||||
| 44 PONDFIELD ROAD SUITE 12 | BRONXVILLE | NY | 10708 | N/A | PC | BUILDING FOR THE FUTURE | $1,023,100 | |||||
| THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | CHARLOTTESVILLE | VA | 229044195 | N/A | PC | TYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS | $211,526 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE | ||||||||||||
| 120 THEORY SUITE 200 | IRVINE | CA | 926971050 | N/A | PC | DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D | $335,309 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | N/A | PC | THE DRUGGABLE GPCROME IN CROHNS DISEASE | $1,309,981 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | N/A | PC | MECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN | $1,015,503 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | IDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF PATIENT REGISTRY | $433,333 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | ENGINEERING ISLET ANTIGEN-SPECIFIC TREGS FOR T1D | $537,711 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $480,988 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION | $1,111,050 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | CULTURALLY SENSITIVE GROUP CLINIC MODEL FOR DIABETES CARE FOR LATINO PATIENTS: FEASIBILITY AND DISSEMINATION TO DIABETES CENTERS IN THE US | $607,893 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | SEEDS PATHWAY: SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY | $1,047,134 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | TRIAL OF EARLY INITIATION OF CGM-GUIDED INSULIN THERAPY IN T1D | $155,376 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | COMPLEMENT SYSTEM IN THE INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY | $99,618 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | $1,169,515 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL | $300,000 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | FAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02 | $266,200 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | DIABETIC KETOACIDOSIS TRENDS AND RESOURCE UTILIZATION AT DIAGNOSIS OF TYPE 1 DIABETES IN THE UNITED STATES | $330,758 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | SINGLE PERSISTENT ISLET AUTOANTIBODY (SPIA) PHENOTYPE: PERSONALIZED RISK ASSESSMENT | $264,341 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | ASK THE EXPERTS | $543,207 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION | $580,677 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | EVALUATING THE FEASIBILITY OF AUTOMATED INSULIN DELIVERY IN PRIMARY CARE AND THROUGH TELEHEALTH | $705,874 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF NEW MEXICO | ||||||||||||
| SPONSORED PROJECTS - PREAWARD | ALBUQUERQUE | NM | 871310001 | N/A | GOV | THE ECHO INSTITUTE: ADDRESSING GLOBAL HEALTHCARE DISPARITIES THROUGH REPLICATION OF THE ECHO MODEL | $1,188,238 | |||||
| THE SDEROT DEVELOPMENT FOUNDATION | ||||||||||||
| N/A | PC | SDEROT MEDICAL CENTER | $1,179,326 | 6 BAR LEV STREET | SDEROT | IS | ||||||
| THE SDEROT DEVELOPMENT FOUNDATION | ||||||||||||
| N/A | PC | SDEROT RESILIENCE COMPLEX, RESILIENCE CENTER AND PARENTHOOD HOUSE | $184,286 | 6 BAR LEV STREET | SDEROT | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | PURCHASING THE REQUISITE EQUIPMENT FOR ESTABLISHING THE SHEBA PANDEMIC PREPAREDNESS RESEARCH INSTITUTE (SPRI) | $2,739,000 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | $798,066 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | THE HELMSLEY CENTER FOR INNOVATIVE SURGICAL TRAINING | $3,614,073 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE SONIA NABETA FOUNDATION INC | ||||||||||||
| PO BOX 2222 | NEW YORK | NY | 100082222 | N/A | PC | PROJECT BODA-BODA | $412,944 | |||||
| THE SONIA NABETA FOUNDATION INC | ||||||||||||
| PO BOX 2222 | NEW YORK | NY | 100082222 | N/A | PC | PROJECT BODA-BODA | $76,580 | |||||
| THE TEL AVIV JAFFA ACADEMIC COLLEGE | ||||||||||||
| N/A | PC | SCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX (HAREDI) MEN PURSUING B.S. DEGREES IN NURSING | $306,724 | RABENU YERUHAM ST 2 POB 8401 | TEL AVIV YAFFO | IS | ||||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $210,638 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | SUPPORT FOR T1D TRANSITION PROGRAMS | $250,000 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | WEBSITE FOR THE NYC*T1D NETWORK | $10,000 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | SPATIALLY RESOLVED GENOMIC PROFILING AT SUB-CELLULAR RESOLUTION AND HIGH THROUGHPUT OF CROHNS DISEASE TISSUE BIOPSIES | $210,228 | |||||
| THE UNITED NATIONS INSTITUTE FOR TRAINING AND RESEARCH | ||||||||||||
| N/A | PC | ACCELERATING ACCESS TO TREATMENT AND CARE FOR PEOPLE LIVING WITH NON-COMMUNICABLE DISEASES IN LOW AND MIDDLE-INCOME COUNTRIES. | $1,000,000 | UNITED NATIONS INSTITUTE FOR | GENEVA | SZ | TRAINING AND RESEARCH | |||||
| THE UNIVERSITY OF ADELAIDE | ||||||||||||
| N/A | PC | ENDIA EXPANDED SUPPORT | $256,408 | THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | ||||||
| THE UNIVERSITY OF ADELAIDE | ||||||||||||
| N/A | PC | ENDIA SCIENCE CONTINUATION | $612,868 | THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | ||||||
| THE UNIVERSITY OF CHICAGO | ||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND | $484,264 | |||||
| THE UNIVERSITY OF CHICAGO | ||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | IMMUNO-PHARMACOGENOMICS TO UNDERSTAND AND PREDICT RESPONSE TO BIOLOGICS IN CROHN'S DISEASE | $305,353 | |||||
| THE UNIVERSITY OF CHICAGO | ||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | A CELL ATLAS OF ILEAL COLONIC CROHN'S DISEASE | $487,806 | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | MITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC) | $618,790 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $444,247 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $382,456 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF MANCHESTER | ||||||||||||
| N/A | PC | A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION | $1,177,927 | OXFORD RD | MANCHESTER | UK | ||||||
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | ||||||||||||
| 5323 HARRY HINES BOULEVARD | DALLAS | TX | 753909020 | N/A | GOV | IMMUNE CHECKPOINT ENGINEERED BETA CELL AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF TYPE I DIABETES | $275,000 | |||||
| THE UNIVERSITY OF WESTERN AUSTRALIA | ||||||||||||
| N/A | PC | CGM ASSESSMENTS OF ENDIA CHILDREN | $72,816 | 35 STIRLING HIGHWAY | CRAWLEY | AS | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | $2,000,000 | 234 HERZEL ST | REHOVOT | IS | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | DECODING THE CLINICAL IMPACT OF HOST AND MICROBIAL INTESTINAL PROTEOMIC LANDSCAPE IN CROHNS DISEASE | $701,115 | 234 HERZEL ST | REHOVOT | IS | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | THE QUANTUM MATERIALS DEVICES FABRICATION LAB | $660,000 | 234 HERZEL ST | REHOVOT | IS | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | DECODING PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IMPACTING CLINICAL AND PROGNOSTIC FEATURES IN CROHNS DISEASE | $1,320,206 | 234 HERZEL ST | REHOVOT | IS | ||||||
| TIDEPOOL PROJECT | ||||||||||||
| 555 BRYANT STREET 429 | PALO ALTO | CA | 94301 | N/A | PC | TIDEPOOL DATA PLATFORM EXPANSION | $500,000 | |||||
| TIDEPOOL PROJECT | ||||||||||||
| 555 BRYANT STREET 429 | PALO ALTO | CA | 94301 | N/A | PC | TIDEPOOL DATA PLATFORM EXPANSION | $500,000 | |||||
| TIDEPOOL PROJECT | ||||||||||||
| 555 BRYANT STREET 429 | PALO ALTO | CA | 94301 | N/A | PC | TIDEPOOL DATA PLATFORM EXPANSION | $1,000,000 | |||||
| TIDEPOOL PROJECT | ||||||||||||
| 555 BRYANT STREET 429 | PALO ALTO | CA | 94301 | N/A | PC | EXPANDING THE AVAILABILITY OF THE LOOP AID SYSTEM | $421,085 | |||||
| TOWNSEND HEALTH SYSTEMS INC | ||||||||||||
| 110 NORTH OAK | TOWNSEND | MT | 59644 | N/A | PC | TELE-PHARMACY AT BILLINGS CLINIC BROADWATER | $35,128 | |||||
| TRICKLE UP PROGRAM INC | ||||||||||||
| 104 WEST 27TH STREET 12TH FLOOR | NEW YORK | NY | 10001 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | |||||
| TRI-COUNTY HOSPITAL INC | ||||||||||||
| 415 JEFFERSON ST N | WADENA | MN | 56482 | N/A | PC | TRI-COUNTY HEALTH CARE ULTRASOUND PROJECT | $400,329 | |||||
| TRUSTEES OF INDIANA UNIVERSITY | ||||||||||||
| 509 E 3RD ST | BLOOMINGTON | MI | 474013654 | N/A | GOV | TARGETING METABOLIC DRIVERS OF B CELL DIFFERENTIATION IN TYPE 1 DIABETES | $114,365 | |||||
| TRUSTEES OF INDIANA UNIVERSITY | ||||||||||||
| 509 E 3RD ST | BLOOMINGTON | MI | 474013654 | N/A | GOV | MOLECULAR DESIGN AND TESTING OF GLUCOSE-RESPONSIVE THERAPIES | $696,962 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS | $407,000 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE | $285,463 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE | $285,463 | |||||
| UNITED HOSPITAL DISTRICT INC | ||||||||||||
| 515 SOUTH MOORE STREET | BLUE EARTH | MN | 56013 | N/A | PC | UNITED HOSPITAL DISTRICT INC. ULTRASOUND PROJECT | $240,907 | |||||
| UNITED NATIONS DEVELOPMENT PROGRAMME | ||||||||||||
| 1 UNITED NATIONS PLAZA | NEW YORK | NY | 10017 | N/A | PC | INCREASING ACCESS TO HEALTHCARE FOR PEOPLE LIVING WITH DIABETES AND OTHER NCDS | $377,955 | |||||
| UNITED STATES AFRICAN DEVELOPMENT FOUNDATION | ||||||||||||
| 1400 I STREET NW | WASHINGTON | DC | 20005 | N/A | GOV | LIVELIHOOD IMPROVEMENT PROGRAM | $1,779,762 | |||||
| UNIVERSITE CATHOLIQUE DE LOUVAIN | ||||||||||||
| N/A | PC | STUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN WITH T1D | $147,087 | PLACE DE LUNIVERSITE 1 | LOUVAINLANEUVE | BE | ||||||
| UNIVERSITE LIBRE DE BRUXELLES | ||||||||||||
| N/A | GOV | GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING | $295,566 | AVENUE FRANKLIN ROOSEVELT 50 | BRUSSELS | BE | ||||||
| UNIVERSITY OF BIRMINGHAM | ||||||||||||
| N/A | PC | DEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES: AN EXPERIMENTAL MEDICINE STUDY | $322,498 | INSTITUTE OF IMMUNOLOGY AND | BIRMINGHAM | UK | IMMUNOTHERAPY | |||||
| UNIVERSITY OF BRISTOL | ||||||||||||
| N/A | PC | TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY | $407,937 | SENATE HOUSE | BRISTOL | UK | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| N/A | PC | EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE | $711,485 | THE OLD SCHOOLS | CAMBRIDGE | UK | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| N/A | PC | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2) | $496,568 | THE OLD SCHOOLS | CAMBRIDGE | UK | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| N/A | PC | STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES | $157,744 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| N/A | PC | ADVANCING B-CELL SPECIFIC THERAPY BY IDENTIFYING B-CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS | $190,161 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| N/A | PC | STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES | $30,509 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | ||||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | N/A | GOV | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | $837,493 | |||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | N/A | GOV | THE NETWORK FOR PANCREATIC ORGAN DONORS WITH DIABETES (NPOD): A COLLABORATIVE TYPE 1 DIABETES RESEARCH PROJECT | $1,199,692 | |||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | N/A | GOV | HUMAN ATLAS OF NEONATAL DEVELOPMENTAL AND EARLY LIFE PANCREAS / IMMUNITY (HANDEL)-P/I CONTINUATION | $1,043,638 | |||||
| UNIVERSITY OF GLASGOW COURT | ||||||||||||
| N/A | PC | COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY | $672,494 | UNIVERSITY AVENUE | GLASGOW | UK | ||||||
| UNIVERSITY OF IOWA | ||||||||||||
| DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | N/A | GOV | SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION | $194,408 | |||||
| UNIVERSITY OF IOWA | ||||||||||||
| DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | N/A | GOV | SIMULATION IN MOTION IOWA (SIM-IA) | $999,877 | |||||
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||||||
| 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | N/A | PC | PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D | $1,740,145 | |||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | ||||||||||||
| 55 LAKE AVENUE NORTH | WORCESTER | MA | 01655 | N/A | GOV | DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS | $482,825 | |||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | ||||||||||||
| 55 LAKE AVENUE NORTH | WORCESTER | MA | 01655 | N/A | GOV | DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS | $311,133 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | N/A | PC | DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES | $295,977 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | N/A | PC | A HOLISTIC DIET INTERVENTION FOR PEOPLE WITH CROHN'S DISEASE | $471,158 | |||||
| UNIVERSITY OF NEBRASKA FOUNDATION | ||||||||||||
| 1010 LINCOLN MALL | LINCOLN | NE | 68501 | N/A | PC | SIMULATION IN MOTION NEBRASKA SUSTAINABILITY AND BUSINESS MODEL DEVELOPMENT | $582,072 | |||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | PC | DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR | $1,019,519 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | PC | GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES | $585,750 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | PC | MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS | $966,865 | 1350 | ||||
| UNIVERSITY OF NORTH DAKOTA | ||||||||||||
| SCHOOL OF MEDICINE HEALTH SCIENCES | GRAND FORKS | ND | 58202 | N/A | GOV | SIMULATION IN MOTION (SIM) CONSORTIUM | $114,070 | |||||
| UNIVERSITY OF NOTRE DAME DU LAC | ||||||||||||
| 940 GRACE HALL | NOTRE DAME | IN | 465565708 | N/A | PC | DEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM | $397,048 | |||||
| UNIVERSITY OF PITTSBURGH | ||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | ANALOGUE VS HUMAN INSULIN FOR YOUTH WITH TYPE 1 DIABETES IN LOW-RESOURCE SETTINGS: A RANDOMIZED CONTROLLED TRIAL (ANHUT1D TRIAL). | $1,338,570 | |||||
| UNIVERSITY OF PITTSBURGH | ||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | $239,587 | |||||
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||||||
| 3720 SOUTH FLOWER STREET | LOS ANGELES | CA | 900890701 | N/A | PC | CGM REAL WORLD | $120,000 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $63,693 | |||||
| UNIVERSITY OF UTAH | ||||||||||||
| 201 S PRESIDENTS CIRCLE | SALT LAKE CITY | UT | 84112 | N/A | PC | ANTI-PHAGE ANTIBODIES IN STRATIFYING CROHNS DISEASE DIAGNOSIS AND TREATMENT RESPONSE | $203,988 | |||||
| UNIVERSITY OF WASHINGTON | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | SEATTLE | WA | 981959472 | N/A | GOV | PATHOGENIC ACTION OF AUTOANTIBODIES ON ISLET FUNCTION AND VIABILITY IN TYPE 1 DIABETES | $220,000 | |||||
| UNIVERSITY OF ZURICH | ||||||||||||
| N/A | GOV | GENERATE BISPECIFIC INTERLEUKIN-2 IMMUNOTHERAPY TO TREAT T1D MELLITUS | $126,830 | DEPARTMENT OF IMMUNOLOGY | CH | SZ | ||||||
| UPPSALA UNIVERSITET | ||||||||||||
| N/A | GOV | ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION | $76,573 | BOX 256 | UPPSALA | SW | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS | $244,200 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | SCREENING HUMAN ISLETS TO IDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA | $108,069 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | COMBINATORIAL SINGLE CELL STRATEGIES FOR A CROHN'S DISEASE GUT CELL ATLAS | $146,933 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA | $275,000 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS | $244,200 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $140,766 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | COMBINATORIAL SINGLE CELL STRATEGIES FOR A CROHN'S DISEASE GUT CELL ATLAS | $656,092 | |||||
| VANDERBILT UNIVERSITY | ||||||||||||
| SPONSORED PROGRAMS ADMINISTRATION | NASHVILLE | TN | 372032417 | N/A | PC | NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING | $275,000 | |||||
| VAYU HEALTH | ||||||||||||
| 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | N/A | PC | VAYU FEASIBILITY PILOT | $700,486 | |||||
| VAYU HEALTH | ||||||||||||
| 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | N/A | PC | VAYU FEASIBILITY PILOT | $122,000 | |||||
| VAYU HEALTH | ||||||||||||
| 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | N/A | PC | VAYU FEASIBILITY PILOT | $591,068 | |||||
| VETERANS MEMORIAL HOSPITAL | ||||||||||||
| 40 1ST STREET SE | WAUKON | IA | 52172 | N/A | GOV | ECARE PHARMACY AND EMERGENCY SERVICES AT VETERANS MEMORIAL HOSPITAL | $74,191 | |||||
| VILLAGES OF HOPE AFRICA SOCIETY | ||||||||||||
| N/A | PC | VILLAGES OF HOPE COMMUNITY DEVELOPMENT - FOOD PRODUCTION FACILITIES, WATER SUPPLY UPGRADE, AND EDUCATION FACILITIES. | $502,010 | 2450 MILLTOWER COURT | MISSISSAUGA | CA | ||||||
| WARREN COMMUNITY HOSPITAL INC | ||||||||||||
| 300 WEST GOOD SAMARITAN DRIVE | WARREN | MN | 56762 | N/A | PC | NORTH VALLEY HEALTH CENTER ULTRASOUND PROJECT | $146,513 | |||||
| WARREN MEMORIAL HOSPITAL | ||||||||||||
| 905 2ND ST | FRIEND | NE | 68359 | N/A | GOV | TELE-EMERGENCY SERVICES AT FRIEND COMMUNITY HEALTHCARE SYSTEM | $118,006 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 63130 | N/A | PC | CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE | $187,844 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 63130 | N/A | PC | RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING | $330,000 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 63130 | N/A | PC | COVID-19 VACCINE RESPONSES IN PATIENTS WITH AUTOIMMUNE DISEASE (COVARIPAD) | $656,480 | |||||
| WASHOE BARTON MEDICAL CLINIC | ||||||||||||
| 1107 US HIGHWAY 395 N | GARDNERVILLE | NV | 89410 | N/A | PC | CARSON VALLEY MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT | $1,465,248 | |||||
| WATER4 INC | ||||||||||||
| 2405 NW 10TH STREET | OKLAHOMA CITY | OK | 73107 | N/A | PC | SCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER | $1,439,503 | |||||
| WATERAID AMERICA INC | ||||||||||||
| 233 BROADWAY | NEW YORK | NY | 10279 | N/A | PC | RESOLUTION TO REVOLUTION: CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA (R2R) | $2,166,773 | |||||
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 100654805 | N/A | PC | TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE | $863,618 | |||||
| WELIA HEALTH | ||||||||||||
| 301 HIGHWAY 65 S | MORA | MN | 55051 | N/A | PC | WELIA HEALTH ULTRASOUND EQUIPMENT PROJECT | $191,358 | |||||
| WHITE EARTH HEALTH CENTER | ||||||||||||
| 40520 COUNTY HIGHWAY 34 | OGEMA | MN | 56569 | N/A | GOV | NAYTAHWAUSH CLINIC ULTRASOUND PROJECT | $192,403 | |||||
| WHITE EARTH HEALTH CENTER | ||||||||||||
| 40520 COUNTY HIGHWAY 34 | OGEMA | MN | 56569 | N/A | GOV | WHITE EARTH INDIAN HEALTH CENTER ULTRASOUND PROJECT | $188,669 | |||||
| WILDLIFE CONSERVATION SOCIETY | ||||||||||||
| 2300 SOUTHERN BOULEVARD | BRONX | NY | 10460 | N/A | PC | GENERAL OPERATING SUPPORT FOR THE ELEPHANT CONSERVATION PROGRAM | $10,000 | |||||
| WINONA HEALTH SERVICES | ||||||||||||
| 855 MANKATO AVE | WINONA | MN | 55987 | N/A | PC | ULTRASOUND REVITALIZATION PROJECT AT WINONA HEALTH | $216,473 | |||||
| WNET FOR THE WLIW-21 PUBLIC BROADCASTING | ||||||||||||
| 825 EIGHTH AVENUE | NEW YORK | NY | 100197435 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | |||||
| WORLD HEALTH ORGANIZATION | ||||||||||||
| N/A | PC | STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT | $4,420,294 | AVENUE APPIA 20 | GENEVA | SZ | ||||||
| WYOMING DEPARTMENT OF HEALTH | ||||||||||||
| 6101 YELLOWSTONE RD SUITE 400 | CHEYENNE | WY | 82009 | N/A | GOV | WYOMING FIRST RESPONDER AED PROJECT | $167,693 | |||||
| WYOMING STATE PARKS AND CULTURAL RESOURCES | ||||||||||||
| 2301 CENTRAL AVENUE | CHEYENNE | WY | 82002 | N/A | GOV | SHINING MOUNTAINS INTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE | $30,000 | |||||
| YALE UNIVERSITY | ||||||||||||
| OFFICE OF SPONSORED PROJECTS | NEW HAVEN | CT | 065208327 | N/A | PC | EXPOSOMICS FOR EARLY LIFE CROHNS DISEASE | $443,827 | |||||
| YITZHAK SHAMIR MEDICAL CENTER | ||||||||||||
| N/A | GOV | EXPANSION AND RENOVATION OF THE CANCER INSTITUTE AT SHAMIR MEDICAL CENTER | $6,082,143 | BEER YAAKOV | TZRIFIN | IS | ||||||
| YOUTH DEVELOPMENT ORGANIZATION INC | ||||||||||||
| 15 UNION STREET 563 | LAWRENCE | MA | 01840 | N/A | PC | CAPACITY BUILDING PROJECT SUPPORT 2022 | $200,000 | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grant Or Contri Pd Dur Yr | $433,687,275 | TotalGrantOrContriPdDurYrAmt |
Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (641 entries)
| Address Line1RecipientUSAddress/AddressLine1Txt | CityRecipientUSAddress/CityNm | State AbbreviationRecipientUSAddress/StateAbbreviationCd | ZIPRecipientUSAddress/ZIPCd | Recipient RelationshipRecipientRelationshipTxt | Recipient Foundation StatusRecipientFoundationStatusTxt | Grant Or Contribution PurposeGrantOrContributionPurposeTxt | AmtAmt | Address Line1RecipientForeignAddress/AddressLine1Txt | CityRecipientForeignAddress/CityNm | CountryRecipientForeignAddress/CountryCd | Address Line2RecipientUSAddress/AddressLine2Txt | Address Line2RecipientForeignAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A GLIMMER OF HOPE FOUNDATION | ||||||||||||
| 3103 BEE CAVES ROAD | AUSTIN | TX | 78746 | N/A | PF | EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY | $2,053,426 | |||||
| A GLIMMER OF HOPE FOUNDATION | ||||||||||||
| 3103 BEE CAVES ROAD | AUSTIN | TX | 78746 | N/A | PF | EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY | $1,446,574 | |||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | ||||||||||||
| 1300 MORRIS PARK AVE | BRONX | NY | 104611975 | N/A | PC | PRECLINICAL ACTIVITIES TO ADVANCE D-PEPTIDES AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES | $556,499 | |||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | ||||||||||||
| 1300 MORRIS PARK AVE | BRONX | NY | 104611975 | N/A | PC | PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY | $168,556 | |||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | ||||||||||||
| 1300 MORRIS PARK AVE | BRONX | NY | 104611975 | N/A | PC | PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY | $173,613 | |||||
| ALIMENTIV INC | ||||||||||||
| N/A | NC | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | $542,299 | 100 DUNDAS STREET | LONDON | CA | ||||||
| ALIMENTIV INC | ||||||||||||
| N/A | NC | DEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD AND IMPROVE HEALTH OUTCOMES | $267,835 | 100 DUNDAS STREET | LONDON | CA | ||||||
| ALIMENTIV INC | ||||||||||||
| N/A | NC | DEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD AND IMPROVE HEALTH OUTCOMES | $259,951 | 100 DUNDAS STREET | LONDON | CA | ||||||
| ALYN HOSPITAL - REHABILITATION CENTER FOR CHILDREN AND YOUTH | ||||||||||||
| N/A | PC | ALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH | $694,034 | 84 SHMARYAHU LEVIN ST | JERUSALEM | IS | ||||||
| AMC MEDICAL RESEARCH BV | ||||||||||||
| N/A | PC | IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE | $50,570 | MEIBERGDREEF 9 | AMSTERDAM | NL | ||||||
| AMERICAN CAMPING ASSOCIATION INC | ||||||||||||
| 5000 STATE ROAD 67 NORTH | MARTINSVILLE | IN | 46151 | N/A | PC | ACA PROFESSIONAL DEVELOPMENT 2022-2024 | $51,040 | |||||
| AMERICAN COLLEGE OF DIABETOLOGY INC | ||||||||||||
| PO BOX 87633 | FAYETTEVILLE | NC | 28304 | N/A | PC | IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS | $1,093,900 | |||||
| AMERICAN COLLEGE OF DIABETOLOGY INC | ||||||||||||
| PO BOX 87633 | FAYETTEVILLE | NC | 28304 | N/A | PC | IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS | $1,087,885 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | MENTAL HEALTH EDUCATION PROGRAM PHASE 2 (2022 2024) | $337,310 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | 2022-2024 TYPE 1 DIABETES CAMP INITIATIVE | $399,368 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | MENTAL HEALTH EDUCATION PROGRAM PHASE 2 (2022 2024) | $278,350 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | 2022-2024 TYPE 1 DIABETES CAMP INITIATIVE | $399,368 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | TRAINING AND MENTORSHIP PROGRAMS | $805,382 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | TRAINING AND MENTORSHIP PROGRAMS | $805,382 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | TRAINING AND MENTORSHIP PROGRAMS | $805,382 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | MISSION: LIFELINE STROKE MONTANA AND POST-ACUTE STROKE CARE QUALITY STANDARDS FIELD TESTING | $1,024,257 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | POST-ACUTE STROKE CARE: IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA | $1,102,824 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | MISSION: LIFELINE STROKE IOWA | $2,105,298 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | $996,262 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | $1,011,199 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | MISSION: LIFELINE STROKE IOWA | $2,521,277 | |||||
| AMERICAN PHARMACISTS ASSOCIATION FOUNDATION | ||||||||||||
| 2215 CONSTITUTION AVE NW | WASHINGTON | DC | 20037 | N/A | PC | PROJECT IMPACT CGM: EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES | $1,502,893 | |||||
| AMERICARES FOUNDATION INC | ||||||||||||
| 88 HAMILTON AVE | STAMFORD | CT | 06840 | N/A | PC | MATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS | $749,599 | |||||
| ANTHOS HOME INC | ||||||||||||
| 238 SEELEY ST | BROOKLYN | NY | 11218 | N/A | PC | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | $2,500,000 | |||||
| ANTHOS HOME INC | ||||||||||||
| 238 SEELEY ST | BROOKLYN | NY | 11218 | N/A | PC | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | $2,500,000 | |||||
| APHP ST ANTOINE HOSPITAL | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $474,464 | 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | ||||||
| APHP ST ANTOINE HOSPITAL | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $948,928 | 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | ||||||
| APHP ST ANTOINE HOSPITAL | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $367,129 | 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | ||||||
| APHP ST ANTOINE HOSPITAL | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $421,681 | 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | ||||||
| ARAD MUNICIPALITY | ||||||||||||
| N/A | GOV | ARAD OCCUPATIONAL REHABILITATION CENTER | $290,000 | 6 HAPALMACH STREET | ARAD | IS | ||||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | ||||||||||||
| 125 SOUTH WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | N/A | NC | EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE | $831,327 | |||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | ||||||||||||
| 125 SOUTH WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | N/A | NC | EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE | $855,546 | |||||
| ASSOCIATION SANTE DIABTE | ||||||||||||
| N/A | PC | IMPROVE THE MANAGEMENT OF DIABETES AND THE SUPPORT TO PEOPLE AFFECTED BY THE DISEASE IN BURKINA FASO, MALI AND THE UNION OF COMOROS | $205,984 | 17 AVENUE MALHERBE | GRENOBLE | FR | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | ||||||||||||
| N/A | PC | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES | $450,697 | LEVEL 2 | FITZROY | AS | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | ||||||||||||
| N/A | PC | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES | $907,233 | LEVEL 2 | FITZROY | AS | ||||||
| AVERA MCKENNAN FOR THE AVERA MCKENNAN HOSPITAL AND UNI HEALTH CENTER | ||||||||||||
| 1325 S CLIFF AVENUE | SIOUX FALLS | SD | 57105 | N/A | PC | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | $1,000,000 | |||||
| AVERA MCKENNAN FOR THE AVERA MCKENNAN HOSPITAL AND UNI HEALTH CENTER | ||||||||||||
| 1325 S CLIFF AVENUE | SIOUX FALLS | SD | 57105 | N/A | PC | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | $1,500,000 | |||||
| BALLAD RESEARCH INSTITUTE | ||||||||||||
| 10865 ROAD TO THE CURE | SAN DIEGO | CA | 92121 | N/A | PC | CD127-HIGH T-CELL POPULATIONS AS BIOMARKERS | $325,801 | |||||
| BAYLOR COLLEGE OF MEDICINE | ||||||||||||
| OFFICE OF RESEARCH | HOUSTON | TX | 77030 | N/A | PC | PILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE | $500,180 | |||||
| BAYLOR COLLEGE OF MEDICINE | ||||||||||||
| OFFICE OF RESEARCH | HOUSTON | TX | 77030 | N/A | PC | PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS: SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE | $532,841 | |||||
| BAYLOR COLLEGE OF MEDICINE | ||||||||||||
| OFFICE OF RESEARCH | HOUSTON | TX | 77030 | N/A | PC | PILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE | $524,854 | |||||
| BAYLOR COLLEGE OF MEDICINE | ||||||||||||
| OFFICE OF RESEARCH | HOUSTON | TX | 77030 | N/A | PC | PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS: SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE | $547,540 | |||||
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | ||||||||||||
| 1201 NINTH AVENUE | SEATTLE | WA | 981012795 | N/A | PC | LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D | $661,927 | |||||
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | ||||||||||||
| 1201 NINTH AVENUE | SEATTLE | WA | 981012795 | N/A | PC | LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D | $567,763 | |||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| N/A | PC | COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CROHN'S DISEASE. | $938,641 | BEN-GURION BLVD 1 | BEER SHEVA | IS | ||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| N/A | PC | CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING | $5,785,714 | BEN-GURION BLVD 1 | BEER SHEVA | IS | ||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| N/A | PC | COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CROHN'S DISEASE. | $765,436 | BEN-GURION BLVD 1 | BEER SHEVA | IS | ||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| N/A | PC | CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING | $9,542,857 | BEN-GURION BLVD 1 | BEER SHEVA | IS | ||||||
| BETH ISRAEL DEACONESS MEDICAL CENTER INC | ||||||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 022155491 | N/A | PC | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE | $797,851 | |||||
| BETH ISRAEL DEACONESS MEDICAL CENTER INC | ||||||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 022155491 | N/A | PC | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE | $797,851 | |||||
| BEYOND TYPE 1 | ||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | CAPACITY BUILDING SUPPORT | $1,200,000 | |||||
| BEYOND TYPE 1 | ||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | CAPACITY BUILDING SUPPORT | $940,000 | |||||
| BEYOND TYPE 1 | ||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | CAPACITY BUILDING SUPPORT | $1,060,000 | |||||
| BEYOND TYPE 1 | ||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | DIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3 | $149,166 | |||||
| BEYOND TYPE 1 | ||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | CAPACITY BUILDING SUPPORT | $1,200,000 | |||||
| BHSH SYSTEM | ||||||||||||
| 100 MICHIGAN ST NE | GRAND RAPIDS | MI | 49503 | N/A | PC | STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS | $3,104,271 | |||||
| BHSH SYSTEM | ||||||||||||
| 100 MICHIGAN ST NE | GRAND RAPIDS | MI | 49503 | N/A | PC | STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS | $2,081,202 | |||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $1,740,266 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $1,740,267 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $3,480,533 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $3,480,533 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $4,470,844 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $4,470,844 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $3,470,843 | ORANGE STREET | ||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | ULTRASOUND TRAINING INITIATIVE IN NEVADA | $197,208 | |||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | CARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM | $101,000 | |||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | ULTRASOUND TRAINING INITIATIVE IN NEVADA | $197,208 | |||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | CARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM | $101,000 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE | $836,979 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | DEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D | $1,483,787 | |||||
| BOULDER CITY HOSPITAL INC | ||||||||||||
| 901 ADAMS BLVD | BOULDER CITY | NV | 89005 | N/A | PC | BOULDER CITY HOSPITAL EQUIPMENT REVITALIZATION PROJECT | $34,997 | |||||
| BREAKING GROUND HOUSING DEVELOPMENT FUND CORPORATION | ||||||||||||
| 505 EIGHTH AVENUE 5TH FLOOR | NEW YORK | NY | 10018 | N/A | PC | PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING | $567,155 | |||||
| BREAKING GROUND HOUSING DEVELOPMENT FUND CORPORATION | ||||||||||||
| 505 EIGHTH AVENUE 5TH FLOOR | NEW YORK | NY | 10018 | N/A | PC | PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING | $585,924 | |||||
| BRIDGES TO PROSPERITY INC | ||||||||||||
| 1031 33RD STREET | DENVER | CO | 80205 | N/A | PC | TRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA | $2,648,126 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | $1,785,375 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | INVESTIGATION OF ANTI-GM-CSF AUTOANTIBODIES AS A DISEASE DETERMINANT IN CROHNS DISEASE | $499,459 | |||||
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | PEN-PLUS EXPANSION | $9,013,397 | |||||
| CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | ||||||||||||
| N/A | GOV | THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | $292,476 | HILLS ROAD | CAMBRIDGE | UK | ||||||
| CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | ||||||||||||
| N/A | GOV | THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | $462,323 | HILLS ROAD | CAMBRIDGE | UK | ||||||
| CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | ||||||||||||
| N/A | GOV | THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | $767,757 | HILLS ROAD | CAMBRIDGE | UK | ||||||
| CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | ||||||||||||
| N/A | GOV | THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | $657,605 | HILLS ROAD | CAMBRIDGE | UK | ||||||
| CARE-FOR-RARE FOUNDATION | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MUNICH STUDIES | $655,603 | DR VON HAUNERSCHES KINDERSPITAL | MUNICH | GM | KLINIKUM DER UNIVERSITAT MUNCHEN | |||||
| CARE-FOR-RARE FOUNDATION | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MUNICH STUDIES | $667,252 | DR VON HAUNERSCHES KINDERSPITAL | MUNICH | GM | KLINIKUM DER UNIVERSITAT MUNCHEN | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: CEDARS-SINAI | $115,500 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $200,041 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | LONG-TERM RESPONSES TO SARS-COV-2 VACCINATION IN A DIVERSE INFLAMMATORY BOWEL DISEASE POPULATION: A MULTI-OMIC STUDY | $364,763 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $202,791 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION | $701,215 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: CEDARS-SINAI | $115,500 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $219,514 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $211,815 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION | $488,364 | |||||
| CENTER FOR HEALTH CARE STRATEGIES INC | ||||||||||||
| 200 AMERICAN METRO BLVD | TRENTON | NJ | 08619 | N/A | PC | TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN | $1,002,514 | |||||
| CENTER FOR HEALTH CARE STRATEGIES INC | ||||||||||||
| 200 AMERICAN METRO BLVD | TRENTON | NJ | 08619 | N/A | PC | TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN | $626,707 | |||||
| CENTRAL MONTANA MEDICAL FACILITIES INC | ||||||||||||
| 408 WENDELL AVE | LEWISTOWN | MT | 59457 | N/A | PC | CANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER | $3,690,035 | |||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | ||||||||||||
| N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $95,277 | 29 AVENUE MAL DE LATTRE DE TASSIGNY | NANCY | FR | ||||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | ||||||||||||
| N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $103,796 | 29 AVENUE MAL DE LATTRE DE TASSIGNY | NANCY | FR | ||||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | ||||||||||||
| N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $153,102 | 29 AVENUE MAL DE LATTRE DE TASSIGNY | NANCY | FR | ||||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | THE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD | $244,860 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA | $438,659 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE | $221,420 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | THE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD | $244,860 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA | $279,999 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| N/A | PC | INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE | $93,443 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | DEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM FOR THE PREVENTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $1,072,041 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE | $374,591 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | NOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI) | $666,216 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: BOSTON STUDIES | $1,249,403 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE | $374,591 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | DEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM FOR THE PREVENTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $1,255,105 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: BOSTON STUDIES | $1,226,580 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | NOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI) | $665,654 | |||||
| CHILDREN'S HOSPITAL LOS ANGELES | ||||||||||||
| SABAN RESEARCH INSTITUTE | LOS ANGELES | CA | 90027 | N/A | PC | BEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE | $679,025 | |||||
| CHILDREN'S HOSPITAL LOS ANGELES | ||||||||||||
| SABAN RESEARCH INSTITUTE | LOS ANGELES | CA | 90027 | N/A | PC | BEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE | $684,686 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | DELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D | $1,009,535 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | ARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE | $1,421,241 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | ARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE | $1,093,319 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | ROLE OF PPAR-ALPHA IN PROMOTING BRUSH BORDER MATURITY OF INTESTINAL ENTEROCYTES | $439,601 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | DELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D | $725,157 | |||||
| CHILDREN'S HOSPITAL OF PHILADELPHIA | ||||||||||||
| 2716 SOUTH STREET | PHILADELPHIA | PA | 191462305 | N/A | PC | LEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D | $228,375 | |||||
| CHILDREN'S MERCY HOSPITAL | ||||||||||||
| 2401 GILLHAM ROAD | KANSAS CITY | MO | 64108 | N/A | PC | TYPE 1 DIABETES RAPID LEARNING LAB | $1,399,624 | |||||
| CIVICA FOUNDATION | ||||||||||||
| 2912 WEST EXECUTIVE PARKWAY | LEHI | UT | 84043 | N/A | PC | AFFORDABLE INSULIN | $2,500,000 | |||||
| CIVICA FOUNDATION | ||||||||||||
| 2912 WEST EXECUTIVE PARKWAY | LEHI | UT | 84043 | N/A | PC | AFFORDABLE INSULIN | $2,500,000 | |||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION | $243,216 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | $1,445,914 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT | $138,626 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES | $452,465 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | $5,200,000 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT | $145,605 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES | $463,512 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| N/A | PC | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | $700,000 | 101 ARLOZOROV STREET | TEL AVIV | IS | ||||||
| CLINTON HEALTH ACCESS INITIATIVE INC | ||||||||||||
| 383 DORCHESTER AVENUE SUITE 400 | BOSTON | MA | 02127 | N/A | PC | MARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE | $1,243,053 | |||||
| CONSORCI INSTITUT D'INVESTIGACIONES BIOMDICAS AUGUST PI I SUNYER | ||||||||||||
| N/A | GOV | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING | $261,570 | ROSSELL 149 | BARCELONA | SP | ||||||
| CRITICAL PATH INSTITUTE | ||||||||||||
| 1730 E RIVER RD | TUCSON | AZ | 85718 | N/A | PC | T1D CONSORTIUM 2.0 | $266,741 | |||||
| CRITICAL PATH INSTITUTE | ||||||||||||
| 1730 E RIVER RD | TUCSON | AZ | 85718 | N/A | PC | T1D CONSORTIUM 2.0 | $266,741 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE | $588,266 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | IBD VENTURES ACADEMIC INCUBATOR | $1,180,400 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | TRAINING AWARDS PROGRAM - CLASS OF 2021 | $1,067,400 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE | $588,266 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | IBD VENTURES ACADEMIC INCUBATOR | $1,180,400 | |||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CROHNS PATIENTS IN CANADA | $275,588 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE | $284,646 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CROHNS PATIENTS IN CANADA | $286,838 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE | $297,612 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| N/A | PC | IMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS | $374,912 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | ||||||
| CROHN'S AND COLITIS UK | ||||||||||||
| N/A | PC | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK: KNOWLEDGE AND EVIDENCE PERSONNEL | $75,900 | 1 BISHOPS SQUARE | HATFIELD | UK | ||||||
| CROHN'S COLITIS CURE | ||||||||||||
| N/A | PC | DEVELOPMENT OF A PEDIATRIC-SPECIFIC CROHNS DISEASE ELECTRONIC MEDICAL RECORD TO DRIVE CARE CONSISTENCY AND ENHANCE TRANSITIONS IN CARE | $115,418 | 1 OCONNELL STREET | SYDNEY | AS | ||||||
| DARTMOUTH- HITCHCOCK CLINIC | ||||||||||||
| ONE MEDICAL CENTER DRIVE | LEBANON | NH | 03756 | N/A | PC | CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | $509,790 | |||||
| DARTMOUTH- HITCHCOCK CLINIC | ||||||||||||
| ONE MEDICAL CENTER DRIVE | LEBANON | NH | 03756 | N/A | PC | CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | $525,177 | |||||
| DE LA SALLE SOLIDARIET INTERNAZIONALE ONLUS | ||||||||||||
| N/A | PC | ETHIOPIAN CATHOLIC UNIVERSITY DIAGNOSTIC LABORATORY | $94,780 | VIA AUREALIA 476 | ROME | IT | ||||||
| DIABETES NSW | ||||||||||||
| N/A | PC | IMPROVE OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES, VIA GEOGRAPHIC EXPANSION AND COUNTRY-DRIVEN INITIATIVES | $3,000,000 | 26 ARUNDEL ST | SYDNEY | AS | ||||||
| DIABETES NSW | ||||||||||||
| N/A | PC | IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES | $3,000,000 | 26 ARUNDEL ST | SYDNEY | AS | ||||||
| DREAMED DIABETES LTD | ||||||||||||
| N/A | NC | INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES | $1,350,000 | 14 KAPLAN ST | PETAH TIKVA | IS | ||||||
| DUKE UNIVERSITY | ||||||||||||
| C/O OFFICE OF RESEARCH SUPPORT | DURHAM | NC | 277054677 | N/A | PC | AMINO ACIDS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE AS A SAFEGUARD AGAINST INSULIN-INDUCED HYPOGLYCEMIA IN T1D | $71,503 | |||||
| DUKE UNIVERSITY | ||||||||||||
| C/O OFFICE OF RESEARCH SUPPORT | DURHAM | NC | 277054677 | N/A | PC | AMINO ACIDS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE AS A SAFEGUARD AGAINST INSULIN-INDUCED HYPOGLYCEMIA IN T1D | $203,497 | |||||
| DUNDY COUNTY HOSPITAL | ||||||||||||
| 1313 N CHEYENNE ST | BENKELMAN | NE | 69021 | N/A | GOV | TELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL | $29,310 | |||||
| DUNDY COUNTY HOSPITAL | ||||||||||||
| 1313 N CHEYENNE ST | BENKELMAN | NE | 69021 | N/A | GOV | TELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL | $11,725 | |||||
| EMORY UNIVERSITY | ||||||||||||
| 1599 CLIFTON ROAD NE | ATLANTA | GA | 303224250 | N/A | PC | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | $283,099 | |||||
| EMORY UNIVERSITY | ||||||||||||
| 1599 CLIFTON ROAD NE | ATLANTA | GA | 303224250 | N/A | PC | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | $313,686 | |||||
| EMORY UNIVERSITY | ||||||||||||
| 1599 CLIFTON ROAD NE | ATLANTA | GA | 303224250 | N/A | PC | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | $302,430 | |||||
| FAIRVIEW HEALTH SERVICES | ||||||||||||
| 2450 RIVERSIDE AVE | MINNEAPOLIS | MN | 55454 | N/A | PC | IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE | $4,889,200 | |||||
| FAIRVIEW HEALTH SERVICES | ||||||||||||
| 2450 RIVERSIDE AVE | MINNEAPOLIS | MN | 55454 | N/A | PC | IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE | $1,960,000 | |||||
| FAIRVIEW HEALTH SERVICES | ||||||||||||
| 2450 RIVERSIDE AVE | MINNEAPOLIS | MN | 55454 | N/A | PC | IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE | $3,176,500 | |||||
| FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND | ||||||||||||
| N/A | PC | ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT | $1,614,046 | CAMPUS BIOTECH | GENEVA | SZ | ||||||
| FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND | ||||||||||||
| N/A | PC | ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT | $779,789 | CAMPUS BIOTECH | GENEVA | SZ | ||||||
| FRANCISCAN CARE SERVICES INC | ||||||||||||
| 430 N MONITOR ST | WEST POINT | NE | 68788 | N/A | PC | TELE-EMERGENCY SERVICES AT FRANCISCAN HEALTHCARE | $42,729 | |||||
| FRANCISCAN CARE SERVICES INC | ||||||||||||
| 430 N MONITOR ST | WEST POINT | NE | 68788 | N/A | PC | TELE-EMERGENCY SERVICES AT FRANCISCAN HEALTHCARE | $17,093 | |||||
| FRIENDS OF THE ISRAEL DEFENSE FORCES | ||||||||||||
| 60 EAST 42 STREET | NEW YORK | NY | 10165 | N/A | PC | IMPACT! SCHOLARSHIP PROGRAM | $503,200 | |||||
| FUND FOR PUBLIC HOUSING INC | ||||||||||||
| 90 CHURCH STREET | NEW YORK | NY | 10007 | N/A | PC | DEVELOPING AND ACTIVATING GREENSPACE USING THE CONNECTED COMMUNITIES' PARTICIPATORY PROCESS AT FOUR NYCHA DEVELOPMENTS | $1,630,000 | |||||
| GALILEE MEDICAL CENTER | ||||||||||||
| N/A | GOV | RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER | $2,200,000 | GALILEE MEDICAL CENTER | NAHARIYA | IS | ||||||
| GALILEE MEDICAL CENTER | ||||||||||||
| N/A | GOV | RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER | $2,200,000 | GALILEE MEDICAL CENTER | NAHARIYA | IS | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| N/A | PC | MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $251,522 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| N/A | PC | MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $397,123 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| N/A | PC | MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $402,672 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| N/A | PC | MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $187,672 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| N/A | PC | MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $143,892 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | ||||||
| GEORGIA TECH RESEARCH CORPORATION | ||||||||||||
| 505 10TH STREET NW | ATLANTA | GA | 303320420 | N/A | SOIII FI | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | $480,848 | |||||
| GEORGIA TECH RESEARCH CORPORATION | ||||||||||||
| 505 10TH STREET NW | ATLANTA | GA | 303320420 | N/A | SOIII FI | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | $485,617 | |||||
| GEORGIA TECH RESEARCH CORPORATION | ||||||||||||
| 505 10TH STREET NW | ATLANTA | GA | 303320420 | N/A | SOIII FI | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | $485,616 | |||||
| GLOBAL SOLIDARITY FUND | ||||||||||||
| 425 LEXINGTON AVE | NEW YORK | NY | 10017 | N/A | PC | JOB CREATION IN ETHIOPIA | $1,508,200 | |||||
| GUARDIAN ORG FOUNDATION | ||||||||||||
| 900 17TH STREET NW SUITE 250 | WASHINGTON | DC | 20006 | N/A | PC | A GROWING CRISIS: NON-COMMUNICABLE DISEASES, AN INDEPENDENT JOURNALISM SERIES BY THE GUARDIAN | $625,000 | |||||
| HADASSAH MEDICAL ORGANIZATION | ||||||||||||
| N/A | PC | CREATING AND EQUIPPING A NEW COMPREHENSIVE DIAGNOSTIC AND INTERVENTIONAL IMAGING CENTER | $681,600 | EIN KEREM ADDRESS KALMAN YAAKOV MAN | JERUSALEM | IS | STREET | |||||
| HADASSAH MEDICAL ORGANIZATION | ||||||||||||
| N/A | PC | CREATING AND EQUIPPING A NEW COMPREHENSIVE DIAGNOSTIC AND INTERVENTIONAL IMAGING CENTER | $454,400 | EIN KEREM ADDRESS KALMAN YAAKOV MAN | JERUSALEM | IS | STREET | |||||
| HEALTH ADVOCACY SUMMIT INC | ||||||||||||
| 1962 DOCKSIDE DRIVE | GREENWOOD | IN | 46143 | N/A | PC | CROHNS AND COLITIS YOUNG ADULTS NETWORK LEARNING COMMUNITY, ROUNDTABLE ON ADOLESCENTS AND YOUNG ADULTS WITH IBD | $60,060 | |||||
| HEBREW UNIVERSITY OF JERUSALEM | ||||||||||||
| N/A | PC | METHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS DISEASE | $362,703 | OFFICE OF THE PRESIDENT | JERUSALEM | IS | ||||||
| HELEN KELLER INTERNATIONAL | ||||||||||||
| ONE DAG HAMMARSKJOLD PLAZA | NEW YORK | NY | 10017 | N/A | PC | A CONTINUED PATH TO RESILIENCE AND EMPOWERMENT | $1,441,293 | |||||
| HELEN KELLER INTERNATIONAL | ||||||||||||
| ONE DAG HAMMARSKJOLD PLAZA | NEW YORK | NY | 10017 | N/A | PC | A CONTINUED PATH TO RESILIENCE AND EMPOWERMENT | $1,652,490 | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-02 STUDY: IDENTIFICATION OF INFANTS WITH HIGH RISK OF TYPE 1 DIABETES FOR PRIMARY PREVENTION | $1,431,241 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $859,607 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,481,163 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $2,040,499 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | CONTINUATION OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED T1D RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $2,584,495 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | $178,540 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,481,162 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $2,193,719 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $4,136,248 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $870,315 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH AND AUTOIMMUNITY OUTCOMES IN CHILDREN | $82,445 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD BIOSAMPLE RFP | $1,046,486 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | EUROPEAN PRE-T1D REGISTRY | $196,089 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH AND AUTOIMMUNITY OUTCOMES IN CHILDREN | $80,432 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $870,314 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,352,233 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $2,193,718 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $4,136,248 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | $49,500 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $1,004,503 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,352,232 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD BIOSAMPLE RFP | $95,294 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $1,004,503 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,486,275 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,486,274 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,412,946 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,412,946 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,479,330 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,479,329 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $526,471 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | |||||
| HENRY J KAISER FAMILY FOUNDATION | ||||||||||||
| 185 BERRY STREET NO 2000 | SAN FRANCISCO | CA | 94107 | N/A | PC | KAISER HEALTH NEWS RURAL HEALTH DESK | $1,458,159 | |||||
| HERLEV OG GENTOFTE HOSPITAL | ||||||||||||
| N/A | GOV | TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | $285,339 | HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | ||||||
| HERLEV OG GENTOFTE HOSPITAL | ||||||||||||
| N/A | GOV | UTILIZATION OF INTERACTION BETWEEN AMINO ACIDS & GIP IN PANCREATIC CELLS | $217,256 | HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | ||||||
| HILLEL YAFFE MEDICAL CENTER | ||||||||||||
| N/A | GOV | EYE INSTITUTE AND AMBULATORY SURGERY CENTER | $3,158,400 | HA-SHALOM ST | HADERA | IS | ||||||
| HOLY ROSARY HEALTHCARE FOUNDATION | ||||||||||||
| 2600 WILSON STREET | MILES CITY | MT | 59301 | N/A | PC | HOLY ROSARY HEALTHCARE COMPREHENSIVE CANCER CENTER | $2,000,000 | |||||
| HUMBOLDT COUNTY MEMORIAL HOSPITAL | ||||||||||||
| 1000 N 15TH ST | HUMBOLDT | IA | 50548 | N/A | GOV | TELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL | $15,775 | |||||
| HUMBOLDT COUNTY MEMORIAL HOSPITAL | ||||||||||||
| 1000 N 15TH ST | HUMBOLDT | IA | 50548 | N/A | GOV | TELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL | $117,600 | |||||
| HUMBOLDT COUNTY MEMORIAL HOSPITAL | ||||||||||||
| 1000 N 15TH ST | HUMBOLDT | IA | 50548 | N/A | GOV | TELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL | $39,438 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | STUDY TO EVALUATE SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC SUBJECTS WITH MILD-TO-MODERATE CROHN'S DISEASE | $214,842 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES | $220,000 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | THE MELODY TRIAL: MODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHN'S DISEASE | $759,619 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE | $404,688 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE FOR NYCS MOST VULNERABLE MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS. | $672,617 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE | $305,349 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES | $220,000 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE FOR NYCS MOST VULNERABLE MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS. | $779,716 | |||||
| INNODIA | ||||||||||||
| N/A | NC | INNODIA NONPROFIT LAUNCH FOR THE CARE AND PREVENTION OF T1D. | $434,183 | HERESTRAAT 49 | LEUVEN | BE | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $87,446 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | $164,873 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $92,999 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $98,553 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $94,105 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $99,659 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $97,317 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| N/A | GOV | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | $60,914 | 1 RUE LOUIS RECH | DUDELANGE | LU | ||||||
| INSULIN FOR LIFE USA INC | ||||||||||||
| 2555 SW 76TH STREET | GAINESVILLE | FL | 32608 | N/A | PC | INSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY | $341,606 | |||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| N/A | NC | DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE. | $375,221 | HARKORTSTR 1 | MUNSTER | GM | ||||||
| IOWA DEPARTMENT OF PUBLIC HEALTH | ||||||||||||
| 321 EAST 12TH | DES MOINES | IA | 50319 | N/A | GOV | IOWA FIRST RESPONDER AED INITIATIVE | $58,968 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EXERCISE IN DIABETES INITIATIVE: LARGE ADULT STUDY | $159,838 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | $283,542 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING | $468,008 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $410,774 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $413,871 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $357,597 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $188,007 | |||||
| JDRF AUSTRALIA | ||||||||||||
| N/A | PC | ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA | $1,196,912 | 80-84 CHANDOS STREET ST LEONARDS | SYDNEY | AS | 2065 NSW AUSTRALIA | |||||
| JDRF AUSTRALIA | ||||||||||||
| N/A | PC | ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA | $997,843 | 80-84 CHANDOS STREET ST LEONARDS | SYDNEY | AS | 2065 NSW AUSTRALIA | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | FOCUSING DEVELOPMENT EFFORTS TO ACCELERATE COMMERCIAL RELEASE OF CLOSED LOOP SENSOR SYSTEM | $147,000 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | FOCUSING DEVELOPMENT EFFORTS TO ACCELERATE COMMERCIAL RELEASE OF CLOSED LOOP SENSOR SYSTEM | $175,000 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE | $133,332 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | CO-FUNDED DEVELOPMENT OF A 3-B-HYDROXYBUTYRATE BINDING PROTEIN BASED CONTINUOUS KETONE MONITORING MICROSENSOR | $200,000 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | AUTOIMMUNITY SCREENING FOR KIDS PROGRAM TRANSITION TOWARDS A SUSTAINABLE SCREENING FOR T1D AND CELIAC DISEASE IN COLORADO | $555,046 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | $150,000 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | $150,000 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE | $133,334 | |||||
| JDRF T1D FUND LLC | ||||||||||||
| 50 MILK STREET 16TH FLOOR | BOSTON | MA | 02109 | N/A | PC | T1D FUND INITIATIVE TO DRIVE PHARMA INVESTMENT IN T1D | $500,000 | |||||
| JERUSALEM COLLEGE OF TECHNOLOGY | ||||||||||||
| N/A | PC | HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING | $1,300,000 | 21 HAVAAD HALEUMI ST | JERUSALEM | IS | ||||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING | $652,589 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS | $568,782 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | ENGINEERED CYTOKINE/ANTIBODY FUSION PROTEIN TO TREAT CROHNS DISEASE | $750,000 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING | $657,403 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS | $571,287 | |||||
| JOSLIN DIABETES CENTER INC | ||||||||||||
| ONE JOSLIN PLACE | BOSTON | MA | 02215 | N/A | PC | AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES | $941,354 | |||||
| JOSLIN DIABETES CENTER INC | ||||||||||||
| ONE JOSLIN PLACE | BOSTON | MA | 02215 | N/A | PC | AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES | $857,270 | |||||
| JUVENILE DIABETES RESEARCH FOUNDATION CANADA | ||||||||||||
| N/A | PC | JDRF CANADA PSYCHOSOCIAL HEALTH INITIATIVE | $19,000 | 235 YORKLAND BLVD SUITE 600 | TORONTO | CA | ||||||
| KATHOLIEKE UNIVERSITEIT LEUVEN | ||||||||||||
| N/A | PC | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY | $297,898 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | ||||||
| KATHOLIEKE UNIVERSITEIT LEUVEN | ||||||||||||
| N/A | PC | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | $246,662 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | ||||||
| KATHOLIEKE UNIVERSITEIT LEUVEN | ||||||||||||
| N/A | PC | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY | $770,816 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | T CELL RECEPTOR SEQUENCING IN TYPE 1 DIABETES - BIOMARKER DISCOVERY AND TECHNOLOGY DEVELOPMENT | $115,097 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL | $195,494 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | HYPO - RESOLVE - EVALUATION OF BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA | $307,779 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS | $278,644 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,069,889 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,325,562 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,147,254 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | $825,146 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,296,483 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $369,984 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS | $208,787 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $778,535 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | $781,151 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,079,926 | 150 STAMFORD STREET | LONDON | UK | ||||||
| KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | $649,424 | FEODOR-LYNEN-STRABE 17 | MUNCHEN | GM | ||||||
| KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | $600,891 | FEODOR-LYNEN-STRABE 17 | MUNCHEN | GM | ||||||
| KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN | ||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | $606,581 | FEODOR-LYNEN-STRABE 17 | MUNCHEN | GM | ||||||
| LUCAS COUNTY HEALTH CENTER | ||||||||||||
| 1200 NORTH 7TH STREET | CHARITON | IA | 50049 | N/A | PC | AVERA ECARE EMERGENCY VIRTUAL HEALTH AT LUCAS COUNTY HEALTH CENTER | $17,970 | |||||
| MACCABI HEALTHCARE SERVICES | ||||||||||||
| N/A | PC | MOBILE MAMMOGRAPHY UNIT | $31,500 | 27 HAMERED ST | TEL AVIV | IS | ||||||
| MACCABI HEALTHCARE SERVICES | ||||||||||||
| N/A | PC | MOBILE MAMMOGRAPHY UNIT | $31,500 | 27 HAMERED ST | TEL AVIV | IS | ||||||
| MADISON COUNTY MEMORIAL HOSPITAL | ||||||||||||
| 300 W HUTCHINGS STREET | WINTERSET | IA | 50273 | N/A | GOV | IMPLEMENTATION OF EEMERGENCY AT MADISON COUNTY HEALTH CARE SYSTEM | $15,187 | |||||
| MAINEHEALTH | ||||||||||||
| 22 BRAMHALL STREET | PORTLAND | ME | 04102 | N/A | PC | TRANSFORMING RURAL DIABETES CARE IN MAINE | $848,894 | |||||
| MAINEHEALTH | ||||||||||||
| 22 BRAMHALL STREET | PORTLAND | ME | 04102 | N/A | PC | TRANSFORMING RURAL DIABETES CARE IN MAINE | $596,795 | |||||
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | WIRELESS INFRARED IMAGING CAPSULE FOR PINPOINTING INFLAMMATION IN CROHNS DISEASE | $752,326 | |||||
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | CROHN'S DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION AND BETTER TREATMENT | $705,894 | |||||
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | ||||||||||||
| 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | N/A | PC | COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS | $300,000 | |||||
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | ||||||||||||
| 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | N/A | PC | COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS | $300,000 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | FEASIBILITY OF OFF-SITE REMOTE CONTROL ROBOTIC PERCUTANEOUS CORONARY INTERVENTIONS: A PILOT ANIMAL FEASIBILITY STUDY | $385,906 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $334,407 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | MILITARY SCIENCES MEDICAL TRAINING 2022-2024 | $250,000 | |||||
| MAYO CLINIC | ||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $151,705 | |||||
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | ||||||||||||
| 179 ASHLEY AVENUE | CHARLESTON | SC | 29425 | N/A | GOV | ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES | $137,500 | |||||
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | ||||||||||||
| 179 ASHLEY AVENUE | CHARLESTON | SC | 29425 | N/A | GOV | ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES | $412,500 | |||||
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | ||||||||||||
| 179 ASHLEY AVENUE | CHARLESTON | SC | 29425 | N/A | GOV | ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES | $275,000 | |||||
| MEDICINES FOR HUMANITY INC | ||||||||||||
| 800 HINGHAM STREET | ROCKLAND | MA | 02370 | N/A | PC | MAI MBELEKI II EXPANSION | $322,909 | |||||
| MEDICINES FOR HUMANITY INC | ||||||||||||
| 800 HINGHAM STREET | ROCKLAND | MA | 02370 | N/A | PC | MAI MBELEKI II EXPANSION | $436,472 | |||||
| MILLE LACS HEALTH SYSTEM | ||||||||||||
| 200 ELM STREET NORTH | ONAMIA | MN | 56359 | N/A | PC | TELE-PHARMACY AT MILLE LACS HEALTH SYSTEM | $17,020 | |||||
| MILLE LACS HEALTH SYSTEM | ||||||||||||
| 200 ELM STREET NORTH | ONAMIA | MN | 56359 | N/A | PC | TELE-PHARMACY AT MILLE LACS HEALTH SYSTEM | $6,809 | |||||
| MINNESOTA ACADEMY OF FAMILY PHYSICIANS FOUNDATION | ||||||||||||
| 1400 VANBUREN STE STE 215 | MINNEAPOLIS | MN | 55413 | N/A | PC | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | $2,016,319 | |||||
| MINNESOTA ACADEMY OF FAMILY PHYSICIANS FOUNDATION | ||||||||||||
| 1400 VANBUREN STE STE 215 | MINNEAPOLIS | MN | 55413 | N/A | PC | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | $1,801,545 | |||||
| MINNESOTA RURAL HEALTH ASSOCIATION | ||||||||||||
| 27011 460TH AVE | HENNING | MN | 56551 | N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA | $318,700 | |||||
| MINNESOTA RURAL HEALTH ASSOCIATION | ||||||||||||
| 27011 460TH AVE | HENNING | MN | 56551 | N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA | $378,700 | |||||
| MINNESOTA STATE COLLEGES AND UNIVERSITIES | ||||||||||||
| 30 E 7TH STREET | ST PAUL | MN | 55101 | N/A | GOV | EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA | $217,428 | |||||
| MINNESOTA STATE COLLEGES AND UNIVERSITIES | ||||||||||||
| 30 E 7TH STREET | ST PAUL | MN | 55101 | N/A | GOV | EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA | $205,285 | |||||
| MONROE COUNTY HOSPITAL | ||||||||||||
| 6580 165TH STREET | ALBIA | IA | 52531 | N/A | GOV | EPHARMACY AT MONROE COUNTY HOSPITAL & CLINICS | $7,031 | |||||
| MONTANA PEDIATRICS | ||||||||||||
| 259 W FRONT STREET | MISSOULA | MT | 59802 | N/A | NC | CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D | $417,700 | |||||
| MONUMENT HEALTH STURGIS HOSPITAL | ||||||||||||
| 2140 JUNCTION AVE | STURGIS | SD | 57785 | N/A | PC | EEMERGENCY AT MONUMENT HEALTH STURGIS HOSPITAL | $16,568 | |||||
| NATIONAL ACADEMY OF SCIENCES | ||||||||||||
| 500 5TH STREET NW | WASHINGTON | DC | 20001 | N/A | PC | STRENGTHENING MINORITY SERVING INSTITUTIONS | $150,000 | |||||
| NATIONAL COMMITTEE FOR QUALITY ASSURANCE | ||||||||||||
| 1100 13TH ST NW | WASHINGTON | DC | 20005 | N/A | PC | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | $836,732 | |||||
| NATIONAL COMMITTEE FOR QUALITY ASSURANCE | ||||||||||||
| 1100 13TH ST NW | WASHINGTON | DC | 20005 | N/A | PC | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | $621,487 | |||||
| NATIONAL COMMITTEE FOR QUALITY ASSURANCE | ||||||||||||
| 1100 13TH ST NW | WASHINGTON | DC | 20005 | N/A | PC | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | $753,478 | |||||
| NATIONAL PARK FOUNDATION | ||||||||||||
| 1500 K ST NW | WASHINGTON | DC | 20005 | N/A | PC | BERING LAND BRIDGE VISITOR CENTER | $1,163,270 | |||||
| NATIONAL PARK FOUNDATION | ||||||||||||
| 1500 K ST NW | WASHINGTON | DC | 20005 | N/A | PC | BADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER | $1,850,000 | |||||
| NCD ALLIANCE | ||||||||||||
| N/A | PC | 2023-2025 PARTNERSHIP | $1,911,525 | 31-33 AVENUE GIUSEPPE MOTTA | GENEVA | SZ | ||||||
| NCD ALLIANCE | ||||||||||||
| N/A | PC | 2023-2025 PARTNERSHIP | $1,582,350 | 31-33 AVENUE GIUSEPPE MOTTA | GENEVA | SZ | ||||||
| NEBRASKA DEPT OF HEALTH & HUMAN SERVICES DIVISION OF PUBLIC HEALTH | ||||||||||||
| 301 CENTENNIAL MALL SOUTH | LINCOLN | NE | 68508 | N/A | GOV | NEBRASKA FIRST RESPONDER AED PROJECT | $309,887 | |||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA VIRTUAL CRISIS CARE | $1,230,038 | |||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA FIRST RESPONDER AED PROJECT | $153,920 | |||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA VIRTUAL CRISIS CARE | $1,239,092 | |||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA FIRST RESPONDER AED PROJECT | $130,670 | |||||
| NEVADA HEALTH CENTERS INC | ||||||||||||
| 3325 RESEARCH WAY | CARSON CITY | NV | 89706 | N/A | PC | QUALITY ULTRASOUND SERVICES AND TRAINING PROGRAM | $48,108 | |||||
| NEVADA HEALTH CENTERS INC | ||||||||||||
| 3325 RESEARCH WAY | CARSON CITY | NV | 89706 | N/A | PC | QUALITY ULTRASOUND SERVICES AND TRAINING PROGRAM | $48,108 | |||||
| NEVADA RURAL HOSPITAL PARTNERS FOUNDATION INC | ||||||||||||
| 4600 KIETZKE LANE | RENO | NV | 89502 | N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL NEVADA HOSPITALS | $27,500 | |||||
| NEVADA RURAL HOSPITAL PARTNERS FOUNDATION INC | ||||||||||||
| 4600 KIETZKE LANE | RENO | NV | 89502 | N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL NEVADA HOSPITALS | $27,500 | |||||
| NEW DESTINY HOUSING CORPORATION | ||||||||||||
| 12 W 37TH STREET 7TH FLOOR | NEW YORK | NY | 10018 | N/A | PC | PILOTING AFTERCARE INTERVENTION TO IMPROVE HOUSING AND HEALTH STABILITY FOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS | $281,806 | |||||
| NEW VENTURE FUND | ||||||||||||
| 1201 CONNECTICUT AVE NW SUITE 300 | WASHINGTON | DC | 20036 | N/A | PC | TYPE 1 DIABETES CAMPS PROJECT (2022 - 2024) | $1,468,813 | |||||
| NEW YORK CITY HEALTH AND HOSPITALS CORPORATION | ||||||||||||
| 125 WORTH STREET | NEW YORK | NY | 10013 | N/A | PC | EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC | $867,832 | |||||
| NEW YORK CITY HEALTH AND HOSPITALS CORPORATION | ||||||||||||
| 125 WORTH STREET | NEW YORK | NY | 10013 | N/A | PC | EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC | $614,668 | |||||
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | ||||||||||||
| 550 1ST AVENUE | NEW YORK | NY | 10016 | N/A | PC | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | $2,756,847 | |||||
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | ||||||||||||
| 550 1ST AVENUE | NEW YORK | NY | 10016 | N/A | PC | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | $3,692,303 | |||||
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | ||||||||||||
| 550 1ST AVENUE | NEW YORK | NY | 10016 | N/A | PC | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | $1,360,453 | |||||
| NEW YORK UNIVERSITY | ||||||||||||
| 665 BROADWAY | NEW YORK | NY | 10012 | N/A | PC | ANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS | $100,123 | |||||
| NORTH DAKOTA DEPARTMENT OF HEALTH | ||||||||||||
| 600 E BOULEVARD AVENUE | BISMARCK | ND | 585050200 | N/A | GOV | NORTH DAKOTA LAW ENFORCEMENT AED PROJECT | $27,500 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | DISSEMINATION PILOT: THE IMPLEMENTATION OF NOVEL INTERVENTIONS IN CHILDREN'S HEALTHCARE (NICH) IN ANOTHER HEALTHCARE SYSTEM | $322,462 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | DISSEMINATION PILOT: THE IMPLEMENTATION OF NOVEL INTERVENTIONS IN CHILDREN'S HEALTHCARE (NICH) IN ANOTHER HEALTHCARE SYSTEM | $322,462 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT | $1,783,316 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | NICH BAY AREA EXPANSION | $654,234 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT | $1,795,816 | |||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | ||||||||||||
| 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $292,821 | |||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | ||||||||||||
| 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $292,821 | |||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | ||||||||||||
| 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $318,978 | |||||
| PANORAMA GLOBAL | ||||||||||||
| 2101 FOURTH AVENUE SUITE 2100 | SEATTLE | WA | 98121 | N/A | PC | PANORAMA - TYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND | $64,900 | |||||
| PANORAMA GLOBAL | ||||||||||||
| 2101 FOURTH AVENUE SUITE 2100 | SEATTLE | WA | 98121 | N/A | PC | PANORAMA - TYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND | $1,167,087 | |||||
| PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY | ||||||||||||
| 1 LETTERMAN DRIVE | SAN FRANCISCO | CA | 94129 | N/A | PC | UNDERSTANDING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES. | $358,140 | |||||
| PATH | ||||||||||||
| 2201 WESTLAKE AVENUE | SEATTLE | WA | 98121 | N/A | PC | THE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE | $1,838,580 | |||||
| PAWNEE COUNTY MEMORIAL HOSPITAL | ||||||||||||
| 600 I STREET | PAWNEE CITY | NE | 68420 | N/A | GOV | ECARE PHARMACY AT PAWNEE COUNTY MEMORIAL HOSPITAL | $7,139 | |||||
| PENNINGTON COUNTY HEALTH AND HUMAN SERVICES | ||||||||||||
| 321 KANSAS CITY STREET | RAPID CITY | SD | 57701 | N/A | GOV | PENNINGTON COUNTY CRISIS STABILIZATION UNIT | $1,000,000 | |||||
| PENNINGTON COUNTY HEALTH AND HUMAN SERVICES | ||||||||||||
| 321 KANSAS CITY STREET | RAPID CITY | SD | 57701 | N/A | GOV | PENNINGTON COUNTY CRISIS STABILIZATION UNIT | $1,000,000 | |||||
| PERKINS COUNTY HOSPITAL DISTRICT | ||||||||||||
| 900 LINCOLN AVE | GRANT | NE | 69140 | N/A | GOV | TELE-EMERGENCY SERVICES FOR PERKINS COUNTY HEALTH SERVICES | $36,761 | |||||
| PERKINS COUNTY HOSPITAL DISTRICT | ||||||||||||
| 900 LINCOLN AVE | GRANT | NE | 69140 | N/A | GOV | TELE-EMERGENCY SERVICES FOR PERKINS COUNTY HEALTH SERVICES | $14,706 | |||||
| PHILLIPS COUNTY HOSPITAL ASSOCIATION | ||||||||||||
| 311 S 8TH AVENUE EAST | MALTA | MT | 59538 | N/A | PC | TELE-EMERGENCY AND TELE-PHARMACY AT PHILLIPS COUNTY | $64,193 | |||||
| PHILLIPS COUNTY HOSPITAL ASSOCIATION | ||||||||||||
| 311 S 8TH AVENUE EAST | MALTA | MT | 59538 | N/A | PC | TELE-EMERGENCY AND TELE-PHARMACY AT PHILLIPS COUNTY | $25,448 | |||||
| PIONEER MEDICAL CENTER | ||||||||||||
| 301 WEST 7TH AVE | BIG TIMBER | MT | 59011 | N/A | PC | TELE-PHARMACY AT PIONEER MEDICAL CENTER | $24,968 | |||||
| PIONEER MEDICAL CENTER | ||||||||||||
| 301 WEST 7TH AVE | BIG TIMBER | MT | 59011 | N/A | PC | TELE-PHARMACY AT PIONEER MEDICAL CENTER | $9,988 | |||||
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | ||||||||||||
| 1033 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 021385366 | N/A | PC | PRE-SYMPTOMATIC AUTOANTIBODY AND VIRAL PROFILE OF US MILITARY PERSONNEL WITH ADULT-ONSET TYPE 1 DIABETES | $126,636 | |||||
| PULITZER CENTER ON CRISIS REPORTING | ||||||||||||
| 1779 MASSACHUSETTS AVE NW | WASHINGTON | DC | 20036 | N/A | PC | BUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION | $310,123 | |||||
| RAMBAM HEALTH CORPORATION | ||||||||||||
| N/A | PC | MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S | $1,186,800 | HAALIA HASNIA 8 | HAIFA | IS | ||||||
| RAMBAM HEALTH CORPORATION | ||||||||||||
| N/A | PC | MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S | $746,990 | HAALIA HASNIA 8 | HAIFA | IS | ||||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS | $454,441 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | USING NATURAL LANGUAGE PROCESSING OF CLINICAL DOCUMENTATION TO IMPROVE PERSONALIZATION OF CARE IN CROHN'S DISEASE | $369,880 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | $187,370 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | $92,033 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS | $408,267 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | $92,033 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 55455 | N/A | GOV | PRECLINICAL DEVELOPMENT OF A MONOCLONAL ANTIBODY TO SERPINB13 | $308,267 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 55455 | N/A | GOV | MINNESOTA FIRST RESPONDER AED PROJECT | $4,885,390 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 55455 | N/A | GOV | DEVELOPING OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES | $190,677 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 55455 | N/A | GOV | MINNESOTA FIRST RESPONDER AED PROJECT | $1,296,918 | |||||
| REGION HOVEDSTADEN | ||||||||||||
| N/A | GOV | CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES? | $375,228 | KONGENS VNGE 2 | HILLEROD | DA | ||||||
| REGION HOVEDSTADEN | ||||||||||||
| N/A | GOV | CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES? | $113,358 | KONGENS VNGE 2 | HILLEROD | DA | ||||||
| RESEARCH TRIANGLE INSTITUTE | ||||||||||||
| 3040 EAST CORNWALLIS ROAD | RESEARCH TRIANGLE PARK | NC | 277092194 | N/A | PC | USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY | $826,376 | |||||
| RESEARCH TRIANGLE INSTITUTE | ||||||||||||
| 3040 EAST CORNWALLIS ROAD | RESEARCH TRIANGLE PARK | NC | 277092194 | N/A | PC | USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY | $1,110,288 | |||||
| RIVER'S EDGE HOSPITAL AND CLINIC | ||||||||||||
| 1900 N SUNRISE DRIVE | ST PETER | MN | 56082 | N/A | GOV | TELE-EMERGENCY SERVICES FOR RIVER'S EDGE HOSPITAL | $43,913 | |||||
| RIVER'S EDGE HOSPITAL AND CLINIC | ||||||||||||
| 1900 N SUNRISE DRIVE | ST PETER | MN | 56082 | N/A | GOV | TELE-EMERGENCY SERVICES FOR RIVER'S EDGE HOSPITAL | $17,567 | |||||
| SAFE WATER NETWORK | ||||||||||||
| 122 EAST 42ND STREET | NEW YORK | NY | 10168 | N/A | PC | SCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY | $1,552,050 | |||||
| SAGE BIONETWORKS | ||||||||||||
| 2901 THIRD AVE | SEATTLE | WA | 981213014 | N/A | PC | EXTENSION OF VEOIBD DATA COORDINATION TO ACCELERATE DISCOVERY OF PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES | $73,424 | |||||
| SAGE BIONETWORKS | ||||||||||||
| 2901 THIRD AVE | SEATTLE | WA | 981213014 | N/A | PC | EXTENSION OF VEOIBD DATA COORDINATION TO ACCELERATE DISCOVERY OF PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES | $75,165 | |||||
| SAINT LOUIS UNIVERSITY | ||||||||||||
| 221 NORTH GRAND BOULEVARD | SAINT LOUIS | MO | 63103 | N/A | PC | IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES | $608,000 | |||||
| SAINT LOUIS UNIVERSITY | ||||||||||||
| 221 NORTH GRAND BOULEVARD | SAINT LOUIS | MO | 63103 | N/A | PC | IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES | $608,523 | |||||
| SANFORD RESEARCH | ||||||||||||
| 2301 E 60TH STREET N | SIOUX FALL | SD | 571040569 | N/A | PC | PLEDGE PHASE 3 | $1,086,430 | |||||
| SANFORD RESEARCH | ||||||||||||
| 2301 E 60TH STREET N | SIOUX FALL | SD | 571040569 | N/A | PC | PLEDGE PHASE 3 | $1,118,635 | |||||
| SAPIR ACADEMIC COLLEGE | ||||||||||||
| N/A | PC | PLANNING FOR SAPIR ACADEMIC COLLEGE LAW SCHOOL BUILDING | $303,000 | DN HOF ASHKELON | REGIONAL COUNCIL SHAAR HA | IS | ||||||
| SCHWARTZREISMAN SCIENCE EDUCATION CENTER REHOVOT (RA) | ||||||||||||
| N/A | PC | THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT | $1,982,305 | HERZL ST 234 | REHOVOT | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT | $934,083 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT | $989,083 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | ||||||
| SHATTERPROOF A NONPROFIT CORP | ||||||||||||
| 101 MERRITT 7 CORPORATE PARK 1ST | NORWALK | CT | 06851 | N/A | PC | GENERAL OPERATING SUPPORT | $200,000 | FLOOR | ||||
| SHATTERPROOF A NONPROFIT CORP | ||||||||||||
| 101 MERRITT 7 CORPORATE PARK 1ST | NORWALK | CT | 06851 | N/A | PC | GENERAL OPERATING SUPPORT | $170,000 | FLOOR | ||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $400,000 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | |||||
| SNV NETHERLANDS DEVELOPMENT ORGANISATION | ||||||||||||
| N/A | PC | HEALTHY FUTURE FOR ALL (HF4A) IMPROVING WATER, SANITATION, HYGIENE AND NUTRITION | $962,857 | PARKSTRAAT 83 | DEN HAAG | NL | ||||||
| SOCIAL SCIENCE RESEARCH COUNCIL | ||||||||||||
| ONE PIERREPONT PLAZA 15TH FLOOR | BROOKLYN | NY | 11201 | N/A | PC | DATA2GO.NYC REVAMP AND DATA CLINIC | $597,446 | |||||
| SOUTH LINCOLN HOSPITAL DISTRICT | ||||||||||||
| 711 ONYX ST | KEMMERER | WY | 83101 | N/A | GOV | TELE-EMERGENCY AT SOUTH LINCOLN MEDICAL CENTER | $26,976 | |||||
| SOUTH LINCOLN HOSPITAL DISTRICT | ||||||||||||
| 711 ONYX ST | KEMMERER | WY | 83101 | N/A | GOV | TELE-EMERGENCY AT SOUTH LINCOLN MEDICAL CENTER | $10,791 | |||||
| SOUTHCENTRAL FOUNDATION | ||||||||||||
| 4501 DIPLOMACY DR | ANCHORAGE | AK | 99508 | N/A | PC | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | $903,411 | |||||
| SOUTHCENTRAL FOUNDATION | ||||||||||||
| 4501 DIPLOMACY DR | ANCHORAGE | AK | 99508 | N/A | PC | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | $818,043 | |||||
| ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH | ||||||||||||
| N/A | PC | WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D? | $298,224 | 9 PRINCES ST | MELBOURNE | AS | ||||||
| ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH | ||||||||||||
| N/A | PC | WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D? | $255,857 | 9 PRINCES ST | MELBOURNE | AS | ||||||
| STATE OF NV DEPT OF CONSERVATION AND NATURAL RES DIV OF STATE PARKS | ||||||||||||
| 901 S STEWART ST SUITE 5005 | CARSON CITY | NV | 89701 | N/A | PC | ICE AGE FOSSIL STATE PARK TRAILS AND OUTDOOR AMENITIES | $2,800,000 | |||||
| STICHTING ACCESS TO MEDICINE FOUNDATION | ||||||||||||
| N/A | PC | EXPANDING ACCESS TO T1D CARE | $875,000 | NARITAWEG 227 | AMSTERDAM | NL | ||||||
| STICHTING HEALTH ACTION INTERNATIONAL | ||||||||||||
| N/A | PC | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE III | $1,245,075 | OVERTOOM 60/II | AMSTERDAM | NL | ||||||
| STIFTELSEN FOR UTBILDNING (IOIBD) | ||||||||||||
| N/A | PC | THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD | $132,000 | DEPT OF GASTROENTEROLOGY | OREBRO | SW | ||||||
| STIFTELSEN FOR UTBILDNING (IOIBD) | ||||||||||||
| N/A | PC | THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD | $132,000 | DEPT OF GASTROENTEROLOGY | OREBRO | SW | ||||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $1,917,417 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $1,520,614 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $2,567,417 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $650,000 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $1,283,708 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $633,709 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $2,567,417 | |||||
| T1D EXCHANGE INC | ||||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | N/A | PC | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | $650,000 | |||||
| TECHNISCHE UNIVERSITAT DRESDEN | ||||||||||||
| N/A | GOV | GENOMIC INFLUENCE OF MATERNAL TYPE 1 DIABETES - UNDERSTANDING PROTECTION AGAINST TYPE 1 DIABETES | $210,829 | HELMHOLTZSTR 10 | DRESDEN | GM | ||||||
| TECHNISCHE UNIVERSITAT DRESDEN | ||||||||||||
| N/A | GOV | FR1DA IN SACHSEN | $60,079 | HELMHOLTZSTR 10 | DRESDEN | GM | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| N/A | GOV | GENETICS INSTITUTE AND GENOMICS CENTER | $1,118,516 | WEIZMAN 6 | TEL AVIV | IS | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| N/A | GOV | IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS | $346,330 | WEIZMAN 6 | TEL AVIV | IS | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| N/A | GOV | GENETICS INSTITUTE AND GENOMICS CENTER | $1,420,270 | WEIZMAN 6 | TEL AVIV | IS | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| N/A | GOV | IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS | $268,340 | WEIZMAN 6 | TEL AVIV | IS | ||||||
| THE ACADEMIC COLLEGE AT TEL-HAI | ||||||||||||
| N/A | PC | THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH | $2,078,769 | TEL-HAI COLLEGE | UPPER GALILEE | IS | ||||||
| THE ACADEMIC COLLEGE AT TEL-HAI | ||||||||||||
| N/A | PC | THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH | $2,664,333 | TEL-HAI COLLEGE | UPPER GALILEE | IS | ||||||
| THE ASPEN INSTITUTE INC | ||||||||||||
| 2300 N STREET | WASHINGTON | DC | 20037 | N/A | PC | BUILDING VISIONARY AND EFFECTIVE TEAMS TO ACCELERATE PROGRESS AGAINST TYPE 1 DIABETES (T1D) AND OTHER NON-COMMUNICABLE DISEASES (NCDS) | $998,081 | |||||
| THE BANQUET | ||||||||||||
| 900 E 8TH ST | SIOUX FALLS | SD | 57103 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | |||||
| THE BARUCH PADEH MEDICAL CENTER PORIYA | ||||||||||||
| N/A | GOV | THE HELMSLEY REHABILITATION CENTER OF THE NORTH | $5,431,730 | THE BARUCH PADEH MEDICAL CENTERPORI | TIBERIAS | IS | A | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | $1,500,000 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | $1,500,000 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS | $971,014 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS | $1,129,976 | |||||
| THE CHINESE UNIVERSITY OF HONG KONG | ||||||||||||
| N/A | PC | IBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY | $249,337 | PI CHIU BUILDING | SHATIN | HK | ||||||
| THE CITY OF HOPE | ||||||||||||
| 1500 E DUARTE RD | DUARTE | CA | 91010 | N/A | PC | GENETIC PROTECTION BY HLA-DQ6 IN T1D | $352,126 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $1,355,310 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | THE MILESTONE INITIATIVE: EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA | $331,133 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | DEVELOPMENT OF AN INTESTINAL ULTRASOUND INDEX AND A HISTOPATHOLOGY INDEX FOR STRICTURING SMALL BOWEL CROHNS DISEASE | $111,750 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $1,321,210 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | THE MILESTONE INITIATIVE: EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA | $236,313 | |||||
| THE DIATRIBE FOUNDATION | ||||||||||||
| 804 HAIGHT STREET | SAN FRANCISCO | CA | 94117 | N/A | PC | DIATRIBE LEARN MENTAL HEALTH SERIES | $100,285 | |||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $126,154 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | THE CHANGING EPIDEMIOLOGY AND DEMOGRAPHICS OF CROHNS DISEASE IN THE WESTERN WORLD OVER THE NEXT DECADE | $121,036 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | VISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CROHNS DISEASE: A KNOWLEDGE TRANSLATION STRATEGY | $89,047 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $137,153 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | QUANTITATIVE PROTEOMIC PROFILING OF FIBROSTENOTIC CROHNS DISEASE PATIENTS | $247,654 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $127,077 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $137,417 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| N/A | PC | THE CHANGING EPIDEMIOLOGY AND DEMOGRAPHICS OF CROHNS DISEASE IN THE WESTERN WORLD OVER THE NEXT DECADE | $191,883 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | ||||||
| THE HOPE CENTER | ||||||||||||
| 615 KANSAS CITY STREET | RAPID CITY | SD | 57701 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | |||||
| THE HOSPITAL FOR SICK CHILDREN | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES | $548,276 | 555 UNIVERSITY AVE | TORONTO | CA | ||||||
| THE HOSPITAL FOR SICK CHILDREN | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES | $555,480 | 555 UNIVERSITY AVE | TORONTO | CA | ||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | ||||||||||||
| N/A | PC | UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE | $1,032,574 | EXHIBITION RD | LONDON | UK | ||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | ||||||||||||
| N/A | PC | UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE | $1,081,289 | EXHIBITION RD | LONDON | UK | ||||||
| THE JEWISH AGENCY FOR ISRAEL | ||||||||||||
| N/A | PC | THE JEWISH AGENCY SECURITY FUND (THE FUND) | $161,477 | 48 KING GEORGE STREET | JERUSALEM | IS | ||||||
| THE LEGATUM INSTITUTE FOUNDATION | ||||||||||||
| N/A | NC | PHASE TWO OF US PROSPERITY INDEX: EXPANDING COUNTY-LEVEL INDEX TO INCLUDE WYOMING AND DEEPENING IMPACT | $50,000 | 11 CHARLES STREET | LONDON | UK | ||||||
| THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL LTD (CC) | ||||||||||||
| N/A | PC | OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN-ISRAELIS PURSUING NURSING DEGREES | $220,000 | YEZREEL VALLEY | YEZREEL VALLEY | IS | ||||||
| THE MILKEN INSTITUTE | ||||||||||||
| 1250 FOURTH STREET | SANTA MONICA | CA | 90401 | N/A | PC | FASTERCURES LEADERSLINK PROGRAM EXPANSION | $250,000 | |||||
| THE MILKEN INSTITUTE | ||||||||||||
| 1250 FOURTH STREET | SANTA MONICA | CA | 90401 | N/A | PC | FASTERCURES LEADERSLINK PROGRAM EXPANSION | $250,000 | |||||
| THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | CHARLOTTESVILLE | VA | 229044195 | N/A | PC | TYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS | $321,984 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE | ||||||||||||
| 120 THEORY SUITE 200 | IRVINE | CA | 926971050 | N/A | PC | DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D | $594,335 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE | ||||||||||||
| 120 THEORY SUITE 200 | IRVINE | CA | 926971050 | N/A | PC | DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D | $1,597,074 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES | ||||||||||||
| UCLA OFFICE OF CONTRACTS AND GRANTS | LOS ANGELES | CA | 900951406 | N/A | PC | GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $568,851 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES | ||||||||||||
| UCLA OFFICE OF CONTRACTS AND GRANTS | LOS ANGELES | CA | 900951406 | N/A | PC | GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $568,027 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | N/A | PC | THE DRUGGABLE GPCROME IN CROHNS DISEASE | $1,092,733 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | N/A | PC | MECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN | $1,016,890 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | N/A | PC | THE DRUGGABLE GPCROME IN CROHNS DISEASE | $1,091,471 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $269,368 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $241,173 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $241,173 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $269,368 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL | $300,000 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | $835,489 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | EXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D | $202,073 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | ASK THE EXPERTS | $575,810 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | COMPLEMENT SYSTEM IN THE INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY | $124,200 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | FAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02 | $266,200 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION | $1,008,526 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | DIABETIC KETOACIDOSIS TRENDS AND RESOURCE UTILIZATION AT DIAGNOSIS OF TYPE 1 DIABETES IN THE UNITED STATES | $157,700 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL | $300,000 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | EXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D | $178,454 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | SEEDS PATHWAY: SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY | $612,073 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | $994,996 | F428 | ||||
| THE SDEROT DEVELOPMENT FOUNDATION | ||||||||||||
| N/A | PC | SDEROT MEDICAL CENTER | $993,626 | 6 BAR LEV STREET | SDEROT | IS | ||||||
| THE SDEROT DEVELOPMENT FOUNDATION | ||||||||||||
| N/A | PC | ESTABLISHING A WARM HOME COMPLEX FOR CHILDREN AT RISK IN SDEROT | $2,284,718 | 6 BAR LEV STREET | SDEROT | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | COMPREHENSIVE INDIVIDUALIZED PROACTIVE THERAPY OF CROHN'S DISEASE: THE CURE STUDY | $228,294 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | THE HELMSLEY CENTER FOR INNOVATIVE SURGICAL TRAINING | $4,395,700 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | $704,764 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | $756,699 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| N/A | PC | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | $188,118 | TEL-HASHOMER | RAMAT GAN | IS | ||||||
| THE TEL AVIV JAFFA ACADEMIC COLLEGE | ||||||||||||
| N/A | PC | SCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX (HAREDI) MEN PURSUING B.S. DEGREES IN NURSING | $253,818 | RABENU YERUHAM ST 2 POB 8401 | TEL AVIV YAFFO | IS | ||||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $334,798 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $429,646 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | SUPPORT FOR T1D TRANSITION PROGRAMS | $200,000 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $413,263 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $351,258 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | SUPPORT FOR T1D TRANSITION PROGRAMS | $150,000 | |||||
| THE UNIVERSITY OF ADELAIDE | ||||||||||||
| N/A | PC | ENDIA SCIENCE CONTINUATION | $181,471 | THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | ||||||
| THE UNIVERSITY OF ADELAIDE | ||||||||||||
| N/A | PC | ENDIA EXPANDED SUPPORT | $163,010 | THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | ||||||
| THE UNIVERSITY OF CHICAGO | ||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND | $784,751 | |||||
| THE UNIVERSITY OF CHICAGO | ||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND | $333,042 | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $444,246 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | UNDERSTANDING ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN TYPE 1 DIABETES. | $159,623 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $212,881 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | MITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC) | $854,515 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $209,222 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| N/A | PC | UNDERSTANDING ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN TYPE 1 DIABETES. | $179,714 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | |||||
| THE UNIVERSITY OF MANCHESTER | ||||||||||||
| N/A | PC | A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION | $1,113,915 | OXFORD RD | MANCHESTER | UK | ||||||
| THE UNIVERSITY OF MANCHESTER | ||||||||||||
| N/A | PC | A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION | $692,839 | OXFORD RD | MANCHESTER | UK | ||||||
| THE UNIVERSITY OF QUEENSLAND | ||||||||||||
| N/A | PC | LIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET TYPE 1 DIABETES | $435,713 | CUMBRAE STEWART BUILDING 72 | BRISBANE | AS | ||||||
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | ||||||||||||
| 5323 HARRY HINES BOULEVARD | DALLAS | TX | 753909020 | N/A | GOV | IMMUNE CHECKPOINT ENGINEERED BETA CELL AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF TYPE I DIABETES | $275,000 | |||||
| THE UNIVERSITY OF WESTERN AUSTRALIA | ||||||||||||
| N/A | PC | CGM ASSESSMENTS OF ENDIA CHILDREN | $94,107 | 35 STIRLING HIGHWAY | CRAWLEY | AS | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | THE QUANTUM MATERIALS DEVICES FABRICATION LAB | $1,750,000 | 234 HERZEL ST | REHOVOT | IS | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | $2,500,000 | 234 HERZEL ST | REHOVOT | IS | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | DECODING THE CLINICAL IMPACT OF HOST AND MICROBIAL INTESTINAL PROTEOMIC LANDSCAPE IN CROHNS DISEASE | $961,620 | 234 HERZEL ST | REHOVOT | IS | ||||||
| TOWNSEND HEALTH SYSTEMS INC | ||||||||||||
| 110 NORTH OAK | TOWNSEND | MT | 59644 | N/A | PC | TELE-PHARMACY AT BILLINGS CLINIC BROADWATER | $15,112 | |||||
| TRUSTEES OF INDIANA UNIVERSITY | ||||||||||||
| 509 E 3RD ST | BLOOMINGTON | MI | 474013654 | N/A | GOV | COLLABORATIVE EFFORT TO VALIDATE MICRORNA AS BIOMARKERS OF T1D | $426,380 | |||||
| TRUSTEES OF INDIANA UNIVERSITY | ||||||||||||
| 509 E 3RD ST | BLOOMINGTON | MI | 474013654 | N/A | GOV | TARGETING METABOLIC DRIVERS OF B CELL DIFFERENTIATION IN TYPE 1 DIABETES | $58,372 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE | $285,079 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS | $407,000 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE | $293,370 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS | $407,000 | |||||
| UNITED JEWISH APPEAL FEDERATION OF JEWISH PHILANTHROPIES OF NY INC | ||||||||||||
| 130 EAST 59TH STREET | NEW YORK | NY | 10022 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | |||||
| UNITED NATIONS DEVELOPMENT PROGRAMME | ||||||||||||
| 1 UNITED NATIONS PLAZA | NEW YORK | NY | 10017 | N/A | PC | INCREASING ACCESS TO HEALTHCARE FOR PEOPLE LIVING WITH DIABETES AND OTHER NCDS | $339,777 | |||||
| UNITED STATES AFRICAN DEVELOPMENT FOUNDATION | ||||||||||||
| 1400 I STREET NW | WASHINGTON | DC | 20005 | N/A | GOV | LIVELIHOOD IMPROVEMENT PROGRAM | $1,283,255 | |||||
| UNITED STATES FUND FOR UNICEF | ||||||||||||
| 125 MAIDEN LANE | NEW YORK | NY | 10038 | N/A | PC | ACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS | $869,232 | |||||
| UNITED STATES FUND FOR UNICEF | ||||||||||||
| 125 MAIDEN LANE | NEW YORK | NY | 10038 | N/A | PC | ACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS | $784,421 | |||||
| UNIVERSITAIR MEDISCH CENTRUM UTRECHT | ||||||||||||
| N/A | GOV | EPITHELIAL-BASED DIAGNOSTICS FOR TARGETED THERAPIES OF VEOIBD | $173,250 | HEIDELBERGLAAN 100 | UTRECHT | NL | ||||||
| UNIVERSITAIR MEDISCH CENTRUM UTRECHT | ||||||||||||
| N/A | GOV | EPITHELIAL-BASED DIAGNOSTICS FOR TARGETED THERAPIES OF VEOIBD | $173,250 | HEIDELBERGLAAN 100 | UTRECHT | NL | ||||||
| UNIVERSITE CATHOLIQUE DE LOUVAIN | ||||||||||||
| N/A | PC | LONGITUDINAL STUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN AND ADOLESCENTS WITH NEW-ONSET T1D | $62,567 | PLACE DE LUNIVERSITE 1 | LOUVAINLANEUVE | BE | ||||||
| UNIVERSITE LIBRE DE BRUXELLES | ||||||||||||
| N/A | GOV | GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING | $213,582 | AVENUE FRANKLIN ROOSEVELT 50 | BRUSSELS | BE | ||||||
| UNIVERSITE LIBRE DE BRUXELLES | ||||||||||||
| N/A | GOV | GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING | $213,602 | AVENUE FRANKLIN ROOSEVELT 50 | BRUSSELS | BE | ||||||
| UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C | ||||||||||||
| 1001 MAIN STREET | BUFFALO | NY | 14203 | N/A | PC | FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS | $233,094 | |||||
| UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C | ||||||||||||
| 1001 MAIN STREET | BUFFALO | NY | 14203 | N/A | PC | FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS | $576,839 | |||||
| UNIVERSITY COLLEGE LONDON | ||||||||||||
| N/A | PC | SPIT-C: USING SALIVA TO PREDICT CROHNS DISEASE | $94,104 | GOWER STREET | LONDON | UK | ||||||
| UNIVERSITY HOSPITALS HEALTH SYSTEM INC | ||||||||||||
| 11100 EUCLID AVENUE | CLEVELAND | OH | 44106 | N/A | PC | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | $866,199 | |||||
| UNIVERSITY HOSPITALS HEALTH SYSTEM INC | ||||||||||||
| 11100 EUCLID AVENUE | CLEVELAND | OH | 44106 | N/A | PC | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | $677,700 | |||||
| UNIVERSITY HOSPITALS HEALTH SYSTEM INC | ||||||||||||
| 11100 EUCLID AVENUE | CLEVELAND | OH | 44106 | N/A | PC | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | $707,339 | |||||
| UNIVERSITY OF BIRMINGHAM | ||||||||||||
| N/A | PC | DEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES: AN EXPERIMENTAL MEDICINE STUDY | $233,307 | INSTITUTE OF IMMUNOLOGY AND | BIRMINGHAM | UK | IMMUNOTHERAPY | |||||
| UNIVERSITY OF BRISTOL | ||||||||||||
| N/A | PC | TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY | $431,779 | SENATE HOUSE | BRISTOL | UK | ||||||
| UNIVERSITY OF BRISTOL | ||||||||||||
| N/A | PC | TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY | $358,900 | SENATE HOUSE | BRISTOL | UK | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| N/A | PC | EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE | $718,215 | THE OLD SCHOOLS | CAMBRIDGE | UK | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| N/A | PC | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2) | $500,000 | THE OLD SCHOOLS | CAMBRIDGE | UK | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| N/A | PC | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2) | $353,223 | THE OLD SCHOOLS | CAMBRIDGE | UK | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| N/A | PC | EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE | $713,088 | THE OLD SCHOOLS | CAMBRIDGE | UK | ||||||
| UNIVERSITY OF DUNDEE | ||||||||||||
| N/A | PC | HYPO-RESOLVE - UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA | $133,804 | NETHERGATE | DUNDEE | UK | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| N/A | PC | EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2: FROM OBSERVATION TO MECHANISM | $566,086 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| N/A | PC | ADVANCING B-CELL SPECIFIC THERAPY BY IDENTIFYING B-CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS | $126,104 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| N/A | PC | STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES | $403,451 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| N/A | PC | EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2: FROM OBSERVATION TO MECHANISM | $451,469 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | ||||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | N/A | GOV | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | $665,910 | |||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | N/A | GOV | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | $569,086 | |||||
| UNIVERSITY OF GLASGOW COURT | ||||||||||||
| N/A | PC | COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY | $1,231,291 | UNIVERSITY AVENUE | GLASGOW | UK | ||||||
| UNIVERSITY OF GLASGOW COURT | ||||||||||||
| N/A | PC | COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY | $176,239 | UNIVERSITY AVENUE | GLASGOW | UK | ||||||
| UNIVERSITY OF IOWA | ||||||||||||
| DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | N/A | GOV | SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION | $204,566 | |||||
| UNIVERSITY OF IOWA | ||||||||||||
| DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | N/A | GOV | SIMULATION IN MOTION IOWA (SIM-IA) | $748,244 | |||||
| UNIVERSITY OF IOWA | ||||||||||||
| DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | N/A | GOV | SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION | $199,968 | |||||
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||||||
| 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | N/A | PC | PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D | $706,324 | |||||
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||||||
| 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | N/A | PC | PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D | $579,370 | |||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | ||||||||||||
| 55 LAKE AVENUE NORTH | WORCESTER | MA | 01655 | N/A | GOV | DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS | $881,959 | |||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | ||||||||||||
| 55 LAKE AVENUE NORTH | WORCESTER | MA | 01655 | N/A | GOV | DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS | $473,409 | |||||
| UNIVERSITY OF MELBOURNE | ||||||||||||
| N/A | PC | ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR | $880,551 | LEVEL 4 ALAN GILBERT BUILDING | VICTORIA | AS | ||||||
| UNIVERSITY OF MIAMI | ||||||||||||
| 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | N/A | PC | THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | $326,055 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | N/A | PC | THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | $328,238 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | N/A | PC | DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES | $286,197 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | N/A | PC | DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES | $242,826 | |||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | PC | GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES | $581,625 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | PC | DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR | $1,027,184 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | PC | DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR | $1,116,830 | 1350 | ||||
| UNIVERSITY OF NORTH DAKOTA | ||||||||||||
| SCHOOL OF MEDICINE HEALTH SCIENCES | GRAND FORKS | ND | 58202 | N/A | GOV | SIMULATION IN MOTION (SIM) CONSORTIUM | $61,479 | |||||
| UNIVERSITY OF NORTH DAKOTA | ||||||||||||
| SCHOOL OF MEDICINE HEALTH SCIENCES | GRAND FORKS | ND | 58202 | N/A | GOV | SIMULATION IN MOTION (SIM) CONSORTIUM | $54,978 | |||||
| UNIVERSITY OF NOTRE DAME DU LAC | ||||||||||||
| 940 GRACE HALL | NOTRE DAME | IN | 465565708 | N/A | PC | GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES | $503,082 | |||||
| UNIVERSITY OF NOTRE DAME DU LAC | ||||||||||||
| 940 GRACE HALL | NOTRE DAME | IN | 465565708 | N/A | PC | DEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM | $848,637 | |||||
| UNIVERSITY OF NOTRE DAME DU LAC | ||||||||||||
| 940 GRACE HALL | NOTRE DAME | IN | 465565708 | N/A | PC | GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES | $542,672 | |||||
| UNIVERSITY OF OULU | ||||||||||||
| N/A | PC | MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING | $284,289 | PO BOX 8000 | OULU | FI | ||||||
| UNIVERSITY OF OULU | ||||||||||||
| N/A | PC | MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING | $263,104 | PO BOX 8000 | OULU | FI | ||||||
| UNIVERSITY OF PITTSBURGH | ||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | $243,196 | |||||
| UNIVERSITY OF PITTSBURGH | ||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | $280,115 | |||||
| UNIVERSITY OF PITTSBURGH | ||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | ANALOGUE VS HUMAN INSULIN FOR YOUTH WITH TYPE 1 DIABETES IN LOW-RESOURCE SETTINGS: A RANDOMIZED CONTROLLED TRIAL (ANHUT1D TRIAL). | $998,931 | |||||
| UNIVERSITY OF PITTSBURGH | ||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | $237,102 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $196,411 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $198,646 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $198,646 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $200,927 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $200,927 | |||||
| UNIVERSITY OF TOLEDO | ||||||||||||
| 3000 ARLINGTON AVENUE | TOLEDO | OH | 436142595 | N/A | GOV | TYPE 1 DIABETES CAR TREG THERAPEUTIC APPROACH | $110,480 | |||||
| UNIVERSITY OF VIRGINIA LAW SCHOOL FOUNDATION | ||||||||||||
| 580 MASSIE ROAD | CHARLOTTESVILLE | VA | 22903 | N/A | PC | GENERAL OPERATING SUPPORT FOR THE CATHERINE MURPHY KEATING '87 RESTRICTED FUND | $50,000 | |||||
| UPPSALA UNIVERSITET | ||||||||||||
| N/A | GOV | ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION | $229,347 | BOX 256 | UPPSALA | SW | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | MRI OF THE PANCREAS IN T1D | $373,041 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | EXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY | $659,685 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS | $248,256 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $68,349 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | SCREENING HUMAN ISLETS TO IDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA | $221,931 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES | $200,000 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA | $275,000 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS | $248,256 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $121,999 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES | $163,405 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA | $275,000 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $232,525 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $182,168 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES | $36,595 | |||||
| VANDERBILT UNIVERSITY | ||||||||||||
| SPONSORED PROGRAMS ADMINISTRATION | NASHVILLE | TN | 372032417 | N/A | PC | NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING | $275,000 | |||||
| VANDERBILT UNIVERSITY | ||||||||||||
| SPONSORED PROGRAMS ADMINISTRATION | NASHVILLE | TN | 372032417 | N/A | PC | NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING | $275,000 | |||||
| VAYU HEALTH | ||||||||||||
| 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | N/A | PC | VAYU FEASIBILITY PILOT | $233,495 | |||||
| VAYU HEALTH | ||||||||||||
| 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | N/A | PC | VAYU FEASIBILITY PILOT | $318,000 | |||||
| VETERANS MEMORIAL HOSPITAL | ||||||||||||
| 40 1ST STREET SE | WAUKON | IA | 52172 | N/A | GOV | ECARE PHARMACY AND EMERGENCY SERVICES AT VETERANS MEMORIAL HOSPITAL | $30,504 | |||||
| VIVLI INC | ||||||||||||
| 14 STORY STREET SUITE 406 | CAMBRIDGE | MA | 02138 | N/A | PC | DATA SHARING PLATFORM FOR T1-DEXI DATASETS | $72,174 | |||||
| VIVLI INC | ||||||||||||
| 14 STORY STREET SUITE 406 | CAMBRIDGE | MA | 02138 | N/A | PC | DATA SHARING PLATFORM FOR T1-DEXI DATASETS | $72,174 | |||||
| WARREN MEMORIAL HOSPITAL | ||||||||||||
| 905 2ND ST | FRIEND | NE | 68359 | N/A | GOV | TELE-EMERGENCY SERVICES AT FRIEND COMMUNITY HEALTHCARE SYSTEM | $25,335 | |||||
| WARREN MEMORIAL HOSPITAL | ||||||||||||
| 905 2ND ST | FRIEND | NE | 68359 | N/A | GOV | TELE-EMERGENCY SERVICES AT FRIEND COMMUNITY HEALTHCARE SYSTEM | $11,027 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 63130 | N/A | PC | CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE | $338,970 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 63130 | N/A | PC | RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING | $330,000 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 63130 | N/A | PC | CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE | $488,300 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 63130 | N/A | PC | RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING | $330,000 | |||||
| WATER4 INC | ||||||||||||
| 2405 NW 10TH STREET | OKLAHOMA CITY | OK | 73107 | N/A | PC | SCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER | $1,673,164 | |||||
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 100654805 | N/A | PC | TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE | $863,618 | |||||
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 100654805 | N/A | PC | TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE | $202,620 | |||||
| WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| N/A | PC | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | $500,000 | POB 26 | REHOVOT | IS | ||||||
| WORLD HEALTH ORGANIZATION | ||||||||||||
| N/A | PC | STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT | $3,521,461 | AVENUE APPIA 20 | GENEVA | SZ | ||||||
| WORLD HEALTH ORGANIZATION | ||||||||||||
| N/A | PC | STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT | $2,738,915 | AVENUE APPIA 20 | GENEVA | SZ | ||||||
| WYOMING DEPARTMENT OF HEALTH | ||||||||||||
| 6101 YELLOWSTONE RD SUITE 400 | CHEYENNE | WY | 82009 | N/A | GOV | WYOMING FIRST RESPONDER AED PROJECT | $16,000 | |||||
| YALE UNIVERSITY | ||||||||||||
| OFFICE OF SPONSORED PROJECTS | NEW HAVEN | CT | 065208327 | N/A | PC | EXPOSOMICS FOR EARLY LIFE CROHNS DISEASE | $298,606 | |||||
| YEHUDA ABARBANEL GOVERNMENT HOSPITAL | ||||||||||||
| N/A | GOV | MODERNIZATION OF ABARBANELS INFORMATION TECHNOLOGY AND SECURITY SYSTEMS | $454,960 | 15 KEREN KAYEMET ST | BAT YAM | IS | ||||||
| YITZHAK SHAMIR MEDICAL CENTER | ||||||||||||
| N/A | GOV | EXPANSION AND RENOVATION OF THE CANCER INSTITUTE AT SHAMIR MEDICAL CENTER | $1,978,286 | BEER YAAKOV | TZRIFIN | IS | ||||||
| YOUTH DEVELOPMENT ORGANIZATION INC | ||||||||||||
| 15 UNION STREET 563 | LAWRENCE | MA | 01840 | N/A | PC | CAPACITY BUILDING PROJECT SUPPORT 2022 | $200,000 | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grant Or Contri Apprv Fut | $482,673,051 | TotalGrantOrContriApprvFutAmt |
Analysis Income Producing Acty AnalysisIncomeProducingActyGrp
Int On Sav And Temp Cash Invst IntOnSavAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Exclusion | 14 | ExclusionCd |
| Exclusion | $4,992,185 | ExclusionAmt |
Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business | 901101 | BusinessCd |
| Unrelated Business Taxbl Incm | $8,726,179 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | 14 | ExclusionCd |
| Exclusion | $44,545,320 | ExclusionAmt |
Other Investment Income OtherInvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business | 901101 | BusinessCd |
| Unrelated Business Taxbl Incm | $3,628,291 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | 14 | ExclusionCd |
| Exclusion | $33,579,074 | ExclusionAmt |
Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business | 901101 | BusinessCd |
| Unrelated Business Taxbl Incm | $6,558,490 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | 18 | ExclusionCd |
| Exclusion | $527,087,615 | ExclusionAmt |
Other Revenue Described OtherRevenueDescribedGrp (2 entries)
| DescDesc | ExclusionExclusionCd | ExclusionExclusionAmt |
|---|---|---|
| GRANT RECOVERIES | 01 | $500 |
| OTHER NON-TAXABLE INCOME | 01 | $14,795 |
Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Unrelated Business Taxbl Incm | $18,912,960 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | $610,219,489 | ExclusionAmt |
| Related Or Exempt Function Incm | $0 | RelatedOrExemptFunctionIncmAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Income Producing Acty | $629,132,449 | TotalIncomeProducingActyAmt |
Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trnsfr Of Cash To Nonchrtbl EO | Yes (1) | TrnsfrOfCashToNonchrtblEOInd |
| Trnsfr Other Asset Nonchrtbl EO | 0 | TrnsfrOtherAssetNonchrtblEOInd |
| Sales Or Exchanges Of Assets | 0 | SalesOrExchangesOfAssetsInd |
| Purchase Of Assets Nonchrtbl EO | 0 | PurchaseOfAssetsNonchrtblEOInd |
| Rental Of Facilities Oth Assets | 0 | RentalOfFacilitiesOthAssetsInd |
| Reimbursement Arrangements | 0 | ReimbursementArrangementsInd |
| Loans Or Loan Guarantees | 0 | LoansOrLoanGuaranteesInd |
| Performance Of Services Etc | 0 | PerformanceOfServicesEtcInd |
| Sharing Of Facilities Etc | 0 | SharingOfFacilitiesEtcInd |
Transfer Schedule Detail TransferScheduleDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Line Number | 1a(1) | LineNumberTxt |
| Involved | $413,127 | InvolvedAmt |
Noncharitable Exempt Org Name NoncharitableExemptOrgName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfers Trans And Shr Arrngm | GRANT IN SUPPORT OF EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE | TransfersTransAndShrArrngmDesc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationships Nonchrtbl EO | 0 | RelationshipsNonchrtblEOInd |
Accounting Fees Schedule AccountingFeesSchedule
Accounting Fees Detail AccountingFeesDetail (4 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| DEMASCO, SENA & JAHELKA LLP (BOOKKEEPING) | $34,989 | $4,944 | $20,343 |
| PKF O'CONNOR DAVIES, LLP (AUDIT & TAX) | $754,225 | $543,175 | $162,390 |
| PRICEWATERHOUSECOOPERS ADVISORY LTD. (GRANTS ADMINISTRATION) | $115,449 | $0 | $117,738 |
| OTHER ACCOUNTING CONSULTANTS | $14,616 | $0 | $19,794 |
All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch
All Other Program Related Invst AllOtherProgramRelatedInvstGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| THETIS PHARMACEUTICALS, LLC - DEVELOPMENT OF NOVEL RESOLVIN E1 THERAPY FOR CROHN'S TREATMENT | $903,630 |
| BIORASIS, INC. - EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD | $340,000 |
Expenditure Responsibility Stmt ExpenditureResponsibilityStmt
Expenditure Responsibility ExpenditureResponsibilityGrp (25 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | Province Or StateForeignAddress/ProvinceOrStateNm | CountryForeignAddress/CountryCd | GrantGrantDt | GrantGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Expended By GranteeExpendedByGranteeAmt | Any Diversion By GranteeAnyDiversionByGranteeTxt | Dates Of Reports By GranteeDatesOfReportsByGranteeTxt | Foreign PostalForeignAddress/ForeignPostalCd | Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Address Line2ForeignAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALIMENTIV INC (FKA ROBARTS) | |||||||||||||||
| 100 DUNDAS STREET | LONDON | ON | CA | 2018-11-20 | $3,390,428 | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | $2,471,716 | NONE | PRIOR + 1/2020, 6/2020, 12/2020, 1/2021, 6/2021, 12/2021, 6/2022, 2/2023, 7/ | ||||||
| ASITY MADAGASCAR | |||||||||||||||
| LOT IAB 39 TER C ANALAMHINTSY | ANTANANARIVO | MA | 2017-03-01 | $284,790 | IMPLEMENT SUSTAINABLE MANAGEMENT STRATEGIES FOR WETLAND CONSERVATION | $284,790 | NONE | 2/2018, 2/2019, 5/2020, 9/2021, 10/2022 | 101 | ||||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | |||||||||||||||
| 2021-11-20 | $2,500,000 | EXPANSION OF THE DANATECH PLATFORM TO MIMPROVE T1D CARE | $681,030 | NONE | 1/2022, 5/2022, 12/2022, 1/2023 | 125 S WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | ||||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | |||||||||||||||
| 2018-07-11 | $2,679,637 | AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS | $2,679,637 | NONE | 2/2019, 8/2019, 1/2020, 8/2020, 1/2021, 6/2021, 3/2022, 7/2023 | 125 S WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | |||||||||||||||
| 55 VICTORIA PARADE LEVEL 2 | FITZROY | AS | 2020-07-23 | $3,560,371 | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES | $1,600,433 | NONE | 2/2021, 8/2021, 2/2022, 7/2022, 8/2022, 2/2023, 8/2023 | 3065 | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | |||||||||||||||
| 55 VICTORIA PARADE LEVEL 2 | FITZROY | AS | 2017-02-15 | $3,719,569 | THE ENIGMA STUDIES -TO IMPROVE CARE OF CROHN'S | $3,719,569 | NONE | 3/2019, 7/2019, 11/2019, 1/2020, 4/2020, 10/2020, 11/2020, 3/2021, 9/2021, 3 | 3065 | ||||||
| BIORASIS INC | |||||||||||||||
| 2018-02-06 | $3,016,000 | EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD IN CARE FOR T1D | $1,988,500 | NONE | PRIOR + 2/2020, 5/2020, 8/2020, 11/2020, 2/2021, 7/2021, 5/2022, 11/2022, 5/ | 1392 STORRS RD U4213 ATL ROOM 106 | STORRS | CT | 06269 | ||||||
| CAPILLARY BIOMEDICAL INC | |||||||||||||||
| 2020-09-02 | $1,500,000 | ADVANCED EXTENDED INFUSION SET TO IMPROVE CARE OF T1D | $1,428,325 | NONE | 10/2020, 3/2021, 4/2021, 10/2021, 1/2022, 5/2022, 6/2022, 3/2023, 8/2023 | 2 WRIGLEY | IRVINE | CA | 92617 | ||||||
| DIABETOMICS INC | |||||||||||||||
| 2018-01-11 | $4,031,900 | POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION | $4,031,900 | NONE | PRIOR +10/2020, 4/2021, 10/2021, 12/2021, 2/2022, 4/2022, 9/2022, 10/2022, 7 | 2345 NE OVERLOOK DRIVE SUITE 140 | HILLSBORO | OR | 97006 | ||||||
| DREAMED DIABETES LTD | |||||||||||||||
| 14 KAPLAN ST | PETAH TIKVA | IS | 2023-02-23 | $2,850,000 | INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES | $0 | NONE | 5/2023 | 4952701 | ||||||
| DREAMED DIABETES LTD | |||||||||||||||
| 14 KAPLAN ST | PETAH TIKVA | IS | 2016-02-01 | $3,585,828 | MD-LOGIC PUMP GUIDE4U - ADVISORY SYSTEM TO IMPROVE CARE OF T1D | $3,585,828 | NONE | 10/2016, 1/2017, 7/2017, 9/2017, 2/2018, 6/2018, 9/2018, 12/2019, 1/2023 | 4952701 | ||||||
| GRAND CANYON UNIVERSITY | |||||||||||||||
| 2019-06-26 | $2,274,027 | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR | $2,208,383 | NONE | 6/2020, 7/2020, 7/2021, 4/2022, 1/2023 | 3300 WEST CAMELBACK ROAD | PHOENIX | AZ | 85017 | ||||||
| HEALTH FINANCE INSTITUTE | |||||||||||||||
| 2019-12-16 | $3,163,666 | HEALTH FINANCE INSTITUTE SEED GRANT: CATALYZING FINANCING AND PARTNERSHIPS TO ADDRESS THE GLOBAL BURDEN OF CHRONIC DISEASE | $3,163,666 | NONE | 4/2020, 7/2020, 12/2020, 3/2021, 1/2022, 1/2023 | 1690 NORTH QUINN STREET | ARLINGTON | VA | 22209 | ||||||
| INNODIA | |||||||||||||||
| HERESTRAAT 49 | LEUVEN | VLAAMS-BRABANT | BE | 2022-10-13 | $1,189,643 | INNODIA NONPROFIT LAUNCH FOR THE CARE AND PREVENTION OF T1D. | $19,453 | NONE | 12/2022, 4/2023 | 3000 | |||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||||
| HARKORTSTR 1 | MUNSTER | EI | 2020-10-22 | $3,583,742 | DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE. | $1,798,379 | NONE | 6/2021, 12/2021, 8/2022, 11/2022, 12/2022, 8/2023 | 48163 | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||||
| HARKORTSTR 1 | MUNSTER | EI | 2022-03-23 | $172,967 | POINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES: "INTRODUCTION TO INTESTINAL ULTRASONOGRAPHY" | $172,967 | NONE | 3/2023 | 48163 | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||||
| HARKORTSTR 1 | MUNSTER | EI | 2023-06-22 | $1,556,119 | THE EXTENT STUDY TO IMPROVE THE CARE OF CROHN'S DISEASE. | $0 | NONE | PENDING | 48163 | ||||||
| NURU INTERNATIONAL | |||||||||||||||
| 2013-11-25 | $4,680,506 | CREATING A SELF-SUSTAINING, SCALING, AGRICULTURE-BASED DEVELOPMENT MODEL | $4,680,506 | NONE | 6/2014, 1/2015, 11/2015, 12/2015, 1/2017, 2/2018, 1/2019, 1/2020, 6/2020, 1/ | 2020 PENNSYLVANIA AVE NW | WASHINGTON | DC | 20006 | ||||||
| PERCUSENSE INC | |||||||||||||||
| 2020-09-02 | $2,500,000 | DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER TO IMPROVE CARE OF T1D | $1,350,000 | NONE | 7/2021, 8/2021, 10/2021, 5/2022, 4/2023, 5/2023, 7/2023 | 25134 RYE CANYON LOOP | VALENCIA | CA | 91355 | ||||||
| STARTUP HEALTH T1D PRI LP | |||||||||||||||
| 2023-01-30 | $5,000,000 | CATALYZING SEED AND EARLY-STAGE COMPANIES DEVELOPING INNOVATIVE T1D CARE SOLUTIONS | $0 | NONE | 3/2023 | 2000 BROADWAY 18TH FLOOR | NEW YORK | NY | 10023 | ||||||
| THE LEGATUM INSTITUTE FOUNDATION | |||||||||||||||
| 11 CHARLES STREET | LONDON | UK | 2021-09-21 | $78,169 | PHASE TWO OF US PROSPERITY INDEX: EXPANDING COUNTY-LEVEL INDEX TO INCLUDE WYOMING AND DEEPENING IMPACT | $78,169 | NONE | 1/2022, 10/2022, 1/2023 | W1J 5DW | ||||||
| THE UNIVERSITY OF QUEENSLAND | |||||||||||||||
| CUMBRAE STEWART BUILDING 72 THE | BRISBANE | QUEENSLAND | AS | 2021-09-08 | $1,667,706 | LIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET TYPE 1 DIABETES | $829,416 | NONE | 1/2023 | 4072 | UNIVERSITY OF QUEENSLAND | ||||
| THE UNIVERSITY OF QUEENSLAND | |||||||||||||||
| CUMBRAE STEWART BUILDING 72 THE | BRISBANE | QUEENSLAND | AS | 2023-05-22 | $226,017 | GUT MICROBIAL METABOLITES DURING EARLY-LIFE DEVELOPMENT AS PREDICTORS OF ISLET AUTOIMMUNITY | $0 | NONE | PENDING | 4072 | UNIVERSITY OF QUEENSLAND | ||||
| THETIS PHARMACEUTICALS LLC | |||||||||||||||
| 2022-02-24 | $5,069,660 | DEVELOPMENT OF A NOVEL RESOLVIN E1 THERAPY FOR TREATMENT OF CROHN'S DISEASE | $1,570,712 | NONE | 5/2022, 8/2022, 11/2022, 3/2023, 5/2023 | 54 DANBURY ROAD SUITE 285 | RIDGEFIELD | NJ | 06877 | ||||||
| ZUCARA THERAPEUTICS | |||||||||||||||
| 1300-661 UNIVERSITY AVENUE | TORONTO | ON | CA | 2018-02-06 | $3,900,000 | PRECLINICAL DEVELOPMENT OF ZT-01 TO PREVENT HYPOGLYCEMIA IN T1D | $3,900,000 | NONE | PRIOR + 7/2021, 10/2021, 2/2022, 4/2022, 7/2022, 11/2022, 2/2023, 4/2023, 7/ | M5G 0B7 | |||||
General Explanation Attachment GeneralExplanationAttachment
General Explanation GeneralExplanationGrp (2 entries)
| IdentifierIdentifierTxt | Form And Line ReferenceFormAndLineReferenceDesc | Medium ExplanationMediumExplanationTxt |
|---|---|---|
| CONTROLLED ENTITIES | FORM 990-PF, PART VI-A, LINE 11: | THE FOLLOWING CONTROLLED ENTITIES ARE NOT EXCESS BUSINESS HOLDINGS:CHATHAM CO-INVEST26 MAIN STREET, SUITE 204CHATHAM, NJ 07928EIN# 85-0651355ESTATE OF LEONA M. HELMSLEY230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 20-7535047HELMSLEY ENTERPRISES, INC.230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 13-2665914LACM WORLD SMALL CAP EQUITY FUND, L.P.11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025EIN# 83-2888004MARATHON-LONDON GLOBAL SELECTORION HOUSE, 5 UPPER ST. MARTIN'S LANELONDON, UK WC2H 9EAEIN# 61-1915057MHR LONGEVITY PARTNERS1345 AVENUE OF THE AMERICAS 42ND FLOORNEW YORK, NY 10105EIN# 98-1471155NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER, L.P.2929 ARCH STREET 17TH FLOORPHILADELPHIA, PA 19104EIN# 98-1142649PITANGO SPVBEIT ACKERSHTEIN - BLDG. B, 11 HAMENOFIM ST. 11TH FL.HERZLIYA, ISRAELEIN# 98-1492234 |
| FORM 990-PF, PART VII, LINE 1 AND 2, COLUMN (C), COMPENSATION: | ALL REPORTED COMPENSATION AMOUNTS INCLUDE "SALARY, FEES, BONUSES AND SEVERANCE PAYMENTS RECEIVED BY EACH PERSON LISTED," AS WELL AS CURRENT YEAR PAYMENTS OF AMOUNTS REPORTED OR REPORTABLE AS DEFERRED COMPENSATION IN CURRENT OR PRIOR YEARS. |
Investments Corp Stock Schedule InvestmentsCorpStockSchedule
Investments Corporate Stock InvestmentsCorporateStockGrp (118 entries)
| StockStockNm | EOY Book ValueEOYBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|
| ALPHABET INC, 32,514 SHRS | $3,381,456 | $3,381,456 |
| AMAZON.COM INC, 62,440 SHRS | $6,449,428 | $6,449,428 |
| AMERICAN TOWER CORP, 9,313 SHRS | $1,903,018 | $1,903,018 |
| ANSYS INC, 16,010 SHRS | $5,328,128 | $5,328,128 |
| ATLASSIAN CORP, 3,724 SHRS | $637,437 | $637,437 |
| BIO-TECHNE CORP, 60,654 SHRS | $4,499,920 | $4,499,920 |
| BLACKLINE INC, 27,781 SHRS | $1,865,494 | $1,865,494 |
| CBRE GROUP INC, 65,438 SHRS | $4,764,541 | $4,764,541 |
| CABLE ONE INC, 1,885 SHRS | $1,323,270 | $1,323,270 |
| CARMAX INC, 42,075 SHRS | $2,704,581 | $2,704,581 |
| COSTAR GROUP INC, 37,037 SHRS | $2,549,997 | $2,549,997 |
| CROWDSTRIKE HOLDINGS INC, 12,929 SHRS | $1,774,635 | $1,774,635 |
| DANAHER CORP, 22,680 SHRS | $5,716,267 | $5,716,267 |
| DOLLAR GENERAL CORP, 17,420 SHRS | $3,666,213 | $3,666,213 |
| ECOLAB INC, 25,314 SHRS | $4,190,226 | $4,190,226 |
| ENDAVA PLC, 19,526 SHRS | $1,311,757 | $1,311,757 |
| FASTENAL CO, 59,691 SHRS | $3,219,733 | $3,219,733 |
| GUIDEWIRE SOFTWARE INC, 54,117 SHRS | $4,440,300 | $4,440,300 |
| HEICO CORP, 31,842 SHRS | $4,327,328 | $4,327,328 |
| IDEXX LABORATORIES INC, 2,985 SHRS | $1,492,739 | $1,492,739 |
| ILLUMINA INC, 16,733 SHRS | $3,891,259 | $3,891,259 |
| INTUITIVE SURGICAL INC, 17,554 SHRS | $4,484,520 | $4,484,520 |
| MARKEL CORP, 1,279 SHRS | $1,633,807 | $1,633,807 |
| MASTERCARD INC, 17,212 SHRS | $6,255,013 | $6,255,013 |
| MICROSOFT CORP, 16,736 SHRS | $4,824,989 | $4,824,989 |
| MOODY'S CORP, 13,298 SHRS | $4,069,454 | $4,069,454 |
| OLD DOMINION FREIGHT LINE INC, 6,551 SHRS | $2,232,843 | $2,232,843 |
| QUALCOMM INC, 32,515 SHRS | $4,148,264 | $4,148,264 |
| S&P GLOBAL INC, 16,804 SHRS | $5,793,515 | $5,793,515 |
| SBA COMMUNICATIONS CORP, 6,996 SHRS | $1,826,446 | $1,826,446 |
| SITEONE LANDSCAPE SUPPLY INC, 20,904 SHRS | $2,861,130 | $2,861,130 |
| SPROUT SOCIAL INC, 8,650 SHRS | $526,612 | $526,612 |
| THERMO FISHER SCIENTIFIC INC, 9,077 SHRS | $5,231,710 | $5,231,710 |
| TRANSDIGM GROUP INC, 8,842 SHRS | $6,516,996 | $6,516,996 |
| VEEVA SYSTEMS INC, 16,876 SHRS | $3,101,640 | $3,101,640 |
| VERISK ANALYTICS INC, 11,005 SHRS | $2,111,419 | $2,111,419 |
| VISA INC, 29,616 SHRS | $6,677,223 | $6,677,223 |
| VULCAN MATERIALS CO, 33,046 SHRS | $5,669,372 | $5,669,372 |
| WNS HOLDINGS LTD, 8,376 SHRS | $780,392 | $780,392 |
| WASTE CONNECTIONS INC, 28,069 SHRS | $3,903,556 | $3,903,556 |
| WEST PHARMACEUTICAL SERVICES I, 5,916 SHRS | $2,049,717 | $2,049,717 |
| WILLSCOT MOBILE MINI HOLDINGS, 43,251 SHRS | $2,027,607 | $2,027,607 |
| WORKIVA INC, 11,503 SHRS | $1,178,022 | $1,178,022 |
| ALPHABET INC, 72,435 SHRS | $7,513,683 | $7,513,683 |
| AVERY DENNISON CORP, 33,942 SHRS | $6,073,242 | $6,073,242 |
| BERKSHIRE HATHAWAY INC, 25,167 SHRS | $7,770,815 | $7,770,815 |
| BLACKROCK INC, 5,136 SHRS | $3,436,600 | $3,436,600 |
| BOOKING HOLDINGS INC, 3,637 SHRS | $9,646,815 | $9,646,815 |
| CDW CORP/DE, 34,555 SHRS | $6,734,424 | $6,734,424 |
| CARLISLE COS INC, 22,167 SHRS | $5,011,294 | $5,011,294 |
| CARMAX INC, 77,051 SHRS | $4,952,838 | $4,952,838 |
| DOLLAR GENERAL CORP, 32,069 SHRS | $6,749,242 | $6,749,242 |
| DOLLAR TREE INC, 39,975 SHRS | $5,738,411 | $5,738,411 |
| FRESENIUS MEDICAL CARE AG & CO, 129,576 SHRS | $2,754,786 | $2,754,786 |
| KONINKLIJKE PHILIPS NV, 209,149 SHRS | $3,837,884 | $3,837,884 |
| MASCO CORP, 121,524 SHRS | $6,042,173 | $6,042,173 |
| MICRON TECHNOLOGY INC, 106,364 SHRS | $6,418,004 | $6,418,004 |
| NORTHERN TRUST CORP, 64,709 SHRS | $5,702,804 | $5,702,804 |
| OMNICOM GROUP INC, 62,210 SHRS | $5,868,891 | $5,868,891 |
| PACCAR INC, 72,048 SHRS | $5,273,914 | $5,273,914 |
| PROGRESSIVE CORP/THE, 25,222 SHRS | $3,608,259 | $3,608,259 |
| SAP SE, 49,464 SHRS | $6,259,669 | $6,259,669 |
| SCHLUMBERGER LTD, 63,706 SHRS | $3,127,965 | $3,127,965 |
| CHARLES SCHWAB CORP/THE, 135,357 SHRS | $7,090,000 | $7,090,000 |
| SMITH & NEPHEW PLC, 149,359 SHRS | $4,168,610 | $4,168,610 |
| SONY GROUP CORP, 94,227 SHRS | $8,541,678 | $8,541,678 |
| TJX COS INC/THE, 35,452 SHRS | $2,778,019 | $2,778,019 |
| UNILEVER PLC, 101,750 SHRS | $5,283,878 | $5,283,878 |
| UNITEDHEALTH GROUP INC, 16,258 SHRS | $7,683,368 | $7,683,368 |
| ARCH CAPITAL GROUP LTD, 52,935 SHRS | $3,592,698 | $3,592,698 |
| EATON CORP PLC, 25,890 SHRS | $4,435,993 | $4,435,993 |
| FERGUSON PLC, 55,421 SHRS | $7,412,559 | $7,412,559 |
| UNILEVER PLC, 95,831 SHRS | $4,965,272 | $4,965,272 |
| NINTENDO CO LTD, 175,300 SHRS | $6,758,317 | $6,758,317 |
| RECKITT BENCKISER GROUP PLC, 67,581 SHRS | $5,145,657 | $5,145,657 |
| INFORMA PLC, 692,646 SHRS | $5,931,580 | $5,931,580 |
| GSK PLC, 342,443 SHRS | $6,050,581 | $6,050,581 |
| NOVARTIS AG, 87,389 SHRS | $8,012,372 | $8,012,372 |
| NESTLE SA, 40,044 SHRS | $4,885,670 | $4,885,670 |
| CIE FINANCIERE RICHEMONT SA, 55,725 SHRS | $8,899,652 | $8,899,652 |
| BOOKING HOLDINGS INC, 2,661 SHRS | $7,058,063 | $7,058,063 |
| BRISTOL-MYERS SQUIBB CO, 127,359 SHRS | $8,827,252 | $8,827,252 |
| CORTEVA INC, 86,257 SHRS | $5,202,160 | $5,202,160 |
| EBAY INC, 116,222 SHRS | $5,156,770 | $5,156,770 |
| ELECTRONIC ARTS INC, 49,720 SHRS | $5,988,774 | $5,988,774 |
| FOX CORP, 207,253 SHRS | $7,056,965 | $7,056,965 |
| INTERCONTINENTAL EXCHANGE INC, 53,873 SHRS | $5,618,415 | $5,618,415 |
| JOHNSON & JOHNSON, 25,557 SHRS | $3,961,335 | $3,961,335 |
| MICROSOFT CORP, 17,519 SHRS | $5,050,728 | $5,050,728 |
| NEWS CORP, 338,693 SHRS | $5,849,228 | $5,849,228 |
| NEWS CORP, 135,863 SHRS | $2,368,092 | $2,368,092 |
| ORACLE CORP, 91,710 SHRS | $8,521,693 | $8,521,693 |
| RITCHIE BROS AUCTIONEERS INC, 156,348 SHRS | $8,800,824 | $8,800,824 |
| S&P GLOBAL INC, 12,457 SHRS | $4,294,800 | $4,294,800 |
| SALESFORCE INC, 42,550 SHRS | $8,500,639 | $8,500,639 |
| TRANSUNION, 72,687 SHRS | $4,516,770 | $4,516,770 |
| ZILLOW GROUP INC, 24,908 SHRS | $1,088,480 | $1,088,480 |
| ZILLOW GROUP INC, 138,528 SHRS | $6,160,340 | $6,160,340 |
| AON PLC, 23,026 SHRS | $7,259,868 | $7,259,868 |
| CHINA RENAISSANCE HOLDINGS LTD, 127,556 SHRS | $118,132 | $118,132 |
| MEITUAN, 183,364 SHRS | $3,351,962 | $3,351,962 |
| AFFIRM HOLDINGS INC, 85,000 SHRS | $957,950 | $957,950 |
| AIRBNB INC, 28,899 SHRS | $3,595,036 | $3,595,036 |
| BILL HOLDINGS INC, 6,110 SHRS | $495,765 | $495,765 |
| CROWDSTRIKE HOLDINGS INC, 8,124 SHRS | $1,115,100 | $1,115,100 |
| DIGITALOCEAN HOLDINGS INC, 19,878 SHRS | $778,621 | $778,621 |
| DOORDASH INC, 22,663 SHRS | $1,440,460 | $1,440,460 |
| META PLATFORMS INC, 10,000 SHRS | $2,119,400 | $2,119,400 |
| GUARDANT HEALTH INC, 4,000 SHRS | $93,760 | $93,760 |
| LYFT INC, 17,155 SHRS | $159,027 | $159,027 |
| PDD HOLDINGS INC, 191,556 SHRS | $14,539,100 | $14,539,100 |
| ROBLOX CORP, 72,000 SHRS | $3,238,560 | $3,238,560 |
| SENTINELONE INC, 23,937 SHRS | $391,609 | $391,609 |
| SNOWFLAKE INC, 11,358 SHRS | $1,752,426 | $1,752,426 |
| UBER TECHNOLOGIES INC, 22,578 SHRS | $715,723 | $715,723 |
| UIPATH INC, 155,893 SHRS | $2,737,481 | $2,737,481 |
| ZOOM VIDEO COMMUNICATIONS INC, 11,000 SHRS | $812,240 | $812,240 |
| NU HOLDINGS LTD/CAYMAN ISLANDS, 338,840 SHRS | $1,612,878 | $1,612,878 |
Investments Other Schedule2 InvestmentsOtherSchedule2
Investments Other InvestmentsOtherGrp (188 entries)
| Category Or ItemCategoryOrItemTxt | Listed At Cost Or FMVListedAtCostOrFMVCd | Book ValueBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|---|
| JPM US LARGE CAP | FMV | $89,887,853 | $89,887,853 |
| SPDR TRUST SERIES I | FMV | $112,725,127 | $112,725,127 |
| JPM CORE BOND | FMV | $1,275,527,805 | $1,275,527,805 |
| JPM SHORT DURATION BOND | FMV | $358,827,222 | $358,827,222 |
| CHATHAM | FMV | $110,403,032 | $110,403,032 |
| CHATHAM OFFSHORE | FMV | $108,855,967 | $108,855,967 |
| CAMBER | FMV | $125,446,113 | $125,446,113 |
| ORBIMED GENESIS FUND | FMV | $36,492,369 | $36,492,369 |
| JERICHO | FMV | $162,925,513 | $162,925,513 |
| SEQUOIA CAP GLOBAL | FMV | $159,113,105 | $159,113,105 |
| BLACKROCK US DEBT | FMV | $220,413,634 | $220,413,634 |
| ACADIAN FRONTIER | FMV | $8,586,357 | $8,586,357 |
| HIGHCLERE INTL SC | FMV | $122,902,800 | $122,902,800 |
| HIGHCLERE INTL SMID | FMV | $63,832,240 | $63,832,240 |
| LA CAPITAL GLOBAL | FMV | $79,280,835 | $79,280,835 |
| LACM WORLD SMALL CAP | FMV | $79,786,302 | $79,786,302 |
| MARATHON GLOBAL | FMV | $104,282,397 | $104,282,397 |
| SILCHESTER INTL | FMV | $132,194,805 | $132,194,805 |
| BAYVIEW | FMV | $995,218 | $995,218 |
| EIG ENERGY FUND XVI | FMV | $43,841,076 | $43,841,076 |
| EIG ENERGY XV | FMV | $6,046,353 | $6,046,353 |
| FDAF DISLOCATED II | FMV | $31,319,465 | $31,319,465 |
| FDAF DISLOCATED III | FMV | $40,161,460 | $40,161,460 |
| FDAF DISLOCATED IV | FMV | $29,173,276 | $29,173,276 |
| GSO CAP SOLUTION III | FMV | $5,494,379 | $5,494,379 |
| GSO CAPITAL SOLS II | FMV | $2,731,586 | $2,731,586 |
| HIG BAYSIDE III | FMV | $3,888,027 | $3,888,027 |
| MHR INST PARTNERS IV | FMV | $65,625,654 | $65,625,654 |
| MHR AXIOM | FMV | $180,117,878 | $180,117,878 |
| NEWMARKET IIFC | FMV | $19,881,377 | $19,881,377 |
| ORBIMED ROYALTY II | FMV | $1,818,353 | $1,818,353 |
| ACCEL GROWTH FUND IV | FMV | $23,306,105 | $23,306,105 |
| ACCEL GROWTH II | FMV | $11,525,805 | $11,525,805 |
| ACCEL GROWTH III | FMV | $14,062,197 | $14,062,197 |
| ACCEL GROWTH V | FMV | $30,856,064 | $30,856,064 |
| ACCEL GROWTH VI | FMV | $11,116,513 | $11,116,513 |
| ACCEL INDIA V | FMV | $13,627,732 | $13,627,732 |
| ACCEL INDIA VI | FMV | $9,007,512 | $9,007,512 |
| ACCEL INDIA VII | FMV | $1,445,976 | $1,445,976 |
| ACCEL LEADERS FUND | FMV | $8,403,924 | $8,403,924 |
| ACCEL LEADERS II | FMV | $8,298,931 | $8,298,931 |
| ACCEL LEADERS III | FMV | $24,969,812 | $24,969,812 |
| ACCEL XI | FMV | $6,436,480 | $6,436,480 |
| ACCEL XII | FMV | $20,600,164 | $20,600,164 |
| ACCEL XIII | FMV | $15,293,694 | $15,293,694 |
| ACCEL XIV | FMV | $9,478,212 | $9,478,212 |
| ACCEL XV | FMV | $4,127,349 | $4,127,349 |
| AH BIO FUND I | FMV | $8,001,820 | $8,001,820 |
| AH BIO FUND II | FMV | $16,525,099 | $16,525,099 |
| AH BIO III | FMV | $16,135,427 | $16,135,427 |
| AH BIO IV | FMV | $1,633,128 | $1,633,128 |
| AH CNK IV | FMV | $3,542,478 | $3,542,478 |
| AH CNK SEED I | FMV | $1,381,507 | $1,381,507 |
| AH FUND VII | FMV | $11,579,104 | $11,579,104 |
| AH FUND VIII | FMV | $2,054,633 | $2,054,633 |
| AH III | FMV | $34,421,513 | $34,421,513 |
| AH III PARALLEL | FMV | $6,537,207 | $6,537,207 |
| AH IV | FMV | $36,119,833 | $36,119,833 |
| AH IV PARALLEL | FMV | $15,175,771 | $15,175,771 |
| AH LSV FUND II | FMV | $18,761,485 | $18,761,485 |
| AH LSV FUND III | FMV | $8,558,632 | $8,558,632 |
| AH LSV I | FMV | $18,115,427 | $18,115,427 |
| AH V | FMV | $43,552,481 | $43,552,481 |
| AH V PARALLEL | FMV | $22,036,088 | $22,036,088 |
| AH VI | FMV | $27,983,122 | $27,983,122 |
| ANGELENO INV III | FMV | $18,452,053 | $18,452,053 |
| ARBORETUM III | FMV | $4,460,534 | $4,460,534 |
| ARBORETUM IV | FMV | $20,124,269 | $20,124,269 |
| ARBORETUM V | FMV | $16,318,215 | $16,318,215 |
| ARBORETUM VI | FMV | $405,367 | $405,367 |
| COLLER VI | FMV | $5,196,586 | $5,196,586 |
| COLLER VII | FMV | $29,003,442 | $29,003,442 |
| COLLER VIII | FMV | $25,169,457 | $25,169,457 |
| CONGRUENT CONTINUITY | FMV | $6,433,756 | $6,433,756 |
| CRESTVIEW ELO | FMV | $11,498,951 | $11,498,951 |
| CRESTVIEW III | FMV | $42,364,783 | $42,364,783 |
| CRESTVIEW IV | FMV | $26,969,399 | $26,969,399 |
| EIG ENERGY XVII | FMV | $12,533,917 | $12,533,917 |
| EMERGENCE III | FMV | $59,036,371 | $59,036,371 |
| EMERGENCE IV | FMV | $32,038,902 | $32,038,902 |
| EMERGENCE OPP I | FMV | $6,419,545 | $6,419,545 |
| EMERGENCE V | FMV | $26,452,742 | $26,452,742 |
| EMERGENCE VI | FMV | $3,844,612 | $3,844,612 |
| EPIRIS ELEC CO INV | FMV | $11,433,291 | $11,433,291 |
| EPIRIS II | FMV | $23,727,202 | $23,727,202 |
| EPIRIS III | FMV | $14,650,108 | $14,650,108 |
| FORTISSIMO IV | FMV | $28,048,549 | $28,048,549 |
| FORTISSIMO V | FMV | $20,602,148 | $20,602,148 |
| FRAZIER GTH BUYOUT X | FMV | $8,367,762 | $8,367,762 |
| FRAZIER IX | FMV | $7,560,219 | $7,560,219 |
| FRAZIER OVERAGE | FMV | $3,944,391 | $3,944,391 |
| FRAZIER PUBLIC FUND | FMV | $14,574,138 | $14,574,138 |
| FRAZIER SUNMD CO INV | FMV | $6,000,000 | $6,000,000 |
| FRAZIER X | FMV | $12,212,810 | $12,212,810 |
| FRAZIER XI | FMV | $2,049,716 | $2,049,716 |
| GAVEA IV | FMV | $1,534,310 | $1,534,310 |
| GAVEA V | FMV | $2,971,242 | $2,971,242 |
| GAVEA V PLUS | FMV | $961,041 | $961,041 |
| GENERL ATLANTIC 2013 | FMV | $71,292,650 | $71,292,650 |
| GENERL ATLANTIC 2018 | FMV | $91,410,994 | $91,410,994 |
| HIG BIOVENTURE II | FMV | $14,753,715 | $14,753,715 |
| HIG BRAZIL | FMV | $3,241,268 | $3,241,268 |
| HIG BRAZIL LATAM B | FMV | $19,618,616 | $19,618,616 |
| HIG BRAZIL LATAM C | FMV | $19,618,616 | $19,618,616 |
| HIG CAPITAL V | FMV | $13,303,155 | $13,303,155 |
| HIG GROWTH B&E F II | FMV | $17,091,289 | $17,091,289 |
| HIG GROWTH III | FMV | $4,250,306 | $4,250,306 |
| HIG MID MARKET II | FMV | $19,315,641 | $19,315,641 |
| HIG MID MARKET III | FMV | $16,819,112 | $16,819,112 |
| IDG BREYER | FMV | $6,289,258 | $6,289,258 |
| IDG CHINA CAP III | FMV | $31,294,212 | $31,294,212 |
| IDG CHINA VTR IV | FMV | $37,847,043 | $37,847,043 |
| IDG CHINA VTR V | FMV | $43,351,289 | $43,351,289 |
| IDG-ACCEL CHINA CAP | FMV | $16,259,701 | $16,259,701 |
| IDG-ACCEL CHINA GWTH | FMV | $17,903,730 | $17,903,730 |
| IRON POINT IV | FMV | $20,712,705 | $20,712,705 |
| JPM PEG SECONDRY III | FMV | $6,280,144 | $6,280,144 |
| ORBIMED ASIA III | FMV | $54,142,529 | $54,142,529 |
| ORBIMED ASIA IV | FMV | $17,375,333 | $17,375,333 |
| ORBIMED ISRAEL | FMV | $6,273,845 | $6,273,845 |
| ORBIMED ISRAEL II | FMV | $20,517,862 | $20,517,862 |
| ORBIMED PI IX | FMV | $960,558 | $960,558 |
| ORBIMED PI VI | FMV | $10,180,145 | $10,180,145 |
| ORBIMED PI VII | FMV | $25,368,476 | $25,368,476 |
| ORBIMED PI VIII | FMV | $16,357,264 | $16,357,264 |
| ORBMIED ASIA V | FMV | $901,247 | $901,247 |
| PEP IV CORE | FMV | $20,908 | $20,908 |
| PEP IV SUPPL | FMV | $5,093 | $5,093 |
| PEP VI | FMV | $12,898,545 | $12,898,545 |
| PITANGO GROWTH | FMV | $59,461,225 | $59,461,225 |
| PITANGO GROWTH II | FMV | $19,989,681 | $19,989,681 |
| PITANGO HEALTHTECH I | FMV | $11,088,645 | $11,088,645 |
| PITANGO SPV | FMV | $21,871,504 | $21,871,504 |
| PITANGO VI, LP | FMV | $28,795,364 | $28,795,364 |
| PITANGO VTR VII | FMV | $35,656,703 | $35,656,703 |
| PITANGO VTR VIII | FMV | $14,198,006 | $14,198,006 |
| RIDGEWOOD III | FMV | $44,869,309 | $44,869,309 |
| RIDGEWOOD IV | FMV | $28,696,697 | $28,696,697 |
| S CAPITAL | FMV | $28,544,455 | $28,544,455 |
| S CAPITAL II | FMV | $12,164,961 | $12,164,961 |
| S CAPITAL III | FMV | $388,428 | $388,428 |
| SCF LIQUID PORTFOLIO | FMV | $27,524,885 | $27,524,885 |
| SEQUOIA CH GWTH VI | FMV | $20,303,939 | $20,303,939 |
| SEQUOIA CH VTR IX | FMV | $577,864 | $577,864 |
| SEQUOIA CH VTR VIII | FMV | $4,178,822 | $4,178,822 |
| SEQUOIA CHINA GR III | FMV | $97,694,383 | $97,694,383 |
| SEQUOIA CHINA GR IV | FMV | $25,069,894 | $25,069,894 |
| SEQUOIA CHINA GRTH V | FMV | $31,408,680 | $31,408,680 |
| SEQUOIA CHINA VE VII | FMV | $6,175,889 | $6,175,889 |
| SEQUOIA CHINA VTR IV | FMV | $7,986,024 | $7,986,024 |
| SEQUOIA CHINA VTR V | FMV | $9,003,849 | $9,003,849 |
| SEQUOIA CHINA VTR VI | FMV | $7,209,166 | $7,209,166 |
| SEQUOIA GBL GRTH III | FMV | $105,050,777 | $105,050,777 |
| SEQUOIA GG 3 CH ANX | FMV | $11,510,178 | $11,510,178 |
| SEQUOIA GLB GROWTH | FMV | $28,821,426 | $28,821,426 |
| SEQUOIA GLB GRWTH II | FMV | $43,970,010 | $43,970,010 |
| SEQUOIA IND GWT IV | FMV | $551,014 | $551,014 |
| SEQUOIA IND GWTH III | FMV | $10,109,448 | $10,109,448 |
| SEQUOIA IND VTR VII | FMV | $2,697,610 | $2,697,610 |
| SEQUOIA INDIA V | FMV | $12,012,935 | $12,012,935 |
| SEQUOIA INDIA VI | FMV | $10,886,516 | $10,886,516 |
| SEQUOIA INDIA VIII | FMV | $548,857 | $548,857 |
| SEQUOIA ISRAEL V | FMV | $5,870,937 | $5,870,937 |
| SEQUOIA SCOUT III | FMV | $2,216,538 | $2,216,538 |
| SEQUOIA SCOUT IV | FMV | $1,008,155 | $1,008,155 |
| SEQUOIA SEA I | FMV | $1,223,188 | $1,223,188 |
| SEQUOIA US ECO I | FMV | $195,389 | $195,389 |
| SEQUOIA US EXP I | FMV | $1,952,416 | $1,952,416 |
| SEQUOIA US GROWTH V | FMV | $1,157,680 | $1,157,680 |
| SEQUOIA US GRTH VIII | FMV | $12,172,711 | $12,172,711 |
| SEQUOIA US GRWTH VII | FMV | $8,803,688 | $8,803,688 |
| SEQUOIA US GWTH IX | FMV | $7,332,439 | $7,332,439 |
| SEQUOIA US GWTH VI | FMV | $5,642,511 | $5,642,511 |
| SEQUOIA US GWTH X | FMV | $120,686 | $120,686 |
| SEQUOIA US VENT XVI | FMV | $7,404,060 | $7,404,060 |
| SEQUOIA US VTR XIV | FMV | $13,842,026 | $13,842,026 |
| SEQUOIA US VTR XV | FMV | $4,674,483 | $4,674,483 |
| SEQUOIA US VTR XVII | FMV | $2,757,453 | $2,757,453 |
| SQUOIA GG 3 US IN AX | FMV | $12,369,891 | $12,369,891 |
| STARWOOD X | FMV | $20,971,322 | $20,971,322 |
| STARWOOD XI | FMV | $39,460,847 | $39,460,847 |
| STARWOOD XII | FMV | $10,877,498 | $10,877,498 |
| TAURUS RESOURCES II | FMV | $44,794,352 | $44,794,352 |
| WTI VLL IX | FMV | $17,073,600 | $17,073,600 |
| WTI VLL VII | FMV | $8,812,400 | $8,812,400 |
| WTI VLL VIII | FMV | $16,243,990 | $16,243,990 |
| WTI VLL X | FMV | $4,206,969 | $4,206,969 |
| YORK CO INVEST 1 | FMV | $1,314,740 | $1,314,740 |
Land Etc Schedule2 LandEtcSchedule2
Land Etc LandEtcGrp (3 entries)
| Category Or ItemCategoryOrItemTxt | Cost Or Other BasisCostOrOtherBasisAmt | Accumulated DepreciationAccumulatedDepreciationAmt | Book ValueBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|---|---|
| FURNITURE, FIXTURES AND EQUIPMENT | $2,745,200 | $1,679,582 | $1,065,618 | $1,065,618 |
| LEASEHOLD IMPROVEMENTS | $7,160,401 | $1,365,827 | $5,794,574 | $5,794,574 |
| WORK IN PROGRESS | $30,127 | $0 | $30,127 | $30,127 |
Legal Fees Schedule LegalFeesSchedule
Legal Fees LegalFeesGrp (5 entries)
| CategoryCategoryTxt | Legal FeesLegalFeesAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| HAROLD A MERIAM III (INVESTMENT RELATED) | $18,879 | $18,879 | $0 |
| LOEB & LOEB LLP (GENERAL AND ADMINISTRATIVE) | $76,950 | $0 | $89,475 |
| ROPES & GRAY LLP (INVESTMENT RELATED) | $130,533 | $130,533 | $0 |
| PATTERSON BELKNAP WEBB & TYLER LLP (GENERAL & ADMINISTRATIVE) | $226,572 | $0 | $182,279 |
| OTHER LEGAL FEES | $35,896 | $0 | $27,012 |
Other Assets Schedule OtherAssetsSchedule
Other Assets Schedule OtherAssetsScheduleGrp (7 entries)
| DescDesc | BOY Book ValueBOYBookValueAmt | EOY Book ValueEOYBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|---|
| ACCRUED INCOME RECEIVABLE | $1,399,923 | $1,995,290 | $1,995,290 |
| DUE FROM BROKER | $107,058,082 | $12,161,295 | $12,161,295 |
| RETIREMENT PLAN ASSET | $1,898,891 | $1,969,036 | $1,969,036 |
| ADVANCES AND OTHER RECEIVABLES | $22,058 | $64,252 | $64,252 |
| PREPAID FEDERAL EXCISE TAX | $2,228,391 | $5,573,002 | $5,573,002 |
| PROGRAM RELATED INVESTMENTS | $20,909,674 | $25,653,304 | $25,653,304 |
| OPERATING LEASE RIGHT OF USE ASSET | $8,596,861 | $8,596,861 |
Other Decreases Schedule OtherDecreasesSchedule
Other Decreases Detail OtherDecreasesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | UNREALIZED LOSS ON INVESTMENTS | Desc |
| Amt | $1,092,751,571 | Amt |
Other Expenses Schedule OtherExpensesSchedule
Other Expenses Schedule OtherExpensesScheduleGrp (8 entries)
| DescDesc | Revenue And Expenses Per BooksRevenueAndExpensesPerBooksAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| AMERICAN DEPOSITARY RECEIPT FEE | $14,759 | $14,759 | $0 |
| CONSULTING REIMBURSEMENTS | $126,833 | $0 | $106,618 |
| CUSTODY, BANK, & PERFORMANCE REPORTING FEES | $828,583 | $828,528 | $55 |
| FILING FEES AND PENALTIES | $2,926 | $0 | $4,539 |
| INFORMATION TECHNOLOGY/COMPUTERS | $1,608,732 | $259,091 | $1,489,125 |
| INSURANCE | $393,802 | $46,136 | $348,004 |
| OFFICE EXPENSES | $1,009,161 | $345,552 | $684,777 |
| PORTFOLIO DEDUCTIONS | $13,280,837 | $51,667,723 | $0 |
Other Income Schedule2 OtherIncomeSchedule2
Other Income Detail OtherIncomeDetail (6 entries)
| DescDesc | Revenue And Expenses Per BooksRevenueAndExpensesPerBooksAmt | Net Investment IncomeNetInvestmentIncomeAmt | Adjusted Net IncomeAdjustedNetIncomeAmt |
|---|---|---|---|
| FX TRANSACTION NET LOSS | -$3,721,210 | -$3,793,103 | -$3,721,210 |
| CLASS ACTION PROCEEDS, NET | $17,056 | $17,056 | $17,056 |
| OTHER PARTNERSHIP INCOME | $40,911,519 | $37,759,358 | $40,911,519 |
| SECTION 951(A) INCOME INCLUSION | $4,671,829 | ||
| GRANT RECOVERIES | $500 | $500 | |
| OTHER NON-TAXABLE INCOME | $14,795 | $14,795 |
Other Increases Schedule OtherIncreasesSchedule
Other Increases Detail OtherIncreasesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | DEFERRED FEDERAL EXCISE TAX BENEFIT | Desc |
| Amt | $15,189,247 | Amt |
Other Liabilities Schedule OtherLiabilitiesSchedule
Other Liabilities Detail OtherLiabilitiesDetail (7 entries)
| DescDesc | BOY Book ValueBOYBookValueAmt | EOY Book ValueEOYBookValueAmt |
|---|---|---|
| DEFERRED FEDERAL EXCISE TAX | $37,437,887 | $22,248,640 |
| RETIREMENT PLAN LIABILITY | $2,509,260 | $2,748,166 |
| ACCRUED VACATION | $1,452,558 | $890,327 |
| DEFERRED RENT EXPENSE | $560,586 | $0 |
| REFUNDABLE DEPOSITS | $319 | $0 |
| GRANT REFUNDS PENDING MODIFICATION | $1,005,850 | $6,355,762 |
| OPERATING LEASE LIABILITIES | $0 | $9,441,992 |
Other Professional Fees Schedule OtherProfessionalFeesSchedule
Other Professional Fees Detail OtherProfessionalFeesDetail (29 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| CETERA SERVICES LLC (PROGRAM CONSULTING) | $98,098 | $0 | $87,359 |
| COLLER VI (INVESTMENT MANAGEMENT) | $369,475 | $369,475 | $0 |
| COLLER VII (INVESTMENT MANAGEMENT) | $463,217 | $463,217 | $0 |
| DF DENT & COMPANY, INC. (INVESTMENT MANAGEMENT) | $630,200 | $630,200 | $0 |
| FIDUCIARY MANAGEMENT, INC. (INVESTMENT MANAGEMENT) | $645,119 | $645,119 | $0 |
| GAVEA INVESTMENT FUND V B L.P. (INVESTMENT MANAGEMENT) | $1,069,010 | $1,069,010 | $0 |
| GAVEA V PLUS (INVESTMENT MANAGEMENT) | $51,077 | $51,077 | $0 |
| GENESIS ANALYTICS (PROGRAM CONSULTING) | $101,960 | $0 | $151,960 |
| GLOBAL HEALTH STRATEGIES (PROGRAM CONSULTING) | $601,417 | $0 | $558,754 |
| GLOBAL STRATEGY GROUP LLC (PUBLIC RELATIONS) | $300,000 | $0 | $325,000 |
| IFP GLOBAL EQUITY LP (INVESTMENT MANAGEMENT) | $1,080,516 | $1,080,516 | $0 |
| IMM PRODUCTIONS INC. (PUBLIC RELATIONS) | $51,401 | $0 | $29,701 |
| LEAH WEST (PROGRAM CONSULTING) | $67,200 | $0 | $68,800 |
| NGOSOURCE (GRANTS MANAGEMENT CONSULTING) | $98,390 | $0 | $94,915 |
| OTHER CONSULTING FEES - GENERAL MANAGEMENT | $143,654 | $3,960 | $138,660 |
| OTHER CONSULTING FEES - GRANTS MANAGEMENT | $78,340 | $0 | $78,454 |
| OTHER CONSULTING FEES - HUMAN RESOURCES | $81,321 | $4,250 | $60,271 |
| OTHER CONSULTING FEES - INFORMATION TECHNOLOGY | $11,009 | $0 | $16,569 |
| OTHER INVESTMENT MANAGEMENT & CONSULTING FEES | $2,215 | $2,215 | $0 |
| OTHER PROGRAM RELATED CONSULTING FEES | $230,211 | $0 | $230,433 |
| OTHER PUBLIC RELATIONS CONSULTING FEES | $21,718 | $0 | $18,312 |
| OTHER RECRUITMENT FEES | $85,778 | $0 | $81,835 |
| PRECISION ADVISORS, LLC DBA PRECISION FOR VALUE, LLC (PROGRAM CONSULTING) | $79,656 | $0 | $68,040 |
| SCISTORIES LLC (PUBLIC RELATIONS) | $175,000 | $0 | $173,275 |
| SOLUTION SIMPLE (INFORMATION TECHNOLOGY) | $342,684 | $38,705 | $271,914 |
| STARWOOD X (INVESTMENT MANAGEMENT) | $4,022,881 | $4,022,881 | $0 |
| THE FORWARD GROUP (PROGRAM CONSULTING) | $87,040 | $0 | $87,040 |
| T. ROWE PRICE ASSOCIATES INC. (INVESTMENT MANAGEMENT) | $902,581 | $902,581 | $0 |
| WILSHIRE ASSOCIATES INCORPORATED (INVESTMENT ADVISORY) | $465,953 | $465,953 | $0 |
Taxes Schedule TaxesSchedule
Taxes Detail TaxesDetail (4 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| STATE UBI AND OTHER TAXES | $2,144,102 | $0 | $0 |
| FOREIGN TAXES WITHHELD | $539,426 | $2,824,376 | $0 |
| FEDERAL EXCISE TAX | $11,955,389 | $0 | $0 |
| FEDERAL UNRELATED BUSINESS INCOME TAX | $2,540,000 | $0 | $0 |
Transfers Frm Controlled Entities TransfersFrmControlledEntities
Transfers From Controlled Ent TransfersFromControlledEntGrp (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | DescDesc | AmtAmt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|
| CHATHAM CO-INVEST | |||||||
| 26 MAIN STREET SUITE 204 | CHATHAM | NJ | 07928 | 850651355 | DISTRIBUTION FROM PARTNERSHIP | $0 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | |||||||
| 11150 SANTA MONICA BLVD STE 200 | LOS ANGELES | CA | 90025 | 832888004 | DISTRIBUTION FROM PARTNERSHIP | $0 | |
| MHR LONGEVITY PARTNERS | |||||||
| 1345 AVENUE OF THE AMERICAS 42ND | NEW YORK | NY | 10105 | 981471155 | DISTRIBUTION FROM PARTNERSHIP | $52,819,565 | FLOOR |
| NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP | |||||||
| 2929 ARCH STREET 17TH FLOOR | PHILADELPHIA | PA | 19104 | 981142649 | DISTRIBUTION | $489,903 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $121,088,689 | TotalAmt |
Transfers To Controlled Entities TransfersToControlledEntities
Transfers To Controlled Ent TransfersToControlledEntGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | DescDesc | AmtAmt |
|---|---|---|---|---|---|---|---|
| MHR LONGEVITY PARTNERS | |||||||
| 1345 AVENUE OF THE AMERICAS 42ND | FLOOR | NEW YORK | NY | 10105 | 981471155 | CONTRIBUTION OF CAPITAL | $52,819,565 |
| NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP | |||||||
| 2929 ARCH STREET 17TH FLOOR | PHILADELPHIA | PA | 19104 | 981142649 | CONTRIBUTION OF CAPITAL | $489,903 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $53,309,468 | TotalAmt |